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General. All reactions were carried out under Ar in flame-dried glassware. The solvents were purified 
by distillation over the drying agents indicated and were transferred under Ar: THF, Et2O 
(Mg/anthracene), CH2Cl2 (CaH2), 1,4-dioxane (Na/K alloy), MeOH (Mg). DMF, pyridine and NEt3 were 
dried by an absorption solvent purification system based on molecular sieves. iPr2NH was purified by 
distillation over CaH2 and transferred under Ar. CH3NO2 was used in technical grade quality. Flash 
chromatography: Merck silica gel 60 (40–63 μm). NMR: Spectra were recorded on Bruker AV 400, 
Bruker AV 500 or Bruker AV 600 spectrometers in the solvents indicated; chemical shifts (δ) are given 
in ppm relative to TMS, coupling constants (J) in Hz. The solvent signals were used as references and 
the chemical shifts converted to the TMS scale (CDCl3: residual CHCl3 in CDCl3: δC ≡ 77.16 ppm; δH ≡ 
7.26 ppm; [D6]-DMSO: residual [D5]-DMSO in [D6]-DMSO δC ≡ 39.52 ppm; δH ≡ 2.50 ppm) IR: Spectrum 
One (Perkin-Elmer) spectrometer, wavenumbers ?̃? in cm-1. MS (EI): Finnigan MAT 8200 (70 eV), ESI-
MS: ESQ 3000 (Bruker), accurate mass determinations: Bruker APEX III FT-MS (7 T magnet) or MAT 95 
(Finnigan). Unless stated otherwise, all commercially available compounds (ABCR, Acros, Aldrich, 








were prepared according to literature procedures. 
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Table S-1. Comparison of the 13C NMR Spectra (ppm) recorded in [D4]-MeOH of 
Epipyrone A (NP)[a] with synthetic (20S,22R)-2, (22S,20S)-2, (22R,20R)-2 and 
(20R,22S)-2; arbitrary numbering scheme as shown; signals marked * and ** 
have been mutually interchanged;[b]  = shift (synth. sample – NP) 












1 166,2* 166,2 0,0 166,3 0,1 166.2 0,0 166.2 0,0 
2 101,5 101,9 0,4 101,9 0,4 101.9 0,4 101.9 0,4 
3 171,1* 170,6 -0,5 170,5 -0,6 170.4 -0,7 170.4 -0,7 
4 102,4 102,5 0,1 102,4 0,0 102.3 -0,1 102.3 -0,1 
5 160,0 160,7 0,7 160,7 0,7 160.8 0,8 160.8 0,8 
6 122,5 122,6 0,1 122,6 0,1 122.6 0,1 122.6 0,1 
7 137,5 137,6 0,1 137,6 0,1 137.6 0,1 137.6 0,1 
8 132,0 132,3 0,3 132,3 0,3 132.3 0,3 132.3 0,3 
9 140,5 140,6 0,1 140,6 0,1 140.6 0,1 140.6 0,1 
10 132,4** 133,7 1.3 133,7 1,3 133.6 1,2 133.7 1,3 
11 138,2 138,1 -0,1 138,1 -0,1 138.1 -0,1 138.2 0,0 
12 134,0 134,1 0,1 134,1 0,1 134.1 0,1 134.1 0,1 
13 137,0 137,1 0,1 137,1 0,1 137.1 0,1 137.1 0,1 
14 130,2** 130,1 -0,1 130,2 0,0 130.2 0,0 130.2 0,0 
15 140,5 140,4 -0,1 140,4 -0,1 140.4 -0,1 140.4 -0,1 
16 137,5 136,7 -0,8 136,7 -0,8 136.7 -0,8 136.7 -0,8 
17 131,5 131,5 0,0 131,4 -0,1 131.4 -0,1 131.5 0,0 
18 132,0 132,1 0,1 132,4 0,4 132.4 0,4 132.0 0,0 
19 149,0 149,2 0,2 149,1 0,1 149.1 0,1 149.3 0,3 
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20 33,3 33,1 -0,2 33,2 -0,1 33.2 -0,1 33.1 -0,2 
21 46,1 45,8 -0,3 45,9 -0,2 45.9 -0,2 45.8 -0,3 
22 34,0 33,5 -0,5 33,9 -0,1 33.9 -0,1 33.5 -0,5 
23 31,4 30,3 -1,1 31,3 -0,1 31.3 -0,1 30.3 -1,1 
24 11,8 11,6 -0,2 11,8 0,0 11.7 -0,1 11.6 -0,2 
25 19,5 20,0 0,5 19,6 0,1 19.6 0,1 20.0 0,5 
26 22,0 21,1 -0,9 21,8 -0,2 21.8 -0,2 21.1 -0,9 
27 172,3 172,2 -0,1 172,2 -0,1 172.1 -0,2 172.1 -0,2 
28 14,0 13,8 -0,2 13,8 -0,2 13.8 -0,2 13.8 -0,2 
29 76,7 76,5 -0,2 76,5 -0,2 76.5 -0,2 76.5 -0,2 
30 70,5 70,5 0,0 70,4 -0,1 70.4 -0,1 70.5 0,0 
31 76,8 76,7 -0,1 76,6 -0,2 76.6 -0,2 76.6 -0,2 
32 71,3 71,1 -0,2 71,2 -0,1 71.2 -0,1 71.1 -0,2 
33 81,0 81,1 0,1 81,0 0,0 81.1 0,1 81.1 0,1 
34 62,9 62,8 -0,1 62,9 0,0 62.9 0,0 62.8 -0,1 
          
[][c] +27.8 +147.1  +14.2  44.0  118.4  
 
[a] C. Calder, S. Ford, A. I. Selwood, R. v. Ginkel, A. L. Wilkins, WO 2012/023865 A1;  
[b] As the signal assignment for the synthetic samples is unambiguous, we assume that the signals of C1/C3 and C10/14 are mutually interchanged in the 
literature 
[c] [𝑎]D
20 (c = 0.05, MeOH)  
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Table S-2. Comparison of the 13C NMR Spectra (ppm) recorded in [D6]-DMSO of 
putative Orevactaene (NP)[a] with synthetic (20S,22R)-2, (22S,20S)-2, (22R,20R)-2 and 
(20R,22S)-2; arbitrary numbering scheme as shown; signals marked * and ** have 












1 162.2* 162,3 0,1 162,2 0,0 162.2 0,0 162.3 0,1 
2 101.4 101,4 0,0 101,4 0,0 101.4 0,0 101.4 0,0 
3 167.6* 167,2 -0,4 167,0 -0,6 167.1 -0,5 167.1 -0.5 
4 101.6 101,4 0,2 101,3 -0,3 101.3 -0,3 101.3 -0,3 
5 157.8 157,7 0,1 157,8 0,0 157.7 -0,1 157.7 -0,1 
6 122.5 122,3 0,2 122,3 -0,2 122.3 -0,2 122.3 -0,2 
7 134.7 134,6 0,1 134,7 0,0 134.7 0,0 134.7 0,0 
8 131.8 131,4 0,4 131,9 0,1 131.4 -0,4 131.4 -0,4 
9 138.7 138,5 0,2 138,6 -0,1 138.5 -0,2 138.5 -0,2 
10 132.8** 132,6 -0,2     132.6 -0,2 132.6 -0,2 
11 136.4 136,2 0,2     136.2 -0,2 136.2 -0,2 
12 133.1 132,9 0,2     132.9 -0,2 132.9 -0,2 
13 135.5 135,4 0,1     135.4 -0,1 135.4 -0,1 
14 129.0** 128,8 -0,2     128.8 -0,2 128.8 -0,2 
15 139.1 138,9 0,2 138,9 -0,2 138.9 -0,2 138.9 -0,2 
16 134.7 134,6 0,1 134,5 -0,2 134.5 -0,2 134.6 -0,1 
17 130.6 130,4 0,2 130,4 -0,2 130.4 -0,2 130.4 -0,2 
18 131.4 130,8 0,6 131,2 -0,2 131.4 0,0 130.8 -0,6 
19 146.7 146,7 0,0 146,5 -0,2 146.5 -0,2 146.7 0,0 
20 31.5 31,3 0,2 31,3 -0,2 31.3 -0,2 31.3 -0,2 
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21 44.1 43,0 1,1 43,9 -0,2 43.9 -0,2 43.8 -0,3 
22 32.2 31,6 0,6 32,0 -0,2 32,0 -0,2 31.6 -0,6 
23 29.7 28,4 1,3 29,6 -0,1 29.6 -0,1 28.5 -1,2 
24 11.3 10,9 0,4 11.1 -0,2 11.1 -0,2 11.0 -0,3 
25 18.9 19,3 -0,4 18,8 -0,1 18.8 -0,1 19.4 0,5 
26 21.4 20,5 0,9 21,3 -0,1 21.3 -0,1 20.5 -0,9 
27 169.6 169,4 0,2 169,4 -0,2 169.4 -0,2 169.4 -0,2 
28 13.3 13,1 0,2 13,1 -0,2 13.1 -0,2 13.1 -0,2 
29 74.5 74,4 0,1 74,3 -0,2 74.4 -0,1 74.4 -0,1 
30 67.9 67,9 0,0 67,9 0,0 67.9 0,0 67.9 0,0 
31 75.3 75,0 0,3 75,0 -0,3 75.0 -0,3 75.0 -0,3 
32 69.1 68,9 0,2 68,9 -0,2 68.9 -0,2 68.9 -0,2 
33 79.3 79,1 0,2 79,1 -0,2 79.1 -0,2 79.1 -0,2 
34 60.9 60,7 0,2 60,7 -0,2 60.7 -0,2 60.7 -0,2 
          
 
[a] Y.-Z. Shu, Q. Ye, H. Li, K. F. Kadow, R. A. Hussain, S. Huang, D. R. Gustavson, S. E. Lowe, L.-P. Chang, D. M. Pirnik, K. Kodukula, Bioorg. Med. Chem. Lett. 1997, 
7, 2295-2298. 





Table S-3. Comparison of the 1H NMR Spectra (ppm) recorded in [D4]-MeOH of 
epipyrone A (NP)[b] with synthetic (20S,22R)-2, (22S,20S)-2 (part I) as well as with 





4 6.08 (s, 1H) 6.08 (s, 1H) 6.08 (s, 1H) 
6 6.18 (d, J = 14.8, 1H) 6.20 (d, J = 15.0 Hz, 1H) 6.19 (d, J = 15.1 Hz, 1H) 
7 7.12 (m, 1H)a 7.14 (dd, J = 15.3, 11.3 Hz, 1H) 7.10 - 7.18 (m, 1H) 
8 6.43 (m, 1H)a 6.42 (dd, J = 14.7 11.3 Hz, 1H)a 6.42 (m, 1H)a 
9 6.62 (m, 1H)a 6.64 (dd, J = 14.7, 11.2, 1H) 6.64 (dd, J = 14.7, 11.2 Hz, 1H) 
10 6.32 (m, 1H)a 6.39 (dd, J = 14.6, 11.2 Hz, 1H)a 6.39 (m, 1H)a 
11 6.41 (m, 1H)a 6.50 (dd, J = 14.6, 10.3 Hz, 1H) 6.51 (dd, J = 14.7, 10.3 Hz, 1H) 
12 6.47 (m, 1H)a 6.40 (d, J = 10.3 Hz, 1H)a 6.40 (m, 1H)a 
13 6.39 (m, 1H)a 6.43 (m, 1H)a 6.46 (m, 1H)a 
14 6.34 (1H)a 6.41 (m, 1H)a 6.41 (m, 1H)a 
15 6.44 (m, 1H)a 6.41 (m, 1H)a 6.41 (m, 1H)a 
17 6.13 (s, 1H) 6.13 -6.11 (m, 1H) 6.13 (s, 1H) 
19 5.61 (d, J = 10.5 Hz, 1H) 5.64 (dd, J =10.4, 1.2, 1H) 5.60 (dd, J = 10.4, 1.2 Hz, 1H) 
20 3.03 (m, 1H) 3.06 - 2.95 (m, 1H) 3.02 (m, 1H) 
21 1.12 (m, 1H); 1.35 (m, 1H) 1.17 (m, 1H); 1.29 (m, 1H) 1.11 (m, 1H); 1.35 (m, 1H) 
22 1.32 (m, 1H) 1.39 (m, 1H) 1.31 (m, 1H) 
23 1.16 (m, 1H); 1.33 (m, 1H) 1.09 (dt, J = 12.8, 7.4, 1H); 1.39 (m, 1H)  1.16 (m, 1H); 1.31 (m, 1H) 
24 0.87 (t, J = 7.6 Hz, 3H) 0.86 (t, J = 7.4, 3H)   0.87 (t, J = 7.3 Hz, 3H) 
25 0.85 (d, J = 6.0 Hz, 3H) 0.86 (d, J = 6.5, 3H) 0.85 (d, J = 6.3 Hz, 3H) 
26 1.02 (d, J = 6.6 Hz, 3H) 1.00 (d, J = 6.6, 3H) 1.02 (d, J = 6.6 Hz, 3H) 
28 1.87 (s, 3H) 1.87 (d,  J = 1.2, 3H) 1.87 (d, J = 1.2 Hz, 1H) 
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29 4.55 (d, J = 9.3 Hz, 1H) 4.53 (d, J = 9.7, 1H) 4.54 (d, J = 9.7 Hz, 1H) 
30 4.21 (t, J = 9.9, 1H) 4.19 (t, J = 9.5, 1H) 4.19 (t, J = 9.5 Hz, 1H) 
31 3.53 (dd, J = 2.7, 9.3 Hz, 1H) 3.51 (dd, J = 3.2, 9.4, 1H) 3.52 (dd, J = 9.4, 3.2 Hz, 1H) 
32 3.93 (d, J = 2.7, 1H) 3.91 (d, J = 3.1, 1H) 3.92 (d, J = 3.1 Hz, 1H) 
33 3.62 (m, 1H) 3.62-3.59 (m, 1H) 3.61 (m, 1H) 






4 6.08 (s, 1H) 6.08 (s, 1H) 6.08 (s, 1H) 
6 6.18 (d, J = 14.8, 1H) 6.19 (d, J = 15.1 Hz, 1H) 6.20 (d, J = 15.1 Hz, 1H) 
7 7.12 (m, 1H)a 7.14 (dd, J = 15.3, 11.5 Hz, 1H) 7.14 (dd,  J = 15.2, 11.2 Hz, 1H) 
8 6.43 (m, 1H)a 6.42 (dd, J = 14.4, 11.5 Hz, 1H)a 6.43 (dd, J = 14.5, 11.2 Hz, 1H)a 
9 6.62 (m, 1H)a 6.64 (dd, J = 14.4, 11.1 Hz, 1H) 6.64 (dd, J = 14.5, 11.1 Hz, 1H) 
10 6.32 (m, 1H)a 6.38 (dd, J = 14.8, 11.1 Hz, 1H)a 6.39 (dd, J = 14.7, 11.1 Hz, 1H)a 
11 6.41 (m, 1H)a 6.50 (dd, J = 14.8, 10.1 Hz, 1H) 6.51 (dd, J = 14.7, 10.3 Hz, 1H) 
12 6.47 (m, 1H)a 6.41 (d, J = 14.1 Hz, 1H)a 6.40 (d, J = 10.3 Hz, 1H)a 
13 6.39 (m, 1H)a 6.42 (m, 1H)a 6.43 (m, 1H)a 
14 6.34 (1H)a 6.40 (m, 1H)a 6.42 (m, 1H)a 
15 6.44 (m, 1H)a 6.40 (m, 1H)a 6.41 (m, 1H)a 
17 6.13 (s, 1H) 6.12 (s, 1H) 6.12 (m, 1H) 
19 5.61 (d, J = 10.5 Hz, 1H) 5.60 (d, J = 10.3 Hz, 1H) 5.65 (dd, J = 10.3, 1.2 Hz, 1H) 
20 3.03 (m, 1H) 3.01 (m, 1H) 3.00 (m, 1H) 
21 1.12 (m, 1H); 1.35 (m, 1H) 1.11 (m, 1H); 1.35 (m, 1H) 1.17 (tdd, J = 13.2, 6.6, 5.6 Hz, 1H); 1.29 (dt, J = 13.4, 6.6 Hz, 1H) 
22 1.32 (m, 1H) 1.30 (m, 1H) 1.37 (m, 1H) 
23 1.16 (m, 1H); 1.33 (m, 1H) 1.16 (m, 1H); 1.30 (m, 1H) 1.09 (m); 1.41 (m) 
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24 0.87 (t, J = 7.6 Hz, 3H) 0.86 (m, 3H) 0.86 (m, 3H) 
25 0.85 (d, J = 6.0 Hz, 3H) 0.85 (m, 3H) 0.86 (d, J = 6.6 Hz, 3H) 
26 1.02 (d, J = 6.6 Hz, 3H) 1.01 (d, J = 6.5 Hz, 3H) 1.00 (d, J = 6.6 Hz, 3H) 
28 1.87 (s, 3H) 1.87 (s, 3H) 1.87 (d, J = 1.2 Hz, 3H) 
29 4.55 (d, J = 9.3 Hz, 1H) 4.53 (d, J = 9.7 Hz, 1H) 4.53 (d, J = 9.7 Hz, 1H) 
30 4.21 (t, J = 9.9, 1H) 4.19 (t, J = 9.7 Hz, 1H) 4.19 (t, J = 9.5 Hz, 1H) 
31 3.53 (dd, J = 2.7, 9.3 Hz, 1H) 3.52 (m, 1H) 3.51 (dd, J = 9.4, 3.2 Hz, 1H) 
32 3.93 (d, J = 2.7, 1H) 3.91 (m, 1H) 3.91 (dd, J = 3.3, 0.9 Hz, 1H) 
33 3.62 (m, 1H) 3.61 (m, 1H) 3.60 (m, 1H) 
34 3.72-3.76 (m, 2H) 3.73 (m, 1H) 3.69 (dd, J = 11.5, 5.2 Hz, 1H); 3.74 (dd, J = 11.5, 6.8 Hz, 1H) 
a overlapping signals; [b] data reported in Bioorg. Med. Chem Lett. 2012, 22, 3188 are used for the comparison; the data contained in the patent on epipyrone A 




Table S-4. Comparison of the 13C NMR data ([D6]-DMSO) of putative Orevactaene (NP) and (S,R)-1, 
showing a severe mismatch in the head group; arbitrary numbering scheme as shown; signals 
marked * and ** have been mutually interchanged (see above);  = ppm ((S,R)-1  NP) 
 
 
Nr Literature[a] (S,R)-1  
1 162.2* 162.3 +0.1 
2 101.4 99.8 0.6 
3 74.5 62.5 12.0 
4 67.9 68.9 +1.0 
5 75.3 78.4 +3.1 
6 167.6* 165.0 2.6 
7 101.6 100.9 0.7 
8 157.8 157.7 0.1 
9 122.5 122.1 0.4 
10 134.7 134.8 +0.1 
11 131.8 131.4 0.4 
12 138.7 138.7 0.0 
13 132.8** 132.6 0.2 
14 136.4 136.3 0.1 
15 133.1 132.9 0.2 
16 135.5 135.5 0.0 
17 129.0** 128.8 0.2 
18 139.1 139.0 0.1 
19 134.7 134.5 0.2 
20 130.6 130.5 0.1 
21 131.4 131.3 0.1 
22 146.7 146.4 0.3 
23 31.5 31.3 0.2 
24 44.1 43.9 0.2 
25 32.2 32.0 0.2 
26 29.7 29.6 0.1 
27 11.3 11.1 0.2 
28 18.9 18.8 0.1 
29 21.4 21.3 0.1 
30 169.6 169.5 0.1 
31 13.3 13.2 0.1 
32 69.1 70.6 +1.5 
33 79.3 70.1 9.2 
34 60.9 63.2 +2.3 
 
[a] Y.-Z. Shu, Q. Ye, H. Li, K. F. Kadow, R. A. Hussain, S. Huang, D. R. Gustavson, S. E. Lowe, L.-P. Chang, 
D. M. Pirnik, K. Kodukula, Bioorg. Med. Chem. Lett. 1997, 7, 2295-2298.  
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Table S-5. Comparison of the 1H NMR data ([D6]-DMSO) of putative Orevactaene (NP) and (S,R)-1; 





   
3 4.25 (d, J = 9.5 Hz, 1H) 4.33 (ddd, J = 5.2, 3.8, 1.2 Hz, 1H) 
4 4.11 (dd, J = 9.5, 9.3 Hz, 1H) 3.84 (ddd, J = 4.2, 3.8, 3.5 Hz, 1H) 
5 3.27 (dd, J = 9.3, 2.8 Hz, 1H) 4.59 (dt, J = 3.5, 1.2 Hz, 1H) 
7 6.18 (s, 1H) 6.21 (s, 1H) 
9 6.30 d, J = 15.2 Hz, 1H) 6.33 (d, J = 15.2 Hz, 1H); 
10 7.00 (dd, J = 15.2, 11.4 Hz, 1H) 7.04 (dd, J = 15.2, 11.3 Hz, 1H) 
11 6.45 (dd, overlapping) 6.47 (m, 1H) 
12 6.70 (dd, J = 14.8, 11.3 Hz, 1H) 6.73 (dd, J = 14.6, 11.3 Hz, 1H) 
13 6.42 (dd, overlapping, 1H) 6.44 (m, 1H) 
14 6.51 (dd, overlapping, 1H) 6.53 (dd, J = 14.4, 10.4 Hz, 1H) 
15 6.41 (dd, overlapping, 1H) 6.45 (m, 1H) 
16 6.47 (dd, overlapping, 1H) 6.49 (m, 1H) 
17 6.40 (dd, overlapping, 1H) 6.42 (m, 1H) 
18 6.40 (dd, overlapping, 1H) 6.43 (m, 1H) 
20 6.11 (s, 1H) 6.13 (s, 1H) 
22 5.56 (d, J = 10.3 Hz, 1H) 5.58 (d, J = 10.1 Hz, 1H) 
23 2.90 (m, 1H) 2.92 (m, 1H) 
24 1.24 (m, 1H) 
1.08 (m, 1H) 
1.31 (ddd, J = 13.0, 9.8, 4.0 Hz, 1H) 
1.08 (ddd, J = 13.0, 9.0, 4.6 Hz, 1H) 
25 1.20 (m, 1H) 1.26 (m, 1H) 
26 1.20 (m, 1H) 
1.10 (m, 1H) 
1.25 (m, 1H) 
1.11 (m, 1H) 
27 0.80 (t, J = 7.6 Hz, 3H) 0.82 (t, J = 7.3 Hz, 3H) 
28 0.78 (d, J = 7,1 Hz, 3H) 0.80 (d, J = 6.5 Hz, 3H) 
29 0.96 (d, J = 7.1 Hz, 3H) 0.97 (d, J = 6.6 Hz, 3H) 
30 CO2H 8.00 (bs, 1H) 12.75 (bs, 1H) 
31 1.79 (s, 3H) 1.81 (s, 3H) 
32 3.70 (dd, J = 6.2, 2.8 Hz, 1H) 3.63 (ddd, J = 9.2, 4.1, 1.2 Hz, 1H) 
33 3.37 (m, overlapping, 1H) 3.51 (dddd, J = 9.2, 6.0, 5.2, 3.0 Hz, 1H) 
34 3.42 (m, 1H) 
3.39 (m, 1H) 
3.62 (m, 1H) 
3.40 (ddd, J = 11.2, 5.4, 5.2 Hz, 1H) 
3-OH  6.17 (d, J = 5.2 Hz, 1H) 
4-OH  5.45 (d, J = 4.2 Hz, 1H) 
32-OH  5.13 (d, J = 4.1 Hz, 1H) 
33-OH  4.81 (d, J = 6.0 Hz, 1H) 
34-OH  4.37 (t, J = 5.4 Hz, 1H) 
 
[a] Y.-Z. Shu, Q. Ye, H. Li, K. F. Kadow, R. A. Hussain, S. Huang, D. R. Gustavson, S. E. Lowe, L.-P. Chang, 




Table S-6. Comparison of the 13C NMR data ([D6]-DMSO) of putative Orevactaene (NP) and (S,S)-1, 
showing a severe mismatch in the head group; arbitrary numbering scheme as shown; signals 




Nr Literature[a] (S,S)-1  
1 162.2* 162.3 +0.1 
2 101.4 99.8 1,6 
3 74.5 62.5 12.0 
4 67.9 68.9 +1.0 
5 75.3 78.4 +3.1 
6 167.6* 165.0 2.6 
7 101.6 100.9 0.7 
8 157.8 157.7 0.1 
9 122.5 122.1 0.4 
10 134.7 134.8 +0.1 
11 131.8 131.3 0.5 
12 138.7 138.7 0.0 
13 132.8** 132.4 0.4 
14 136.4 136.4 0.0 
15 133.1 132.7 0.4 
16 135.5 135.5 0.0 
17 129.0** 128.5 0.5 
18 139.1 139.2 +0.1 
19 134.7 n.r.  
20 130.6 n.r.  
21 131.4 n.r.  
22 146.7 n.r.  
23 31.5 31.2 0.3 
24 44.1 43.9 0.2 
25 32.2 31.6 0.6 
26 29.7 28.5 1.2 
27 11.3 11.0 0.3 
28 18.9 19.4 +0.5 
29 21.4 20.6 0.8 
30 169.6 n.r.  
31 13.3 13.1 0.2 
32 69.1 70.6 +1.5 
33 79.3 70.1 9.2 
34 60.9 63.2 +2.3 
 
[a] Y.-Z. Shu, Q. Ye, H. Li, K. F. Kadow, R. A. Hussain, S. Huang, D. R. Gustavson, S. E. Lowe, L.-P. Chang, 
D. M. Pirnik, K. Kodukula, Bioorg. Med. Chem. Lett. 1997, 7, 2295-2298. 
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Table S-7. Comparison of the 1H NMR data ([D6]-DMSO) of putative Orevactaene (NP) and (S,S)-1; 
arbitrary numbering scheme as shown 
 
Nr Literature[a] (S,S)-1 
   
3 4.25 (d, J = 9.5 Hz, 1H) 4.33 (dd, J = 5.2, 3.8 Hz, 1H) 
4 4.11 (dd, J = 9.5, 9.3 Hz, 1H) 3.84 (q, J = 3.8 Hz, 1H) 
5 3.27 (dd, J = 9.3, 2.8 Hz, 1H) 4.58 (d, J = 3.8 Hz, 1H) 
7 6.18 (s, 1H) 6.21 (s, 1H) 
9 6.30 d, J = 15.2 Hz, 1H) 6.33 (d, J = 15.2 Hz, 1H) 
10 7.00 (dd, J = 15.2, 11.4 Hz, 1H) 7.04 (dd, J = 15.2, 11.4 Hz, 1H) 
11 6.45 (dd, overlapping) 6.47 (dd, J = 14.5, 11.4 Hz, 1H) 
12 6.70 (dd, J = 14.8, 11.3 Hz, 1H) 6.73 (dd, J = 14.5, 11.3 Hz, 1H) 
13 6.42 (dd, overlapping, 1H) 6.44 (dd, J = 14.4, 11.3 Hz, 1H) 
14 6.51 (dd, overlapping, 1H) 6.53 (dd, J = 14.4, 10.5 Hz, 1H) 
15 6.41 (dd, overlapping, 1H) 6.44 (m, 1H) 
16 6.47 (dd, overlapping, 1H) 6.49 (m, 1H) 
17 6.40 (dd, overlapping, 1H) 6.40 (m, 1H) 
18 6.40 (dd, overlapping, 1H) 6.43 (m, 1H) 
20 6.11 (s, 1H) 6.12 (s, 1H) 
22 5.56 (d, J = 10.3 Hz, 1H) 5.55 (bs, 1H) 
23 2.90 (m, 1H) 2.89 (m, 1H) 
24 1.24 (m, 1H) 
1.08 (m, 1H) 
1.24 (m, 1H) 
1.12 (m, 1H) 
25 1.20 (m, 1H) 1.32 (m, 1H) 
26 1.20 (m, 1H) 
1.10 (m, 1H) 
1.34 (m, 1H) 
1.06 (m, 1H) 
27 0.80 (t, J = 7.6 Hz, 3H) 0.81 (t, J = 7.4 Hz, 3H) 
28 0.78 (d, J = 7,1 Hz, 3H) 0.81 (d, J = 6.8 Hz, 3H) 
29 0.96 (d, J = 7.1 Hz, 3H) 0.94 (d, J = 6.4 Hz, 3H) 
30 CO2H 8.00 (bs, 1H) 12.76 (bs, 1H) 
31 1.79 (s, 3H) 1.81 (s, 3H) 
32 3.70 (dd, J = 6.2, 2.8 Hz, 1H) 3.64 (dd, J = 9.2, 4.0 Hz, 1H) 
33 3.37 (m, overlapping, 1H) 3.51 (m, 1H) 
34 3.42 (m, 1H) 
3.39 (m, 1H) 
3.62 (m, 1H) 
3.40 (m, 1H) 
3-OH  6.17 (d, J = 5.2 Hz, 1H) 
4-OH  5.45 (d, J = 4.0 Hz, 1H) 
32-OH  5.14 (d, J = 4.0 Hz, 1H) 
33-OH  4.82 (d, J = 5.9 Hz, 1H) 
34-OH  4.38 (m, 1H) 
 
[a] Y.-Z. Shu, Q. Ye, H. Li, K. F. Kadow, R. A. Hussain, S. Huang, D. R. Gustavson, S. E. Lowe, L.-P. Chang, 
D. M. Pirnik, K. Kodukula, Bioorg. Med. Chem. Lett. 1997, 7, 2295-2298. 
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THE PUTATIVE OREVACTAENE SERIES 
2,3,5,6,7 Penta-O-benzyl-D-glycero-D-galacto-heptono-1,4-lactone (6). TfOH (1.70 mL, 19.2 mmol) 
was added to a suspension of D-glycero-D-galacto-heptono-1,4-lactone (5)[1] 
(20.0 g, 96.1 mmol) and benzyl trichloroacetimidate (194.1 g, 768.6 mmol) in 
dioxane (890 mL) and the mixture was stirred for 18 h at room temperature. 
The reaction was quenched with sat. aq. NaHCO3 and the aqueous layer extracted with tBuOMe. The 
combined extracts were washed with brine and dried over MgSO4. The drying agent was filtered off 
and the solvent was evaporated. The residue was boiled with aq. NaOH (1 M, 144 mL) for 30 min. 
After reaching ambient temperature, the mixture was acidified with aq. HCl and the aqueous layer 
extracted with tBuOMe. The combined extracts were washed with brine and dried over MgSO4. The 
drying agent was filtered off and the solvent was evaporated. Purification of the residue by flash 
chromatography (SiO2, hexane:EtOAc, 20:1 to 5:1) afforded the title compound as a yellow 
oil (46.9 g, 74%). [𝑎]D
20: ‒19.3 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 7.41 – 7.24 (m, 21H), 7.23 
– 7.20 (m, 2H), 7.16 -7.13 (m, 2H), 5.06 (d, J = 11.6 Hz, 1H), 4.77 (d, J = 11.6 Hz, 1H), 4.63 (d, J = 11.4 
Hz, 1H), 4.60 – 4.45 (m, 6H), 4.38 (d, J = 7.3 Hz, 1H), 4.30 (d, J = 11.4 Hz, 1H), 4.23 (t, J = 7.6 Hz, 1H), 
4.17 (d, J = 11.6 Hz, 1H), 3.83 (dd, J = 8.3, 2.0 Hz, 1H), 3.80 – 3.70 (m, 2H), 3.63 (dd, J = 10.7, 3.2 Hz, 
1H) ppm; 13C NMR (101 MHz, CDCl3): δ = 172.8, 138.1, 138.0, 137.6, 137.1, 137.0, 128.7, 128.6, 
128.53, 128.48, 128.3, 128.2, 128.1, 127.93, 127.87, 79.8, 78.9, 78.0 ,77.5, 75.0, 74.2, 73.5, 72.5, 
72.4, 72.2, 67.7 ppm; IR (film): ?̃? = 3063, 3030, 2867, 1787, 1655, 1603, 1586, 1496, 1454, 1209, 
1095, 1028 cm-1; HRMS (ESI): m/z calcd. for C42H42O7Na
+: 681.28225; found: 681.28228. 
2,3,5,6,7 Penta-O-benzyl-D-glycero-D-galacto-heptofuranose (S1). DIBAL-H (27.6 mL, 27.6 mmol, 1 
M in CH2Cl2) was added dropwise to a solution of 6 (14.0 g, 21.25 mmol) in 
CH2Cl2 (210 mL) at ‒78 °C. After stirring at ‒78 °C for 1 h, the mixture was 
warmed to ‒45 °C over 2 h and the reaction was quenched with methanol and 
sat. aq. Na/K tartrate. After warming to room temperature the mixture was extracted with tBuOMe 
(3 x). The combined organic layers were washed with brine and dried over MgSO4. The drying agent 
was filtered off and the solvent was evaporated. Purification of the crude product by flash 
chromatography (SiO2, hexanes:EtOAc, 5:1) afforded the title compound as a yellow oil (11.94 g, 
85%). [𝑎]D
20: ‒5.0 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 7.39 – 7.14 (m, 25H), 5.40 (d, J = 5.1 
Hz, 0.5 H), 5.29 (dd, J = 11.6, 4.3 H, 0.5H), 4.72 – 4.25 (m, 11 H), 4.10 – 3.93 (m, 3H), 3.83 – 3.74 (m, 
2H), 3.74 – 3.66 (m, 1H), 2.62 (d, J = 4.5 Hz, 0.5 H), 2.62 (bs, 0.5 H) ppm; 13C NMR (101 MHz, CD2Cl2): δ 
= 139.2, 139.1, 139.0, 138.9, 138.8, 138.4 (2 C), 138.2, 138.1, 137.5, 129.2, 128.91, 128.85, 128.73, 
128.66, 128.64, 128.56, 128.47, 128.41, 128.36, 128.31, 128.26, 128.21, 128.17, 128.14, 128.01, 
127.98, 127.88, 127.85, 101.2, 96.5, 88.5, 85.4, 83.4, 82.5, 82.3, 81.6, 79.5, 79.3, 78.8, 77.98, 77.95, 
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75.2, 74.7, 73.7, 73.6, 72.8, 72.7, 72.4, 72.19, 72.15, 72.0, 70.0, 68.9 ppm; IR (film): ?̃? = 3426, 3062, 
3029, 2867, 1495, 1495, 1453, 1208, 1091, 1028 cm-1; HRMS (ESI): m/z calcd. for 
C42H44O7Na
+: 683.29758; found: 283.29792. 
1-Deoxy-3,4,6,7,8-penta-O-benzyl-D-glycero-D-galacto-oct-1-ynitol (7). nBuLi (1.6 M in hexane, 
30.0 mL, 48.0 mmol) was added dropwise to a solution of iPr2NH (8.8 mL, 
62.8 mmol) in THF (44 mL) at 0 °C. The resulting mixture was stirred for 15 min at 
0 °C and then cooled to ‒78 °C. Diazomethyl)trimethylsilane (15.3 mL, 30.6 mmol, 
2 M in hexane) was added dropwise and stirring was continued for 1 h at ‒78 °C. 
Next, a solution of S1 (6.0 g, 9.1 mmol) in THF (44 mL) was added dropwise and the resulting mixture 
was warmed to room temperature over 18 h. The reaction was quenched with sat. aq. NH4Cl and the 
aqueous phase extracted with tBuOMe. The combined extracts were washed with brine and dried 
over MgSO4. The drying agent was filtered off and the solvent was evaporated. The crude product 
was purified by flash chromatography (SiO2, hexane:EtOAc, 10:1) to give the title compound as a 
yellow oil (3.9 g, 65%). [𝑎]D
20: +1.5 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 7.34 – 7.14 (m, 25H), 
4.90 (d, J = 11.4 Hz, 1H), 4.85 (d, J = 11.9 Hz, 1H), 4.66 (d, J = 11.5 Hz, 1H), 4.58 (d, J = 14.6 Hz, 1H), 
4.54 – 4.45 (m, 5H), 4.41 (d, J = 11.4 Hz, 1H), 4.31 (d, J = 11.6 Hz, 1H), 4.11 (dd, J = 8.1, 5.8 Hz, 1H), 
3.92 – 3.86 (m, 2H), 3.77 – 3.68 (m, 2H), 3.66 – 3.61 (m, 1H), 3.14 (d, J = 5.6 Hz, 1H), 2.47 (d, J = 2.0 
Hz, 1H) ppm; 13C NMR (101 MHz, CDCl3): δ = 138.43 (2 C), 138.37, 138.2, 137.7, 128.5, 128.42, 
128.38, 128.36, 128.2, 128.1, 127.9, 127.8, 127.70, 127.65, 81.4, 80.8, 79.3, 76.3, 76.0, 73.8, 73.5, 
73.1, 72.8, 71.3, 69.87, 67.84, 68.2 ppm; IR (film): ?̃? = 3500, 3287, 3087, 3062, 3030, 1496, 1453, 
1208, 1088, 1068, 1027 cm-1. HRMS (ESI): m/z calcd. for C43H44O6Na
+: 679.30262; found: 679.30301. 
(2R,3R,4S)-3,4-Bis(benzyloxy)-2-((1R,2R)-1,2,3-tris(benzyloxy)propyl)-3,4-dihydro-2H-pyran (9). 
W(CO)6 (42 mg, 0.12 mmol) was added to a degassed (pump and freeze) solution of 7 
(500 mg, 0.76 mmol) and DABCO (dried by sublimation) in THF (4 mL) at room 
temperature and the resulting mixture was irradiated without cooling using UV-A 
lamps, causing gentle reflux. After 4 h the mixture was concentrated and the residue was purified by 
flash chromatography (SiO2, hexanes:EtOAc, 10:1) to afford the title compound (342 mg, 68%). [𝑎]D
20: 
‒13.4 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 7.37 – 7.17 (m, 25H), 6.37 (dd, J = 6.1, 1.3 Hz, 1H), 
5.03 (d, J = 12.6, Hz, 1H), 4.88 (dd, J = 6.0, 2.3 Hz, 1H), 4.66 (t, J = 11.1 Hz, 2H), 4.61 – 4.49 (m, 7H), 
4.39 (dt, J = 6.6, 1.8 Hz, 1H), 4.28 – 4.19 (m, 2H), 4.00 (dd, J = 9.6, 6.6 Hz, 1H), 3.91 – 3.85 (m, 1H), 
3.81 (dd, J = 10.7, 2.6 Hz, 1H), 3.66 (dd, J = 10.6, 4.3 Hz, 1H) ppm; 13C NMR (101 MHz, CDCl3): δ = 
145.3, 138.8, 138.6, 138.5, 138.4, 138.2, 128.6, 128.5, 128.4, 128.2, 128.1, 127.90, 127.88, 127.7, 
127.5, 127.4, 99.9, 78.2, 77.3, 76.6, 75.5, 74.5, 74.0, 73.4, 72.7 (2 C), 70.3, 69.3 ppm; IR (film): ?̃? = 
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3062, 3029, 2963, 1648, 1496, 1553, 1361, 1330, 1208, 1090, 1027 cm-1; HRMS (ESI): m/z calcd. for 
C43H44O6Na
+: 679.30260; found: 679.30301. 
(2R,3R,4S)-3,4-Bis(benzyloxy)-2-((1R,2R)-1,2,3-tris(benzyloxy)propyl)-3,4-dihydro-2H-pyran-5-carb-
aldehyde (10). POCl3 (4.00 mL, 42.91 mmol) was added dropwise over 1.5 h to a solution of 9 (1.40 g, 
2.13 mmol) in DMF (4.5 mL) at 0 °C. The mixture was stirred for 24 h while 
warming slowly to room temperature. For work up, the reaction was quenched 
with sat. aq. NaHCO3 and the aqueous phase was extracted with tBuOMe. The 
combined extracts were washed with brine and dried over MgSO4. The drying agent was filtered off 
and the solvent was evaporated. Purification of the crude product by flash chromatography (SiO2, 
hexanes:EtOAc, 5:1) afforded the title compound as a yellow oil (950 mg, 65%). [𝑎]D
20: ‒24.7 (c = 1, 
CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 9.33 (s, 1H), 7.34 – 7.20 (m, 20H), 7.17 (s, 1H), 7.15 – 7.07 (m, 
5H), 4.79 – 4.72 (m, 2H), 4.70 (d, J = 11.1 Hz, 1H), 4.62 (d, J = 11.4 Hz, 1H), 4.61 (d, J = 11.1 Hz, 1H), 
4.48 (d, J = 11.6 Hz, 1H), 4.44 (d, J = 11.6 Hz, 1H), 4.39 (dd, J = 2.9, 1.7 Hz, 1H), 4.32 – 4.19 (m, 5H), 
3.97 (t, J = 2.6 Hz, 1H), 3.89 – 3.81 (m, 2H), 3.67 – 3.58 (m, 1H) ppm; 13C NMR (101 MHz, CDCl3): δ = 
190.6, 165.0, 138.6, 138.5, 138.1, 137.9, 137.7, 128.5, 128.4, 128.3, 128.1, 128.02, 127.96 127.7, 
127.7, 127.6, 127.5, 127.3, 118.1, 80.4, 78.4, 76.5, 75.2, 73.7, 73.2, 71.9, 71.8, 71.5, 68.8, 67.0 ppm; 
IR (film): ?̃? 3063, 3030, 2866, 1672, 1624, 1454, 1206, 1090, 1072, 1028 cm-1; HRMS (ESI): m/z calcd. 
for C44H44O7Na
+: 707.29789; found: 707.29792. 
(2R,3R,4S)-3,4-Bis(benzyloxy)-2-((1R,2R)-1,2,3-tris(benzyloxy)propyl)-3,4-dihydro-2H-pyran-5-
carboxylic acid (S2). NaH2PO4 (631 mg, 5.26 mmol) followed by H2O2 (0.9 mL, 9.26 mmol, 35% in 
water) were added to a solution of 10 (900 mg, 1.31 mmol) in 
tBuOH/CH3CN/H2O (2:2:1, 6.75 mL) at 0 °C. The mixture was stirred for 5 min 
before NaClO2 (1.22 g, 10.79 mmol, 80%) was added and stirring was continued 
for 16 h at room temperature. The mixture was diluted with water and the aqueous phase was 
extracted with CH2Cl2. The combined extracts were washed with brine and dried over MgSO4. The 
drying agent was filtered off and the solvent was evaporated. Purification of the crude product by 
flash chromatography (SiO2, hexanes:EtOAc, 3:1) afforded the title compound as a colorless oil 
(710 mg, 77%). [𝑎]D
20: ‒15.8 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 7.70 (s, 1H), 7.40 – 7.01 (m, 
25H), 4.80 – 4.66 (m, 3H), 4.66 – 4.56 (m, 2H), 4.52 – 4.42 (m, 2H), 4.39 – 4.14 (m, 6H), 3.99 – 3.94 
(m, 1H), 3.90 – 3.79 (m, 2H), 3.63 (dd, J = 8.7, 3.7 Hz, 1H) ppm; 13C NMR (101 MHz, CDCl3): δ = 173.0, 
158.1, 138.8, 138.7, 138.2, 138.1, 137.9, 128.64, 128.56, 128.55, 128.51, 128.48, 128.4, 128.3, 128.2, 
128.12, 128.11, 128.0, 127.94, 127.85, 127.7, 127.4, 127.3, 105.0, 79.0, 78.6, 76.7, 75.5, 73.7, 72.9, 
71.9, 71.8, 71.3, 69.1 (2 C) ppm; IR (film): ?̃? = 3063, 3030, 2970, 1676, 1625, 1454, 1287, 1197, 1090, 
1072, 1028 cm-1; HRMS (ESI): m/z calcd. for C44H44O8Na




dihydro-2H-pyran-5-carboxylate (11). DEAD (0.55 mL, 3.02 mmol) was added dropwise over 1 h to a 
solution of S2 (700 mg, 1.00 mmol), 2-TMS-ethanol (0.43 mL, 3.00 mmol) and 
PPh3 (945 mg, 3.60 mmol) in THF (5.00 mL) at 0 °C. The resulting mixture was 
stirred for 16 h while warming to room temperature, before the reaction was 
quenched with sat. aq. NH4Cl and the aqueous phase was extracted with 
tBuOMe. The combined extracts were washed with brine and dried over MgSO4. The drying agent 
was filtered off and the solvent was evaporated. Purification of the crude product by flash 
chromatography (SiO2, hexanes:EtOAc, 20:1 to 10:1) afforded the title compound as a colorless oil 
(639 mg, 80%). [𝑎]D
20: ‒2.1 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 7.61 (s, 1H), 7.41 – 7.21 (m, 
21H), 7.20 – 7.10 (m, 4H), 4.79 – 4.59 (m, 5H), 4.53 – 4.44 (m, 2H), 4.41 – 4.37 (m, 1H), 4.34 – 4.22 
(m, 7H), 3.97 (t, J = 2.6 Hz, 1H), 3.91 – 3.86 (m, 1H), 3.86 – 3.79 (m, 1H), 3.65 (dd, J = 9.1, 4.3 Hz, 1H), 
1.10 – 1.01 (m, 2H), 0.09 (s, 9H) ppm; 13C NMR (101 MHz, CDCl3): δ = 167.6, 155.7, 138.9, 138.7, 
138.3, 138.1, 138.0, 128.6, 128.53, 128.47, 128.4, 128.31, 128.25, 128.10, 128.06, 127.93, 127.89, 
127.8, 127.66, 127.57, 127.4, 127.2, 106.2, 78.6, 76.8, 75.5, 73.7, 73.0, 72.1, 71.7, 71.3, 69.5, 69.1, 
62.4 (2 C), 17.6, 1.3 ppm; IR (film): ?̃? = 3063, 3030, 2951, 1700, 1631, 1496, 1454, 1280, 1250, 1196, 
1071 cm-1; HRMS (ESI): m/z calcd. for C49H56O8SiNa
+: 823.36437; found: 823.36369. 
2-(Trimethylsilyl)ethyl (2S,3S,4S)-2-((1S,2R)-2,3-bis((tert-butyldimethylsilyl)oxy)-1-hydroxypropyl)-
3,4-bis((tert-butyldimethylsilyl)oxy)-3,4-dihydro-2H-pyran-5-carboxylate (12). Pd(OH)2/C (62 mg, 
20% loading) was added to a solution of 11 (620 mg, 0.77 mmol) in CH3OH 
(3.7 mL) at room temperature. The suspension was purged with hydrogen and 
stirred for 5 h under hydrogen atmosphere (1 atm). The suspension was filtered 
through a plug of Celite®, which was rinsed with CH3OH. The combined filtrates 
were concentrated and the residue was dried under high vacuum.  
Pyridine (1.9 mL, 22.9 mmol) and TBSOTf (2.8 mL, 11.95 mmol) were added at 0 °C to a solution of 
the crude product in CH2Cl2 (1.9 mL). After stirring for 16 h at room temperature, the reaction was 
quenched with water and the mixture extracted with tBuOMe. The combined extracts were washed 
with brine and dried over MgSO4. The drying agent was filtered off and the solvent was evaporated. 
Purification of the crude product by flash chromatography (SiO2, hexanes:EtOAc, 1:0 to 100:1) 
afforded the title compound as a colorless oil (593 mg, 95%). [𝑎]D
20: ‒13.8 (c = 1, CHCl3); 
1H NMR 
(400 MHz, CDCl3): δ = 7.78 (s, 1H), 4.70 (d, J = 1.0 Hz, 1H), 4.60 (t, J = 1.2 Hz, 1H), 4.42 (t, J = 2.1 Hz, 
1H), ppm. 4.27 – 4.11 (m, 2H), 3.87 (dd, J = 2.4, 1.4 Hz, 1H), 3.80 (dd, J = 10.4, 3.0 Hz, 1H), 3.78 – 3.68 
(m, 2H), 1.02 – 0.96 (m, 2H), 0.90 (s, 9H), 0.89 (s, 9H), 0.87 (s, 9H), 0.84 (s, 9H), 0.27 (s, 3H), 0.17 (s, 
3H), 0.11 (s, 3H), 0.10 (s, 3H), 0.10 – 0.08 (m, 6H), 0.06 – 0.03 m, 12H), 0.03 (s, 3H) ppm; 13C NMR 
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(101 MHz, CDCl3): δ = 167.6, 158.2, 104.7, 77.6, 72.7, 71.8, 71.1, 64.3, 62.0, 26.2, 26.1, 25.9, 25.7, 
18.6, 18.3, 18.2, 18.0, 17.6, -1.3, -4.0, -4.4, -4.6, -4.78, -4.78, -4.83 ppm; IR (film): ?̃? = 3397, 2953, 
2929, 2894, 2858, 1701, 1635, 1472, 1405, 1362, 1251, 1199, 1071 cm-1; HRMS (ESI): m/z calcd. for 
C38H82O8Si5Na
+: 829.47537; found: 829.47483. 
2-(Trimethylsilyl)ethyl (2S,3S,4S)-2-((1S,2R)-2,3-bis((tert-butyldimethylsilyl)oxy)-1-hydroxypropyl)-
3,4-bis((tert-butyldimethylsilyl)oxy)-6-iodo-3,4-dihydro-2H-pyran-5-carboxylate (13). nBuLi (1.6 M 
in hexanes, 4.1 mL, 6.56 mmol) was added dropwise to a solution of 
iPr2NH (1.4 mL, 9.99 mmol) in THF (6.3 mL) at 0 °C and the resulting mixture was 
stirred for 15 min. The solution was cooled to ‒78 °C and a solution of 12 
(450 mg, 0.56 mmol) in THF (6.3 mL) was added dropwise. The mixture was 
stirred for 1.5 h at ‒78 °C before a solution of iodine (1.85 g, 7.29 mmol) in THF (6.3 mL) was added 
dropwise. Stirring was continued for 30 min at ‒78 °C before the reaction was quenched with sat. aq. 
Na2S2O3. The mixture was extracted with tBuOMe, the combined extracts were washed with brine 
and dried over MgSO4. The drying agent was filtered off and the solvent was evaporated. Purification 
of the crude product by flash chromatography (SiO2, hexanes:EtOAc, 60:1) afforded the title 
compound as a colorless oil (370 mg, 71%). [𝑎]D
20: ‒19.1 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 
4.67 – 4.64 (m, 1H), 4.64 – 4.61 (m, 1H), 4.60 (t, J = 2.2 Hz, 1H), 4.39 – 4.30 (m, 1H), 4.15 – 4.06 (m, 
1H), 3.93 (dd, J = 2.3, 1.2 Hz, 1H), 3.84 (dd, J = 10.5, 2.7 Hz, 1H), 3.74 – 3.69 (m, 2H), 1.10 – 1.03 (m, 
2H), 0.89 (s, 9H), 0.88 (s, 9H), 0.86 (s, 9H), 0.85 (s, 9H), 0.22 (s, 3H), 0.13 (s, 3H), 0.12 (s, 3H), 0.11 (s, 
3H), 0.10 (s, 3H), 0.09 (s, 3H), 0.04 (s, 9H), 0.03 (s, 3H), 0.02 (s, 3H) ppm; 13C NMR (101 MHz, CDCl3): δ 
= 166.3, 123.8, 110.2, 83.0, 72.9, 71.1, 70.7, 66.5, 64.2, 63.0, 26.2, 26.1, 25.8, 25.7, 18.6, 18.3, 18.1, 
18.0, 17.7, -1.4, -4.1, -4.4, -4.7 (3 C), -4.8, -5.2, -5.3 ppm; IR (film): ?̃? = 3395, 2954, 2929, 2857, 1693, 





carboxylate (14). Pd(PPh3)2Cl2 (34 mg, 0.05 mmol) and CuI (17 mg, 0.09 mmol) followed by 
propargyl alcohol (150 µL, 2.6 mmol) were added to a degassed (pump and 
freeze, 3 cycles) solution of 13 (404 mg, 0.43 mmol) in NEt3 (4.1 mL). The 
mixture was stirred for 18 h before the reaction was quenched with water. 
The aqueous phase was extracted with tBuOMe, and the combined 
extracts were washed with brine and dried over MgSO4. The drying agent was filtered off and the 
solvent was evaporated. Purification of the residue by flash chromatography (SiO2, hexanes:EtOAc, 
10:1) afforded the title compound as a colorless oil (318 mg, 85%). [𝑎]D
20: ‒34.6 (c = 1, CHCl3); 
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1H NMR (400 MHz, CDCl3): δ = 4.62 – 4.56 (m, 2H), 4.51 (s, 1H), 4.46 (d, J = 6.1 Hz, 2H), 4.38 – 4.28 (m, 
1H), 4.17 – 4.07 (m, 1H), 3.87 (t, J = 2.0 Hz, 1H), 3.82 (dd, J = 10.9, 2.3 Hz, 1H), 3.77 – 3.69 (m, 3H), 
1.78 (bt, J = 6.1 Hz, 1H), 1.08 – 1.00 (m, 2H), 0.90 (s, 9H), 0.89 (s, 9H), 0.86 (s, 9H), 0.85 (s, 9H), 0.24 
(s, 3H), 0.14 (s, 3H), 0.124 (s, 3H), 0.119 (s, 3H), 0.10 (s, 3H), 0.09 (s, 3H), 0.04 (s, 9H), 0.03 (s, 3H), 
0.02 (s, 3H) ppm; 13C NMR (101 MHz, CDCl3): δ = 166.8, 147.3, 108.8, 93.1, 80.9, 78.0, 72.8, 71.2, 
71.1, 65.8, 64.2, 62.7, 51.8, 26.21, 26.15, 25.8, 25.7, 18.6, 18.3, 18.2, 18.0, 17.7, -1.4, -4.0, -4.4, -4.6,   
-4.65, -4.67, -4.72, -5.25, -5.32 ppm; IR (film): ?̃? = 3414, 2954, 2930, 2894, 2858, 1689, 1600, 1472, 






(10) (2.3 mg, 0.003 mmol) was added to a solution of 14 
(220 mg, 0.26 mmol) in CH3NO2 (2.6 mL) and the resulting mixture was 
stirred for 18 h at room temperature. The reaction was quenched with sat. 
aq. NH4Cl and the mixture was extracted with tBuOMe. The combined extracts were washed with 
brine and dried over MgSO4. The drying agent was filtered off and the solvent was evaporated. 
Purification of the crude product by flash chromatography (SiO2, hexane:EtOAc, 5:1) afforded the 
title compound as a white foam (160 mg, 82%). [𝑎]D
20: ‒45.4 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): 
δ = 6.12 (s, 1H), 4.84 (s, 1H), 4.75 (t, J = 1.3 Hz, 1H), 4.50 (t, J = 1.9 Hz, 1H), 4.38 (t, J = 3.8 Hz, 1H), 3.95 
(dd, J = 2.5, 1.5 Hz, 1H), 3.84 (dd, J = 8.7, 1.4 Hz, 1H), 3.79 (dd, J = 10.5, 3.2 Hz, 1H), 3.75 – 3.67 (m, 
2H), 2.45 (bs, 1H), 0.91 (s, 9H), 0.88 (s, 9H), 0.88 (s, 9H), 0.82 (s, 9H), 0.31 (s, 3H), 0.24 (s, 3H), 0.13 (s, 
6H), 0.10 (s, 3H), 0.09 (s, 3H), 0.03 (s, 3H), 0.02 (s, 3H) ppm; 13C NMR (101 MHz, CDCl3): δ = 166.4, 
164.0, 163.4, 99.0, 97.9, 78.4, 72.6, 71.7, 70.8, 64.1, 64.0, 61.2, 26.2, 26.1, 25.9, 25.7, 18.6, 18.3, 
18.2, 18.0, -4.0, -4.4, -4.7, -4.8 (2 C), -5.0, -5.3, -5.4 ppm; IR (film): ?̃? = 3400, 2954, 2929, 2888, 2857, 
1721, 1696, 1586, 1472, 1434, 1253, 1111, 1094 cm-1; HRMS (ESI): m/z calcd. for 
C36H72O9Si4Na
+: 783.41499; found: 783.41457.  
(2S,3S,4S)-2-((1S,2R)-2,3-Bis((tert-butyldimethylsilyl)oxy)-1-hydroxypropyl)-3,4-bis((tert-butyl-
dimethylsilyl)oxy)-5-oxo-3,4-dihydro-2H,5H-pyrano[4,3-b]pyran-7-carbaldehyde (S3). Dess-Martin 
periodinane (7 mg, 0.017 mmol) was added in one portion to a solution of 
15 (10 mg, 0.013 mmol) in THF (0.1 mL) and the resulting mixture was 
stirred for 1 h. The reaction was quenched with sat. aq. Na2S2O3 and the 
aqueous phase was extracted with tBuOMe. The combined extracts were washed with brine and 
dried over MgSO4. The drying agent was filtered off and the solvent was evaporated. Purification of 
the crude product by flash chromatography (SiO2, hexanes:EtOAc, 10:1) afforded the title compound 
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(9 mg, 90%) as a white foam. [𝑎]D
20: ‒75.6 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 9.53 (s, 1H), 
6.72 (s, 1H), 4.82 (t, J = 1.5 Hz, 1H), 4.63 (d, J = 1.8 Hz, 1H), 4.52 (t, J = 1.9 Hz, 1H), 3.98 (dd, J = 2.3, 1.5 
Hz, 1H), 3.86 (dd, J = 8.7, 1.7 Hz, 1H), 3.79 (dd, J = 10.6, 3.3 Hz, 1H), 3.75 – 3.67 (m, 2H), 0.92 (s, 9H), 
0.89 (s, 18H), 0.82 (s, 9H), 0.33 (s, 3H), 0.25 (s, 3H), 0.14 (s, 6H), 0.11 (s, 3H), 0.10 (s, 3H), 0.04 (s, 3H), 
0.02 (s, 3H) ppm; 13C NMR (101 MHz, CDCl3): δ = 183.5, 164.3, 161.8, 153.5, 108.4, 104.8, 79.0, 72.6, 
71.5, 70.7, 64.0, 63.9, 26.2, 26.1, 25.9, 25.6, 18.6, 18.3, 18.2, 17.9, -3.9, -4.4, -4.7 (2 C), -4.8, -4.9, -5.3, 
-5.4 ppm; IR (film): ?̃? = 3404, 2955, 2930, 2858, 1715, 1643, 1583, 1434, 1389, 1362, 1255, 1111, 
1067 cm-1; HRMS (ESI): m/z calcd. for C36H70O9Si4Na
+: 781.39864; found: 781.39892. 
(2S,3S,4S)-2-((1S,2R)-2,3-Bis((tert-butyldimethylsilyl)oxy)-1-hydroxypropyl)-3,4-bis((tert-butyl-
dimethylsilyl)oxy)-7-((E)-2-iodovinyl)-3,4-dihydro-2H,5H-pyrano[4,3-b]pyran-5-one (16). A solution 
of CHI3 (52 mg, 0.13 mmol) in dioxane (0.7 mL) was added dropwise to a 
suspension of CrCl2 (50 mg, 0.41 mmol) and aldehyde S3 (50 mg, 
0.066 mmol) in THF (0.7 mL) at 0 °C. The resulting mixture was stirred for 
1.5 h at 0 °C, the reaction was quenched with sat. aq. NH4Cl and the aqueous phase was extracted 
with tBuOMe. The combined extracts were washed with brine and dried over MgSO4. The drying 
agent was filtered off and the solvent was evaporated. The crude product was purified by flash 
chromatography (SiO2, hexane:EtOAc, 50:1), affording the title compound as a colorless oil (33 mg, 
57%). [𝑎]D
20: 82.6 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 7.45 (d, J = 14.7 Hz, 1H), 6.94 (d, J = 
14.7 Hz, 1H), 5.84 (s, 1H), 4.77 – 4.72 (m, 2H), 4.48 (t, J = 2.0 Hz, 1H), 3.93 (dd, J = 2.3, 1.5 Hz, 1H), 
3.82 (dd, J = 8.9, 1.8 Hz, 1H), 3.81 – 3.67 (m, 3H), 0.91 (s, 9H), 0.88 (s, 9H), 0.88 (s, 9H), 0.82 (s, 9H), 
0.31 (s, 3H), 0.24 (s, 3H), 0.13 (s, 6H), 0.10 (s, 3H), 0.09 (s, 3H), 0.03 (s, 3H), 0.02 (s, 3H) ppm; 13C NMR 
(101 MHz, CDCl3): δ = 165.7, 163.1, 157.1, 136.0, 101.2, 99.5, 78.3, 78.6, 72.7, 71.7, 70.8, 64.1, 64.0, 
26.2, 26.1, 25.9, 25.7, 18.6, 18.3, 18.2, 18.0, -3.9, -4.4, -4.6, -4.8 (2C), -5.0, -5.3, -5.4 ppm; IR (film): 
?̃? = 3398, 2954, 2929, 2895, 2858, 1726, 1642, 1597, 1471, 1426, 1254, 1145, 1112 cm-1; HRMS (ESI): 
m/z calcd. for C37H71O8Si4INa
+: 905.31739; found: 905.31630. 
(2E,4E,6E)-7-(Tributylstannyl)hepta-2,4,6-trienal (S4). This reaction was performed in the dark. A 
solution of SO3/pyridine (556 mg, 3.49 mmol) in DMSO (2.60 mL) was added 
dropwise to a solution of (2E,4E,6E)-7-(tributylstannyl)hepta-2,4,6-trien-1-ol 
(24)[2] (465 mg, 1.16 mmol) and NEt3 (0.82 mL, 5.88 mmol) in CH2Cl2 (6.5 mL) at 0 °C. The mixture was 
stirred for 3 h before it was concentrated and the residue was purified by flash chromatography 
(SiO2, hexanes:tBuOMe, 25:1 + 2.5% NEt3) to give the title compound as an orange-red oil (356 mg, 
77%). 1H NMR (400 MHz, CDCl3): δ = 9.57 (d, J = 8.1 Hz, 1H), 7.14 (dd, J = 15.4, 11.1 Hz, 1H), 6.80 – 
6.54 (m, 3H), 6.39 (dd, J = 14.1, 11.1 Hz, 1H), 6.18 (dd, J = 15.2, 8.1 Hz, 1H), 1.56 – 1.45 (m, 6H), 1.36 – 
1.26 (m, 6H), 0.97 – 0.86 (m, 15H) ppm; 13C NMR (101 MHz, CDCl3): δ = 193.8, 152.6, 145.6, 145.3, 
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144.9, 131.8, 128.6, 29.2, 27.4, 13.9, 9.8 ppm; IR (film): ?̃? = 2956, 2925, 1682, 1617, 1463, 1376, 
1290, 1173, 1122, 1012 cm-1; HRMS (ESI): m/z calcd. for C19H34OSnNa
+: 421.15228; found: 421.15231. 
Tributyl((1E,3E,5E,7E)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)octa-1,3,5,7-tetraen-1-yl)-
stannane (35). This reaction was carried out in the dark. nBuLi (1.6 M in hexane, 2.31 mL, 3.70 mmol) 
was added dropwise to a solution of 2,2-6,6-tetramethylpiperidine 
(0.63 mL, 3.73 mmol) in THF (1.3 mL) at 0 °C and the resulting mixture 
was stirred for 30 min. A solution of bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)methane (38) (991 mg, 3.70 mmol) in THF (2.6 mL) was added dropwise and the 
resulting mixture was stirred for 10 min at 0 °C before it was cooled to ‒78 °C. A solution of S4 
(367 mg, 0.924 mmol) in THF (1.3 mL) was added dropwise. The suspension was stirred for 6 h at ‒
78 °C, the reaction was quenched with sat. aq. NH4Cl and the mixture was extracted with Et2O. The 
combined extracts were washed with brine and dried over MgSO4. The drying agent was filtered off 
and the solvent was evaporated. Purification of the crude product by flash chromatography (SiO2, 
hexanes + 2.5% NEt3) afforded the title compound as an orange oil (405 mg, 84%). 
1H NMR (400 MHz, 
CDCl3): δ = 7.05 (dd, J = 17.6, 10.0 Hz, 1H), 6.59 (dd, J = 18.5, 9.5 Hz, 1H), 6.44 – 6.16 (m, 5H), 5.55 (d, 
J = 17.7 Hz, 1H), 1.55 – 1.43 (m, 6H), 1.35 – 1.26 (m, 6H), 1.27 (s, 12H), 0.93 – 0.86 (m, 15H) ppm; 
13C NMR (101 MHz, CDCl3): δ = 149.8, 146.8, 138.0, 137.5, 136.8, 134.9, 131.4, 120.7, 83.3, 29.2, 27.4, 
24.9, 13.9, 9.7 ppm; IR (film): ?̃? = 2956, 2925, 2852, 1614, 1582, 1541, 1387, 1358, 1322, 1269, 1144, 
1010 cm-1; HRMS (EI): m/z calcd. for C26H47O2BSn
+: 522.26922; found: 522.26904. 
(R)-4-Benzyl-3-((R)-2-methylbutanoyl)oxazolidin-2-one (S5). NaHMDS (42.8 mL, 42.8 mmol, 1 M in 
THF) was added dropwise to a solution of (R)-4-benzyl-3-butyryloxazolidin-2-one[6] 
(6.22 g, 25.15 mmol) in THF (36.7 mL) at ‒78 °C. The mixture was stirred for 30 min 
before CH3I (4.7 mL, 75.46 mmol) was added dropwise. Stirring was continued for 4 h 
at ‒78 °C before the reaction was quenched with brine and the aqueous layer was extracted with 
CH2Cl2. The combined extracts were dried over Na2SO4, the drying agent was filtered off and the 
solvent was evaporated. The crude product was purified by flash chromatography (SiO2, 
hexanes:EtOAc, 10:1), affording the title compound as a colorless oil (5.43 g, 83%). [𝑎]D
20: ‒77.5 (c = 
1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 7.37 – 7.26 (m, 3H), 7.24 – 7.19 (m, 2H), 4.73 – 4.64 (m, 1H), 
4.24 – 4.14 (m, 2H), 3.64 (q, J = 6.8 Hz, 1H), 3.27 (dd, J = 13.3, 3.2 Hz, 1H), 2.77 (dd, J = 13.4, 9.6 Hz, 
1H), 1.84 – 1.70 (m, 1H), 1.54 – 1.41 (m, 1H), 1.22 (d, J = 6.8 Hz, 3H), 0.93 (t, J = 7.5 Hz, 3H) ppm; 
13C NMR (101 MHz, CDCl3): δ = 177.3, 153.2, 135.5, 129.6, 129.1, 127.5, 66.1, 55.5, 39.3, 38.0, 26.5, 
17.0, 11.8 ppm; IR (film): ?̃? = 2967, 2877, 1774, 1693, 1455, 1383, 1234, 1205, 1097, 1015 cm-1; 
HRMS (ESI): m/z calcd. for C15H19O3NNa
+: 284.12571; found: 284.12551. 
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(R)-2-Methylbutan-1-ol (S6). LiBH4 (11.41 g, 31.27 mmol) was added to a solution of S5 (5.97 g, 
22.85 mmol) in Et2O (38.4 mL) and CH3OH (3.2 mL) at ‒20 °C. The mixture was stirred 
for 2 h at 0 °C and for another 2 h at room temperature before the reaction was 
quenched with NaOH (1 M). The mixture was extracted with Et2O, the combined extracts were dried 
over Na2SO4, the drying agent was filtered off and the solution was concentrated. The crude product 
was purified by flash chromatography (SiO2, pentane:Et2O 3:1), affording the title compound as a 
colorless oil (1.93 g, 96%, ee = 89%). [𝑎]D
20: +5.7 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 3.51 (dd, 
J = 10.4, 5.8 Hz, 1H), 3.42 (dd, J = 10.5, 6.4 Hz, 1H), 1.59 – 1.49 (m, 1H), 1.49 – 1.40 (m, 1H), 1.39 – 
12.7 (bs, 1H), 1.20 – 1.07 (m, 1H), 0.91 (d, J = 6.6 Hz, 3H), 0.91 (t, J = 7.3 Hz, 3H) ppm; 13C NMR 
(101 MHz, CDCl3): δ = 68.2, 37.5, 25.9, 16.3, 11.5 ppm; IR (film): ?̃? = 3330, 2960, 2920, 2876, 1462, 
1380, 1043, 1015 cm-1. HRMS (ESI): m/z calcd. for C5H12ONa
+: 88.08882; found: 88.08885. 
(R)-1-Iodo-2-methylbutane (ent-21). Iodine (10.54 g, 41.5 mmol) was added to a solution of 
imidazole (2.83 g, 41.5 mmol) and PPh3 (10.89 g, 41.52 mmol) in CH2Cl2 (66 mL) at 0 °C 
and the resulting mixture was stirred for 10 min. A solution of S6 (3.05 g, 34.6 mmol) in 
CH2Cl2 (33 mL) was added dropwise and stirring was continued for 3 h. The mixture was diluted with 
pentane (100 mL), the suspension was vigorously stirred for 5 min and filtered through a plug of 
silica. The filtrate was concentrated cautiously. The residue was again diluted with pentane and 
filtered through a plug of silica, affording the title compound as a colorless oil (5.07 g, 74%). [𝑎]D
20: 
9.4 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 3.23 (dd, J = 9.6, 4.6 Hz, 1H), 3.17 (dd, J = 9.6, 5.8 
Hz, 1H), 1.47 – 1.34 (m, 2H), 1.32 – 1.22 (m, 1H), 0.98 (d, J = 6.3 Hz, 3H), 0.89 (t, J = 7.2 Hz, 3H) ppm; 
13C NMR (101 MHz, CDCl3): δ = 36.5, 29.3, 20.3, 17.7, 11.5 ppm. IR (film): ?̃? 2960, 29263, 2874, 1455, 
1378, 1191 cm-1; HRMS (EI): m/z calcd. for C5H11I: 197.99055; found: 197.99039. 
(2R,4S)-N-((1S,2S)-1-Hydroxy-1-phenylpropan-2-yl)-N,2,4-trimethylhexanamide (S7). nBuLi (1.6 M in 
hexane, 27.2 mL, 43.6 mmol) was added dropwise to a solution of iPr2NH 
(6.4 mL, 45.9 mmol) and LiCl (5.83 g, 42.4 mmol) in THF (15.5 mL) at  
‒78 °C. The mixture was warmed to 0 °C, stirred for 15 min, and then re-cooled to ‒78 °C. A 
precooled (0 °C) solution of N-((1S,2S)-1-hydroxy-1-phenylpropan-2-yl)-N-methylpropionamide[4] 
(5.1 g, 22.93 mmol) in THF (77.5 mL) was added dropwise and stirring was continued for 1 h at 
78 °C, before the mixture was warmed to 0 °C. (S)-1-iodo-2-methylbutane[3] (2.2 g, 11.0 mmol) was 
added dropwise and stirring continued for 18 h at room temperature. The reaction was quenched 
with sat. aq. NH4Cl, the aqueous phase was extracted with EtOAc, and the combined extracts were 
washed with brine and dried over MgSO4. The drying agent was filtered off and the solvent was 
evaporated. The crude product was purified by flash chromatography (SiO2, hexane:EtOAc, 3:2), 
affording the title compound as a colorless oil (2.35 g, 74%). [𝑎]D




(400 MHz, CDCl3, signals of the major conformer): δ = 7.41 – 7.22 (m, 5H), 4.62 (d, J = 7.6 Hz, 1H), 
4.36 (bs, 1H), 2.84 (s, 3H), 2.72 – 2.60 (m, 1H), 1.49 – 1.19 (m, 5H), 1.18 – 1.09 (m, 1H), 1.15 (d, J = 7.1 
Hz, 3H), 1.06 (d, J = 6.6 Hz, 3H), 0.84 (t, J = 7.1 Hz, 3H), 0.82 (d, J = 6.1 Hz, 3H) ppm; 13C NMR 
(101 MHz, CDCl3) of the major conformer: δ = 179.7, 142.8, 128.4, 127.6, 126.4, 76.7, 59.6, 40.8, 
34.3, 33.3, 32.1, 29.8, 19.1, 17.1, 14.6, 11.4 ppm; IR (film): ?̃? = 3370, 2961, 2931, 2874, 1615, 1453, 
1408, 1376, 1112, 1084, 1049 cm-1; HRMS (ESI): m/z calcd. for C18H29O2NNa
+: 314.20905; 
found: 314.20922. 
The analytical data of (2S,4R)-N-((1R,2R)-1-hydroxy-1-phenylpropan-2-yl)-N,2,4-
trimethylhexanamide (ent-S7) are identical; [𝑎]D
20: ‒75.6 (c = 1, CHCl3). 
(2S,4S)-N-((1R,2R)-1-Hydroxy-1-phenylpropan-2-yl)-N,2,4-trimethylhexanamide (S8). Prepared 
analogously using N-((1R,2R)-1-hydroxy-1-phenylpropan-2-yl)-N-methyl-
propionamide[5] (1.5 g, 6.78 mmol), (S)-1-iodo-2-methylbutane[3] (644 mg, 
3.25 mmol), nBuLi (1.6 M in hexane, 8.05 mL, 12.88 mmol), LiCl (1.72 g, 40.67 mmol), iPr2NH 
(1.95 mL, 13.90 mmol) in THF (28 mL). Yield: 750 mg, 79%. [𝑎]D
20: ‒60.7 (c = 1, CHCl3); 
1H NMR 
(400 MHz, CDCl3, signals of the major conformer): δ = 7.41 – 7.27 (m, 5H), 4.61 (d, J = 7.6 Hz, 1H), 
4.38 (bs, 1H), 2.85 (s, 3H), 2.76 – 2.61 (m, 1H), 1.70 (ddd, J = 5.2, 8.5, 13.5 Hz, 1H), 1.46 – 1.19 (m, 
3H), 1.14 (d, J = 7.1 Hz, 3H), 1.08 – 1.00 (m, 2H), 1.06 (d, J = 6.8 Hz, 3H), 0.86 (t, J = 7.5 Hz, 3H), 0.77 
(d, J = 6.6 Hz, 3H) ppm; 13C NMR (101 MHz, CDCl3) of the major conformer: δ = 179.4, 142.8, 128.4, 
127.6, 126.4, 76.6, 59.5, 41.3, 34.3, 33.5, 32.1, 29.8, 19.3, 18.1, 14.6, 11.3 ppm; IR (film): ?̃? = 3372, 
2961, 2930, 2874, 1616, 1453, 1408, 1376, 1303, 1111, 1083, 1050 cm-1; HRMS (ESI): m/z calcd. for 
C18H29O2NNa
+: 314.20905; found: 314.20919. 
The analytical data of (2R,4R)-N-((1S,2S)-1-hydroxy-1-phenylpropan-2-yl)-N,2,4-trimethyl-
hexanamide (ent-S8) are identical; [𝑎]D
20: +63.2 (c = 1, CHCl3). 
(2R,4S)-2,4-Dimethylhexan-1-ol (2R,4S-22). nBuLi (1.6 M in hexane, 4.00 mL, 6.33 mmol) was added 
dropwise to a solution of iPr2NH (0.96 mL, 6.82 mmol) in THF (8 mL) at 0 °C. The 
mixture was stirred for 10 min before BH3·NH3 (200 mg, 6.49 mmol) was added in 
one portion. Stirring was continued for 15 min at 0 °C and 15 min at ambient temperature. After re-
cooling to 0 °C, a solution of S7 (473 mg, 1.62 mmol) in THF (5 mL) was added dropwise and the 
mixture was stirred at room temperature for 3 h. The reaction was quenched cautiously at 0 °C with 
HCl (3 M) and extracted with Et2O. The combined extracts were washed with HCl (3 M), NaOH (2 M) 
and brine, and then dried over Na2SO4. The drying agent was filtered off and the solvent was 
evaporated. The crude product was purified by flash chromatography (SiO2, hexane:EtOAc, 4:1), 
affording the title compound as a colorless oil (210 mg, 99%). [𝑎]D




(400 MHz, CDCl3): δ = 3.52 – 3.45 (m, 1H), 3.45 – 3.37 (m, 1H), 1.78 – 1.64 (m, 1H), 1.48 – 1.37 (m, 
1H), 1.34 – 1.25 (m, 2H), 1.21 – 1.03 (m, 3H), 0.89 (d, J = 6.8 Hz, 3H), 0.87 (t, J = 7.3 Hz, 3H), 0.84 (d, J 
= 6.6 Hz, 3H) ppm; 13C NMR (101 MHz, CDCl3): δ = 69.3, 40.3, 33.3, 31.6, 30.6, 19.0, 16.4, 11.6 ppm; IR 
(film): ?̃? = 3322, 2959, 2914, 2874, 1462, 1378, 1079, 1032 988 cm-1; HRMS (ESI): m/z calcd. for 
C8H19ONa
+: 131.14359; found: 131.14347. 
The analytical data of (2S,4R)-2,4-dimethylhexan-1-ol (2S,4R-22) are identical; [𝑎]D
20: +28.9 (c = 1.06, 
CHCl3). 
(2S,4S)-2,4-Dimethylhexan-1-ol (2S,4S-22). Prepared analogously using S8 (200 mg, 0.69 mmol) 
BH3·NH3 (85 mg, 2.75 mmol) nBuLi (1.6 M in hexane, 1.7 mL, 2.68 mmol), iPr2NH 
(0.40 mL, 2.88 mmol) and THF (5 mL). Yield: 67 mg, 75%. [𝑎]D
20: ‒2.2 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 3.56 – 3.49 (m, 1H), 3.42 – 3.33 (m, 1H), 1.77 – 1.66 (m, 1H), 1.47 – 
1.25 (m, 4H), 1.12 – 1.01 (m, 1H), 0.97 – 0.89 (m, 1H), 0.92 (d, J = 6.8 Hz, 3H), 0.87 (d, J = 6.6 Hz, 3H), 
0.86 (t, J = 7.3 Hz, 3H) ppm; 13C NMR (101 MHz, CDCl3): δ = 68.5, 40.7, 33.2, 31.6, 29.1, 19.9, 17.4, 
11.3 ppm; IR (film): ?̃? = 3322, 2957, 2914, 2874, 1461, 1378, 1029 cm-1; HRMS (ESI): m/z calcd. for 
C8H19ONa
+: 131.14359; found: 131.14367. 
The analytical data of (2R,4R)-2,4-dimethylhexan-1-ol ((2R,4R-22) are identical; [𝑎]D
20: +3.6 (c = 1.16, 
CHCl3). 
(4R,6S)-4,6-Dimethyloct-2-yn-1-ol (4R,6S-23). DMSO (2.73 mL, 38.39 mmol) was added dropwise to 
a solution of (COCl)2 (1.85 mL, 21.50 mmol) in CH2Cl2 (30 mL) at ‒78 °C and the 
resulting mixture was stirred for 15 min. A solution of 4R,6S-22 (2.00 g, 
15.35 mmol) in CH2Cl2 (35 mL) was added dropwise and stirring was continued for 30 min. NEt3 
(10.70 mL, 76.78 mmol) was added dropwise at ‒78 °C, the mixture was warmed to 0 °C and stirring 
was continued for 45 min. The reaction was quenched with sat. aq. NH4Cl and the aqueous phase 
extracted with CH2Cl2. The combined extracts were dried over Na2SO4, the drying agent was filtered 
off and the solvent was evaporated (bath temperature below 10 °C). The crude aldehyde was used 
without further purification. 
A solution of CBr4 (9.32 g, 28.10 mmol) in CH2Cl2 (25 mL) was added dropwise to a solution of PPh3 
(14.54 g, 55.44 mmol) in CH2Cl2 (20 mL) at 0 °C and the resulting mixture was stirred for 15 min. A 
solution of the crude aldehyde in CH2Cl2 (20 mL) was added dropwise and stirring was continued for 
15 min at 0 °C and for 2.5 h at ambient temperature. For work up, the mixture was poured onto 
Et2O/hexanes (4:1, 100 mL), the biphasic mixture was stirred for 10 min and filtered through a pad of 
Florisil®. The filtrate was evaporated, the residue was dispersed in hexanes and the suspension 
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filtered through Florisil®. The filtrate was concentrated to give the crude dibromoolefin that was 
used without further purification. 
nBuLi (1.6 M in hexane, 19.01 mL, 64.06 mmol) was added dropwise to a solution of the crude 
dibromoolefin in THF (29.4 mL) at ‒78 °C. The mixture was warmed to room temperature, stirred for 
30 min and then re-cooled to ‒78 °C. para-Formaldehyde (2.17 g, 72.43 mmol) was added in one 
portion and stirring was continued for 18 h while warming to room temperature. The reaction was 
quenched with sat. aq. NH4Cl and the aqueous phase was extracted with CH2Cl2. The combined 
extracts were washed with brine and dried over Na2SO4. The drying agent was filtered off and the 
solvent was evaporated. Purification of the crude product by flash chromatography (SiO2, 
pentane:tBuOMe, 10:1) afforded the title compound as a colorless oil (1.27 g, 54%). [𝑎]D
20: ‒20.6 (c = 
1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 4.26 (dd, J = 6.1, 2.0 Hz, 2H), 2.48 (ht, J = 6.8, 1.9 Hz, 1H), 
1.59 – 1.50 (m, 1H), 1.50 – 1.44 (m, 1H), 1.44 – 1.36 (m, 1H), 1.36 – 1.30 (m, 2H), 1.14 (d, J = 6.8 Hz, 
3H), 1.14 – 1.04 (m, 1H), 0.87 (d, J = 6.8 Hz, 3H), 0.86 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (101 MHz, 
CDCl3): δ = 91.5, 78.2, 51.6, 44.1, 32.1, 28.8, 23.7, 21.1, 19.4, 11.2 ppm; IR (film): ?̃? = 3317, 2962, 
2917, 2874, 1455, 1377, 1333, 1172, 1075 cm-1; HRMS (ESI): m/z calcd. for C10H18ONa
+: 177.12498; 
found: 177.12499. 
The analytical data of (4S,6R)-4,6-dimethyloct-2-yn-1-ol (4S,6R-23) are identical; [𝑎]D
20: +18.0 
(c = 1.28, CHCl3). 
(4S,6S)-4,6-Dimethyloct-2-yn-1-ol (4S,6S-23). Prepared analogously (3.81 g, 51%). [𝑎]D
20: +38.0 (c = 
1.24, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 4.25 (dd, J = 5.3, 1.8 Hz, 2H), 2.60 – 
2.46 (m, 1H), 1.67 – 1.52 (m, 2H), 1.51 – 1.42 (m, 1H), 1.37 – 1.25 (m, 1H), 1.15 
(d, J = 6.9 Hz, 3H), 1.21 – 1.05 (m, 2H), 0.87 (t, J = 7.4 Hz, 3H), 0.85 (d, J = 6.6 Hz, 3H) ppm; 13C NMR 
(101 MHz, CDCl3): δ = 91.0, 78.5, 51.6, 44.1, 32.5, 30.1, 23.9, 21.8, 18.8, 11.4 ppm; IR (film): ?̃? = 3325, 
2962, 2925, 2874, 1460, 1378, 1328, 1226, 1171, 1076 cm-1; HRMS (ESI): m/z calcd. for 
C10H18ONa
+: 177.12498; found: 177.12516. 
The analytical data of (4R,6R)-4,6-dimethyloct-2-yn-1-ol (4R,6R-23) are identical; [𝑎]D
20: ‒32.0 
(c = 1.1, CHCl3). 
(4R,6S,Z)-4,6-Dimethyl-2-(prop-1-yn-1-yl)oct-2-en-1-ol (4R,6S-26). Ethyl-3,3,3-trifluoropyruvate 
(0.93 mL, 7.02 mmol) was added dropwise to a solution of 4R,6S-23 (900 mg, 
5.83 mmol) in THF (6.4 mL) and the resulting mixture was stirred for 30 min at 
room temperature before it was cooled to ‒78 °C. Thexylborane (7.50 mL, 
7.00 mmol, 0.93 M in THF)[8] was added dropwise. The mixture was stirred for 10 min at ‒78 °C before 
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it was warmed to room temperature. Trimethylamine N-oxide (681 mg, 6.13 mmol) was added in one 
portion and stirring was continued for 30 min. Next, aq. KOH (14.6 mL, 43.8 mmol, 3 M in water) was 
added, followed by 1-iodo-1-propyne[7] (4.85 g, 29.22 mmol) and Pd(dppf)Cl2 (477 mg, 0.58 mmol). 
The resulting mixture was heated to 70 °C for 1.5 h before it was allowed to cool to room 
temperature. The aqueous phase was extracted with tBuOMe and the combined extracts were 
washed with brine and dried over MgSO4. The drying agent was filtered off and the solvent was 
evaporated. Purification of the crude product by flash chromatography (SiO2, hexanes:EtOAc, 20:1) 
afforded the title compound as pale orange oil (645 mg, 57%). [𝑎]D
20: ‒36.0 (c = 0.5, CHCl3); 
1H NMR 
(400 MHz, CDCl3): δ = 5.67 (d, J = 10.1 Hz, 1H), 4.23 – 4.06 (m, 2H), 2.63 – 2.44 (m, 1H), 1.97 (s, 3H), 
1.71 t, J = 6.2 Hz, 1H), 1.39 – 1.18 (m, 3H), 1.12 – 1.00 (m, 2H), 0.93 (d, J = 6.6 Hz, 3H), 0.87 – 0.79 (m, 
6H) ppm; 13C NMR (101 MHz, CDCl3): δ = 145.3, 121.2, 85.3, 79.1, 60.4, 44.4, 32.0, 30.4, 29.2, 20.9, 
19.6, 11.3, 4.4 ppm; IR (film): ?̃? = 3395, 2956, 2916, 2873, 1456, 1377, 1258, 1046, 992, 971 cm-1; 
HRMS (ESI): m/z calcd. for C13H22ONa
+: 217. 15628; found: 217.15627. 
The analytical data of (4S,6R,Z)-4,6-dimethyl-2-(prop-1-yn-1-yl)oct-2-en-1-ol (4S,6R-26) are identical; 
[𝑎]D
20: +45.5 (c = 1, CHCl3). 
(4S,6S,Z)-4,6-Dimethyl-2-(prop-1-yn-1-yl)oct-2-en-1-ol (4S,6S-26). Prepared analogously (597 mg, 
57%). [𝑎]D
20: +44.7 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 5.23 (d, J = 10.1 
Hz, 1H), 4.16 (d, J = 5.6 Hz, 1H), 2.62 – 2.50 (m, 1H), 1.97 (s, 3H), 1.70 t, J = 5.9 
Hz, 1H), 1.31 – 1.22 (m, 3H), 1.15 – 1.05 (m, 2H), 0.95 (d, J = 6.6 Hz, 3H), 0.85 (t, 
J = 7.3 Hz, 3H), 0.81 (d, J = 6.3 Hz, 3H) ppm; 13C NMR (101 MHz, CDCl3): δ = 145.0, 121.7, 85.3, 79.2, 
60.5, 44.6, 32.3, 30.6, 30.2, 21.8, 19.0, 11.4, 4.4 ppm; IR (film): ?̃? = 3390, 2917, 2873, 1458, 1377, 
1264, 1002 cm-1; HRMS (ESI): m/z calcd. for C13H22ONa
+: 217.15628; found: 217.15638. 
The analytical data of (4R,6R,Z)-4,6-dimethyl-2-(prop-1-yn-1-yl)oct-2-en-1-ol (4R,6R-26) are 
identical; [𝑎]D
20: ‒46.3 (c = 1, CHCl3). 
(4R,6S,Z)-2-((E)-2-(Dimethyl(phenyl)silyl)prop-1-en-1-yl)-4,6-dimethyloct-2-en-1-ol (4R,6S-27). 
PhMe2SiLi (3.30 mL, 3.30 mmol, 1 M in THF)
[9] was added dropwise to a 
suspension of CuCN (127 mg, 1.42 mmol) in THF (1.10 mL) at ‒50 °C. The 
mixture was warmed to ‒10 °C, stirred for 45 min and then re-cooled to ‒50 °C. H2O (72 µL, 
4.00 mmol) was added, the solution was warmed to ‒10 °C, stirred for 30 min and re-cooled to 
50 °C. A solution of 4R,6S-26 (110 mg, 0.57 mmol) in THF (1.10 mL) was added dropwise and the 
mixture stirred at ‒10 °C for 2 h before the reaction was quenched with sat. aq. NH4Cl. The aqueous 
phase was extracted with tBuOMe, the combined extracts were washed with brine and dried over 
MgSO4. The drying agent was filtered off and the solvent was evaporated. Purification of the crude 
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product by flash chromatography (SiO2, hexanes:EtOAc, 1:0 to 30:1) afforded the title compound as a 
colorless oil (165 mg, 88%). [𝑎]D
20: ‒48.7 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 7.55 – 7.49 (m, 
2H), 7.39 – 7.33 (m, 3H), 6.26 (t, J = 1.5 Hz, 1H), 5.28 (d, J = 9.8 Hz, 1H), 4.26 – 4.28 (m, 2H), 2.64 (dq, J 
= 9.8, 6.9 Hz, 1H), 1.86, (d, J = 1.8 Hz, 3H), 1.58 (bs, 1H), 1.42 – 1.33 (m, 2H), 1.31 – 1.25 (m, 1H), 1.13 
– 1.06 (m, 2H), 0.98 (d, J = 6.6 Hz, 3H), 0.86 (d, J = 6.4 Hz, 3H), 0.86 (t, J = 7.2 Hz, 3H), 0.38 (s, 6H) 
ppm; 13C NMR (101 MHz, CDCl3): δ = 140.9, 139.4, 138.4, 138.1, 134.3, 134.1, 129.1, 127.89, 127.88, 
61.0, 45.0, 32.1, 30.2, 29.3, 21.5, 19.7, 16.7, 11.3, -3.3 ppm; IR (film): ?̃? = 3344, 2957, 2925, 1597, 
1460, 1427, 1376, 1247, 1111, 1016, cm-1; HRMS (ESI): m/z calcd. for C21H34OSiNa
+: 353.22711; 
found: 353.22706 
The analytical data of (4S,6R,Z)-2-((E)-2-(dimethyl(phenyl)silyl)prop-1-en-1-yl)-4,6-dimethyloct-2-
en-1-ol (4S,6R-27) are identical; [𝑎]D
20: +38.7 (c = 1, CHCl3). 
(4S,6S,Z)-2-((E)-2-(Dimethyl(phenyl)silyl)prop-1-en-1-yl)-4,6-dimethyloct-2-en-1-ol (4S,6S-27). 
Prepared analoguously (107 mg, 90%). [𝑎]D
20: +76.2 (c = 1, CHCl3); 
1H NMR 
(400 MHz, CDCl3): δ = 7.55 – 7.49 (m, 2H), 7.38 – 7.33 (m, 3H), 6.26 (t, J = 
1.3 Hz, 1H), 5.22 (d, J = 10.1 Hz, 1H), 4.22 (s, 2H), 2.71 – 2.58 (m, 1H), 1.85 (d, J = 1.9 Hz, 3H), 1.58 – 
1.53 (m, 1H), 1.32 – 1.24 (m, 2H), 1.14 – 1.09 (m, 1H), 0.99 (d, J = 6.6 Hz, 3H), 0.95 – 0.88 (m, 2H), 
0.84 (t, J = 7.2 Hz, 3H), 0.84 (d, J = 6.0 Hz, 3H), 0.37 (s, 6H) ppm; 13C NMR (101 MHz, CDCl3): δ = 140.6, 
139.4, 138.4, 138.1, 134.7, 134.2, 129.1, 127.9, 61.0, 44.9, 32.5, 30.4, 30.3, 22.5, 19.2, 16.8, 11.5, -3.3 
ppm; IR (film): ?̃? = 3355, 2957, 2925, 1459, 1427, 1377, 1247, 1111, 1015 cm-1; HRMS (ESI): m/z calcd. 
for C21H34OSiNa
+: 353.22711; found: 353.22713. 
The analytical data of (4R,6R,Z)-2-((E)-2-(dimethyl(phenyl)silyl)prop-1-en-1-yl)-4,6-dimethyloct-2-
en-1-ol (4R,6R-27) are identical; [𝑎]D
20: ‒43.9 (c = 1, CHCl3). 
(4R,6S,Z)-2-((E)-2-(Dimethyl(phenyl)silyl)prop-1-en-1-yl)-4,6-dimethyloct-2-enal (4R,6S-S9). Dess-
Martin periodinane (308 mg, 0.73 mmol) was added in one portion to a 
solution of 4R,6S-27 (160 mg, 0.48 mmol) in CH2Cl2 (4.8 mL) and the 
resulting mixture was stirred for 1.5 h before the reaction was quenched with sat. aq. Na2S2O3. The 
aqueous phase was extracted with tBuOMe, the combined extracts were washed with brine and 
dried over MgSO4. The drying agent was filtered off and the solvent was evaporated. Purification of 
the crude product by flash chromatography (SiO2, hexanes:EtOAc, 50:1) afforded the title compound 
(155 mg, 98%). [𝑎]D
20: ‒34.2 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 10.13 (s, 1H), 7.56 – 7.51 (m, 
2H), 7.38 – 7.34 (m, 3H), 6.44 (t, J = 1.4 Hz, 1H), 6.32 (dd, J = 11.0, 0.9 Hz, 1H), 3.44 – 3.31 (m, 1H), 
1.75 (d, J = 1.8 Hz, 3H), 1.46 – 1.32 (m, 3H), 1.27 – 1.08 (m, 2H), 1.09 (d, J = 6.3 Hz, 3H), 0.88 (d, J = 6.1 
Hz, 3H), 0.85 (t, J = 7.2 Hz, 3H), 0.40 (s, 6H) ppm; 13C NMR (101 MHz, CDCl3): δ = 191.0, 158.2, 140.4, 
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138.0, 135.3, 134.2, 133.6, 129.1, 127.9, 44.6, 32.1, 29.4, 29.1, 21.4, 19.6, 16.9, 11.2, -3.4 ppm; IR 
(film): ?̃? = 2960, 2928, 2874, 1682, 1603, 1457, 1376, 1428, 1248, 1111 cm-1; HRMS (ESI): m/z calcd. 
for C21H32OSiNa
+: 351. 21146; found: 351.21161. 
The analytical data of (4S,6R,Z)-2-((E)-2-(dimethyl(phenyl)silyl)prop-1-en-1-yl)-4,6-dimethyloct-2-
enal (4S,6R-S9) are identical; [𝑎]D
20: +32.2 (c = 0.97, CHCl3). 
(4S,6S,Z)-2-((E)-2-(Dimethyl(phenyl)silyl)prop-1-en-1-yl)-4,6-dimethyloct-2-enal (4S,6S-S9). 
Prepared analogously (55 mg, 92%). [𝑎]D
20: +45.2 (c = 1, CHCl3); 
1H NMR 
(400 MHz, CDCl3): δ = 10.13 (s, 1H), 7.57 – 7.51 (m, 2H), 7.40 – 7.33 (m, 
3H), 6.45 (dd, J = 1.6, 1.4 Hz, 1H), 6.27 (dd, J = 11.1, 1.0 Hz, 1H), 3.46 – 3.30 (m, 1H), 1.75 (d, J = 1.8 
Hz, 3H), 1.43 – 1.14 (m, 5H), 1.12 (d, J = 6.6 Hz, 3H), 0.86 (d, J = 6.8 Hz, 3H), 0.85 (t, J = 7.0 Hz, 3H), 
0.40 (s, 6H) ppm; 13C NMR (101 MHz, CDCl3): δ = 191.0, 158.0, 140.4, 138.0, 135.8, 134.2, 133.6, 
129.1, 127.9, 44.6, 32.6, 30.2, 29.5, 22.3, 19.1, 16.9, 11.4, -3.43, -3.45 ppm; IR (film): ?̃? 2959, 2926, 
2873, 1681, 1459, 1428, 1377, 1248, 1191, 1111 cm-1; HRMS (ESI): m/z calcd. for C21H32OSiNa
+: 351. 
21146; found: 351.21153. 
The analytical data of (4R,6R,Z)-2-((E)-2-(dimethyl(phenyl)silyl)prop-1-en-1-yl)-4,6-dimethyloct-2-
enal (4R,6R-S9) are identical; [𝑎]D
20: ‒48.4 (c = 1, CHCl3). 
2-(Trimethylsilyl)ethyl (4R,6S,Z)-2-((E)-2-(dimethyl(phenyl)silyl)prop-1-en-1-yl)-4,6-dimethyloct-2-
enoate (4R,6S-28). NaH2PO4 (170 mg, 1.42 mmol) and H2O2 (0.26 mL, 2.68 mmol, 35% in water) were 
added to a solution of 4R,6S-S9 (155 mg, 0.47 mmol) in tBuOH/H2O 1:1 
(1.6 mL) at 0 °C and the resulting mixture was stirred for 5 min before 
NaClO2 (256 mg, 2.26 mmol) was added. Stirring was continued for 16 h 
before the reaction was quenched with water and the aqueous phase was extracted with pentane. 
The combined extracts were washed with brine and dried over MgSO4. The drying agent was filtered 
off, the solution was concentrated and the residue used without further purification. 
DEAD (0.31 mL, 1.65 mmol) was added dropwise to a solution of the crude acid, PPh3 (495 mg, 
1.89 mmol) and 2-(TMS)-ethanol (0.25 mL, 1.66 mmol) in THF (2.4 mL) at 0 °C within 15 min and the 
resulting mixture was stirred for 2 h at 0 °C. The reaction was quenched with sat. aq. NH4Cl and the 
aqueous phase was extracted with tBuOMe. The combined extracts were washed with brine and 
dried over MgSO4. The drying agent was filtered off and the solvent was evaporated. Purification of 
the crude product by flash chromatography (SiO2, hexanes to hexanes:EtOAc, 200:1) afforded the 
title compound as a colorless oil (132 mg, 63%). [𝑎]D
20: ‒18.4 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): 
δ = 7.57 – 7.46 (m, 2H), 7.39 – 7.20 (m, 3H), 6.33 (dd, J = 1.8, 1.3 Hz, 1H), 5.62 (dd, J = 10.2, 0.9 Hz, 
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1H), 4.29 – 4.20 (m, 2H), 3.06 – 2.89 (m, 1H), 1.72 (d, J = 1.8 Hz, 3H), 1.41 – 1.30 (m, 2H), 1.30 – 1.22 
(m, 1H), 1.20 – 1.01 (m, 4H), 0.99 (d, J = 6.6 Hz, 3H), 0.85 (d, J = 6.3 Hz, 3H), 0.84 (t, J = 7.2 Hz, 3H), 
0.37 (s, 6H), 0.05 (s, 9H) ppm; 13C NMR (101 MHz, CDCl3): δ = 168.8, 149.1, 138.2, 137.5, 136.5, 134.2, 
129.6, 129.1, 127.9, 44.5, 32.1, 31.5, 29.3, 20.7, 19.6, 17.5, 16.3, 11.3, -1.4, -3.4 ppm; IR (film): ?̃? = 
2956, 1717, 1428, 1249, 1203, 1167, 1111 cm-1; HRMS (ESI): m/z calcd. for C26H44O2Si2Na
+: 467.27721; 
found: 467.27751.  
The analytical data of 2-(trimethylsilyl)ethyl (4S,6R,Z)-2-((E)-2-(dimethyl(phenyl)silyl)prop-1-en-1-
yl)-4,6-dimethyloct-2-enoate (4S,6R-28) are identical; [𝑎]D
20: +19.5 (c = 1, CHCl3). 
2-(Trimethylsilyl)ethyl (4S,6S,Z)-2-((E)-2-(dimethyl(phenyl)silyl)prop-1-en-1-yl)-4,6-dimethyloct-2-
enoate (4S,6S-28). Prepared analogously (42 mg, 62%). [𝑎]D
20: +26.4 (c = 1, CHCl3); 
1H NMR (400 MHz, 
CDCl3): δ = 7.55 – 7.48 (m, 2H), 7.38 – 7.32 (m, 3H), 6.33 (d, J = 1.0 Hz, 1H), 
5.57 (d, J = 10.4 Hz, 1H), 4.28 – 4.20 (m, 2H), 3.08 – 2.95 (m, 1H), 1.72 (d, J 
= 1.5 Hz, 3H), 1.35 – 1.24 (m, 4H), 1.20 – 1.05 (m, 3H), 1.01 (d, J = 6.6 Hz, 
3H), 0.84 (t, J = 7.4 Hz, 3H), 0.83 (d, J = 7.3 Hz, 3H), 0.37 (s, 6H), 0.04 (s, 9H) ppm; 13C NMR (101 MHz, 
CDCl3): δ = 168.8, 148.8, 138.2, 137.5, 136.4, 134.2, 130.1, 129.1, 127.9, 62.9, 44.8, 32.6, 31.6, 30.2, 
21.6, 19.2, 17.5, 16.3, 11.4, -1.4, -3.4 ppm; IR (film): ?̃? = 2956, 2902, 1717, 1460, 1428, 1378, 1249, 
1204, 1167, 1111 cm-1; HRMS (ESI): m/z calcd. for C26H44O2Si2Na
+: 467.27721; found: 467.27751. 
The analytical data of 2-(trimethylsilyl)ethyl (4R,6R,Z)-2-((E)-2-(dimethyl(phenyl)silyl)prop-1-en-1-
yl)-4,6-dimethyloct-2-enoate (4R,6R-28) are identical; [𝑎]D
20: ‒33.5 (c = 1, CHCl3). 
2-(Trimethylsilyl)ethyl (4R,6S,Z)-2-((E)-2-iodoprop-1-en-1-yl)-4,6-dimethyloct-2-enoate (4R,6S-29). 
NIS (83 mg, 0.37 mmol) was added in one portion to a solution of 4R,6S-28 
(110 mg, 0.25 mmol) and 2,6-lutidine (43 µL, 0.37 mmol) in 
hexafluoroisopropanol (0.8 mL) at 0 °C and the resulting mixture was stirred for 
2 min. The reaction was quenched with sat. aq. Na2S2O3 and the aqueous phase extracted with 
tBuOMe. The combined extracts were washed with brine and dried over MgSO4. The drying agent 
was filtered off and the solvent was evaporated. Purification of the crude product by flash 
chromatography (SiO2, hexanes to hexanes:EtOAc, 200:1) afforded the title compound as a colorless 
oil (96 mg, 89%). [𝑎]D
20: ‒14.2 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 6.80 (t, J = 1.5 Hz, 1H), 
5.68 (dd, J = 10.1, 1.3 Hz, 1H), 4.27 – 4.20 (m, 2H), 3.23 – 3.12 (m, 1H), 2.45 (d, J = 1.8 Hz, 3H), 1.38 – 
1.21 (m, 3H), 1.17 – 1.07 (m, 2H), 1.07 – 1.01 (m, 2H), 0.98 (d, J = 6.8 Hz, 3H), 0.84 (d, J = 7.6 Hz, 3H), 
0.83 (t, J = 8.3 Hz, 3H), 0.05 (s, 9H) ppm, 13C NMR (101 MHz, CDCl3): δ = 166.7, 151.7, 138.5, 128.3, 
98.1, 63.1, 44.3, 32.2, 31.4, 29.3, 29.0, 20.4, 19.5, 17.5, 11.3, -1.4 ppm; IR (film): ?̃? = 2955, 2923, 
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2874, 1718, 1456, 1378, 1250, 1205, 1166, 1068 cm-1; HRMS (ESI): m/z calcd. for 
C18H33O2SiINa
+: 459.11868; found: 459.11850. 
The analytical data of 2-(trimethylsilyl)ethyl (4S,6R,Z)-2-((E)-2-iodoprop-1-en-1-yl)-4,6-dimethyloct-
2-enoate (4S,6R-29) are identical; [𝑎]D
20: +16.8 (c = 1, CHCl3). 
2-(Trimethylsilyl)ethyl (4S,6S,Z)-2-((E)-2-iodoprop-1-en-1-yl)-4,6-dimethyloct-2-enoate (4S,6S-29). 
Prepared analoguously (96 mg, 89%). [𝑎]D
20: +24.4 (c = 1, CHCl3); 
1H NMR 
(400 MHz, CDCl3): δ = 6.80 (t, J = 1.5 Hz, 1H), 5.63 (dd, J = 10.5, 1.2 Hz, 1H), 4.27 
– 4.21 (m, 2H), 3.27 – 3.13 (m, 1H), 2.45 (d, J = 1.5 Hz, 3H), 1.34 – 1.22 (m, 3H), 
1.16 – 1.08 (m, 2H), 1.06 – 1.01 (m, 2H), 1.01 (d, J = 6.6 Hz, 3H), 0.84 (t, J = 7.2 Hz, 3H), 0.82 (d, J = 6.3 
Hz, 3H), 0.05 (s, 9H) ppm; 13C NMR (101 MHz, CDCl3): δ = 166.7, 151.4, 138.5, 128.8, 98.1, 63.1, 44.6, 
32.7, 31.5, 30.2, 29.0, 21.2, 19.2, 17.5, 11.5, -1.4 ppm; IR (film): ?̃? = 2956, 2923, 2874, 1718, 1459, 
1378, 1250, 1205, 1166, 1068 cm-1; HRMS (ESI): m/z calcd. for C18H33O2SiINa
+: 459.11868; 
found: 459.11908. 
The analytical data of 2-(trimethylsilyl)ethyl (4R,6R,Z)-2-((E)-2-iodoprop-1-en-1-yl)-4,6-dimethyloct-
2-enoate (4R,6R-29) are identical; [𝑎]D
20: ‒22.3 (c = 1, CHCl3). 
Compound (S,R)-37. This reaction was performed in the dark. Pd(CH3CN)2Cl2 (0.2 mg, 0.0007 mmol) 
was added to a degassed (pump and 
freeze, 3 cycles) solution of Ph3As (0.45 mg, 
0.0015 mmol) and flame dried 
[Ph2O2P][NBu4] (14 mg, 0.0305 mmol)
[11] in 
DMF (0.1 mL). The resulting mixture was stirred for 5 min before it was transferred to a Schlenk tube 
containing alkenyl iodide 4S,6R-29 (6 mg, 0.0137 mmol) and tetraene 35 (7 mg, 0.0134 mmol). The 
mixture was stirred for 20 h at room temperature. aq. K3PO4 (3 M, 3.5 µL, 0.0105 mmol) was added in 
one portion and the mixture was stirred for 5 min before a degassed (pump and freeze, 3 cycles) 
solution of alkenyl iodide 16 (6 mg, 0.0068 mmol) in THF (0.1 mL) was added, followed by Pd(dppf)Cl2 
(0.6 mg, 0.0007 mmol). The suspension was stirred for 18 h before the reaction was quenched with 
water. The aqueous phase was extracted with Et2O, the combined extracts were washed with brine 
and dried over MgSO4, the drying agent was filtered off and the solvent was evaporated (below 
25 °C). Purification of the crude product by flash chromatography (SiO2, pentane + 2.5% NEt3) 
afforded the title compound (4.4 mg, 55%) as a red oil. [𝑎]D
20: –142 (c = 0.1, CHCl3); 
1H NMR 
(400 MHz, CDCl3): δ = 7.16 (dd, J = 15.1, 11.2 Hz, 1H), 6.52, (dd, J = 14.0, 11.5 Hz, 1H), 6.46 ‒ 6.27 (m, 
7H), 6.13 (s, 1H), 6.01 (d, J = 15.2 Hz, 1H), 5.85 (s, 1H), 5.66 (d, J = 10.1 Hz, 1H), 4.82 (s, 1H), 4.73 (s, 
1H), 4.53 (s, 1H), 4.30 – 4.22 (m, 2H), 3.94 (t, J = 1.0 Hz, 1H), 3.85 – 3.77 (m, 2H), 3.76 – 3.68 (m, 2H), 
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3.09 – 2.94 (m, 1H), 1.83 (s, 3H), 1.40 – 1.31 (m, 2H), 1.23 – 1.09 (m, 3H), 1.08 – 1.02 (m, 2H), 1.01 (d, 
J = 6.6 Hz, 3H), 0.92 (s, 9H), 0.90 – 0.87 (m, 18H), 0.87 – 0.80 (m, 15H), 0.33 (s, 3H), 0.25 (s, 3H), 0.15 
– 0.12 (m, 6H), 0.10 (s, 3H), 0.09 (s, 3H), 0.07 – 0.02 (m, 15H) ppm; 13C NMR (125 MHz, CDCl3): δ = 
168.4, 166.2, 163.8, 158.7, 149.8, 139.4, 138.8, 136.6, 136.1, 135.7, 135.5, 132.7, 132.3, 131.2, 130.5, 
129.6, 128.8 121.8, 100.9, 98.3, 78.4, 72.8, 71.9, 70.9, 64.2, 64.1, 63.1, 32.2, 31.8, 29.3, 26.2, 26.1, 
25.9, 25.7, 20.7, 19.6, 18.6, 18.4, 18.3, 18.0, 17.6, 13.7, 11.3, -1.4, -3.9, -4.4, -4.6, -4.75, -4.78, -4.9, -
5.27, 5.34 ppm; IR (film): ?̃? = 2955, 2925, 2869, 2854, 1721, 1460, 1377, 1251, 1188, 1082 cm-1. 
HRMS (ESI): m/z calcd. for C63H112O10Si5Na
+: 1191.69941; found: 1191.70067. 
Compound (S,R)-1. This reaction was performed in the dark. A solution of TASF (8 mg, 0.029 mmol) in 
DMF (40 µL) was added to a solution of (S,R)-
37 (3 mg, 0.0026 mmol) in DMF (40 µL) at 0 °C 
and the resulting mixture was stirred for 16 h 
at room temperature. The reaction was quenched with aq. HCl (pH = 3) and the aqueous phase was 
extracted with EtOAc. The combined extracts were dried over Na2SO4, the drying agent was filtered 
off and the solution was concentrated. The crude product was purified by HPLC (column: 150 mm 
YMC Actus, Ø = 20 mm; stationary phase: YMC ODS-A 5 μm, 20150 00456; mobile phase: 
methanol/TFA in water pH 3.5 =80:20) to give the title compound as an orange solid (1 mg, 64%). 
[𝑎]D
20: ‒124 (c = 0.05, DMSO); 1H NMR (600 MHz, [D6]-DMSO): see Table S-5; 
13C NMR (150 MHz, [D6]-
DMSO): see Table S-4; IR (film): ?̃? = 3375, 2940, 2915, 2824, 1657, 1436, 1407, 1313, 1018, 952 cm-1; 
HRMS (ESI): m/z calcd. for C34H43O10
-: 611.28618; found: 611.28573. 
Compound (S,S)-1. Prepared analogously as an orange-red solid after purification by HPLC (Column: 
150 mm YMC Actus, Ø = 20 mm; stationary 
phase: YMC ODS-A 5 μm, 20150 00456; 
mobile phase: MeOH:TFA in water pH 3.5 = 
80:20). [𝑎]D
20: ‒82 (c = 0.05, CHCl3). 
1H NMR (600 MHz, [D6]-DMSO): see Table S-7; 
13C NMR (150 MHz, 
[D6]-DMSO): see Table S-6; IR (film): ?̃? = 3449, 2250, 2125, 1662, 1053, 1024, 1005 cm
-1; HRMS (ESI): 
m/z calcd. for C34H43O10




THE EPIPYRONE A SERIES 
 6-Methyl-4-(2-(trimethylsilyl)ethoxy)-3-((2S,3S,4R,5S,6R)-3,4,5-tris(benzyloxy)-6-((benzyloxy) 
methyl)tetrahydro-2H-pyran-2-yl)-2H-pyran-2-one (S10). DIAD (5.3 mL, 26.91 
mmol) was added dropwise to a solution of 43 (3.49 g, 5.38 mmol),[12] PPh3 
(8.47 g, 32.29 mmol) and 2-TMS-ethanol (3.86 mL, 26.91 mmol) in THF (17.5 
mL) at 0 °C. The resulting mixture was stirred for 16 h before the reaction was 
quenched with sat. aq. NH4Cl and the aqueous layer was extracted with tBuOMe. The combined org. 
extracts were washed with brine and dried over MgSO4. The drying agent was filtered off and the 
solvent was evaporated. Purification of the crude product by flash chromatography (SiO2, 
hexanes:EtOAc, 5:1 to 2:1) afforded the title compound as a colorless oil (3.34 g, 83%). [𝑎]D
20: ‒18.1 
(c = 0.84, CHCl3). 
1H NMR (400 MHz, CDCl3, mixture of rotamers): δ = 7.50 – 7.04 (m, 20H), 5.94 – 5.57 
(m, 1H), 5.13 – 4.33 (m, 10 H), 4.16 – 3.52 (m, 7H), 2.25 – 2.14 (m, 3H), 0.97 – 0.78 (m, 2H), 0.09 ‒ 
0.16 (m, 9H) ppm; 13C NMR (100 MHz, CDCl3, mixture of rotamers, some signals are overlapping): δ 
= 168.6, 168.4, 165.6, 164.0, 162.9, 162.6, 139.8, 139.6, 139.5, 139.4, 139.0, 138.8, 138.2, 138.1, 
128.5, 128.22, 128.16, 128.1, 128.0, 127.83, 127.78, 127.7, 127.5, 127.4, 127.3, 127.1, 101.5, 101.0, 
96.3, 95.2, 85.5, 77.6, 77.4, 75.7, 75.6, 75.1, 74.9, 74.7, 74.6, 74.3, 74.1, 73.8, 73.5, 72.7, 72.6, 72.4, 
69.1, 68.6, 67.6, 20.7, 20.5, 17.9, 17.5, -1.3, -1.5 ppm; IR (film): ?̃? = 3030, 2869, 1700, 1646, 1556, 
1452, 1354, 1322, 1248, 1087 cm-1; HRMS (ESI): m/z calcd. for C45H52O8SiNa
+: 771.33237; 
found: 771.33216.  
6-Methyl-4-(2-(trimethylsilyl)ethoxy)-3-((2S,3S,4R,5S,6R)-3,4,5-tris((tert-butyldimethylsilyl)oxy)-6-
(((tert-butyldimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-yl)-2H-pyran-2-
one (44). Pd(OH)2/C (30 mg, 20% loading) was added to a solution of S10 
(300 mg, 0.40 mmol) in CH3OH (4.3 mL), the suspension was purged with H2 
and stirred under hydrogen atmosphere for 16 h. The suspension was filtered 
through a plug of Celite®, the filtrate was concentrated and the residue dried under vacuum. 
The crude product was dissolved in CH2Cl2 (2.1 mL), the solution was cooled to 0 °C and pyridine 
(2.1 mL) was added. After 5 min, TBSOTf (0.92 mL, 4.01 mmol) was added dropwise and stirring was 
continued for 16 h at room temperature. The reaction was quenched with sat. aq. NH4Cl and the 
aqueous layer was extracted with tBuOMe. The combined organic phases were washed with brine 
and dried over MgSO4. The drying agent was filtered off and the solvent was evaporated. Purification 
of the crude product by flash chromatography (SiO2, hexanes:EtOAc, 10:1) afforded the title 
compound as a colorless oil (280 mg, 83%). [𝑎]D
20: ‒37.0 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3, 
                                                          
[12] A. Kanai, T. Kamino, K. Kuramochi, S. Kobayashi, Org. Lett. 2003, 5, 2837-2839. 
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mixture of rotamers): δ = 5.90 – 5.81 (m, 1H), 4.77 – 4.38 (m, 2H), 4.17 – 3.99 (m, 3H), 3.75 – 3.51 (m, 
3H), 3.44 – 3.28 (m, 1H), 2.25 – 2.14 (m, 3H), 1.18 – 1.07 (m, 2H), 1.01 – 0.91 (m, 18H), 0.88 – 0.83 
(m, 9H), 0.76 – 0.70 (m, 9H), 0.19 – 0.17 (m, 3H), 0.16 – 0.00 (m, 27H), -0.20 – -0.25 (m, 3H) ppm; 
13C NMR (100 MHz, CDCl3, mixture of rotamers, some signals are overlapping): δ = 168.3, 167.8, 
165.7, 163.5, 162.7, 161.9, 102.4, 102.0, 96.0, 94.8, 79.6, 79.40, 79.36, 79.2, 74.3, 72.7, 71.7, 69.8, 
68.5, 67.4, 67.3, 60.9, 27.3, 27.2, 26.6, 26.4, 26.24, 26.19, 25.9, 20.6, 19.5, 19.4, 19.0, 18.8, 18.7, 
18.2, 18.13, 18.05, 18.0, 17.8, -1.1, -1.4, -1.9, -2.3, --3.2, -3.4, -3.5, -3.6, -3.7, -3.8, -3.9, -4.3, -4.58, 
4.64, -5.0, -5.17, -5.21, -5.23 ppm; IR (film): ?̃? = 2954, 2929, 2887, 2856, 1716, 1648, 1561, 1472, 
1249, 1098, 1082 cm-1; HRMS (ESI): m/z calcd. for C41H84O8Si5Na
+: 867.49048; found: 867.49030.  
6-((3E,5E)-6-Bromo-2-hydroxyhexa-3,5-dien-1-yl)-4-(2-(trimethylsilyl)ethoxy)-3-((2S,3S,4R,5S,6R)-
3,4,5-tris((tert-butyldimethylsilyl)oxy)-6-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydro-2H-
pyran-2-yl)-2H-pyran-2-one (S11). A solution of LiHMDS (806 mg, 4.82 mmol) in THF (4.8 mL) was 
added dropwise to a solution of 44 (815 mg, 0.964 mmol) in THF 
(5 mL) at ‒78 °C. The resulting mixture was stirred for 30 min at 
this temperature before a solution of (2E,4E)-5-bromopenta-2,4-
dienal 45 (775.9 mg, 4.82 mmol)[13] in THF (19 mL) was added 
dropwise, followed by Sc(OTf)3 (949 mg, 1.93 mmol). The mixture was stirred for 2.5 h before the 
reaction was quenched with sat. aq. NH4Cl and the aqueous layer was extracted with tBuOMe. The 
combined extracts were washed with brine and dried over MgSO4. The drying agent was filtered off 
and the solvent was evaporated. Purification of the crude product by flash chromatography (SiO2, 
hexanes:EtOAc, 5:1) afforded the title compound as a yellow oil (611 mg, 63%). [𝑎]D
20: ‒23.5 (c = 1,05, 
CHCl3). 
1H NMR (400 MHz, CDCl3, mixture of rotamers and diastereomers): δ = 6.74 – 6.63 (m, 1H), 
6.41 – 6.31 (m, 1H), 6.29 – 6.17 (m, 1H), 6.00 – 5.92 (m, 1H), 5.79 – 6.68 (m, 1H), 4.76 – 4.39 (m, 3H), 
4.20 – 3.99 (m, 3H), 3.77 -3.51 (m, 3H), 3.46 – 3.31 (m, 1H), 2.75 – 2.52 (m, 2H), 1.86 – 1.73 (m, 1H), 
1.16 – 1.07 (m, 2H), 1.02 – 0.92 (m, 18H), 0.88 – 0.84 (m, 9H), 0.77 – 0.71 (m, 9H), 0.21 – 0.18 (m, 
3H), 0.17 – 0.13 (m, 6H), 0.12 – 0.09 (m, 9H), 0.08 – 0.06 (m, 3H), 0.06 – 0.04 (m, 3H), 0.03 – 0.00 (m, 
6H), -0.19 – -0.25 (m, 3H) ppm. 13C NMR (100 MHz, CDCl3, mixture of rotamers and diastereomers, 
some signals are overlapping): δ = 168.05, 167.96, 167.5, 167.4, 165.6, 165.5, 162.8, 162.7, 162.1, 
161.9, 161.8, 161.7, 136.6, 136.5, 136.43, 136.36, 135.8, 135.5, 128.5, 128.4, 128.2, 128.1, 110.2, 
110.0, 109.8, 103.2, 103.1, 102.8, 102.7, 98.0, 97.9, 96.6, 96.5, 79.7, 79.6, 79.41, 79.36, 79.3, 77.4, 
77.3, 74.4, 74.3, 72.9, 72.7, 72.0, 71.8, 70.61, 70.57, 70.1, 68.9, 68.8, 68.51, 68.47, 67.4, 61.5, 61.3, 
61.0, 43.5, 43.4, 43.24, 43.21, 29.8, 27.31, 27.27, 26.6, 26.4, 26.31, 26.26, 26.0, 19.6, 19.5, 19.43, 
19.41, 19.0, 18.8, 18.7, 18.3, 18.2, 18.1, 17.8, 0.6, 0.4, 0.3, -1.1, -1.4, -1.97, -2.00, -2.3, -2.4, -3.15, 
                                                          
[13] I. Paterson, G. J. Florence, A. C. Heimann, A. C. Mackay, Angew. Chem. Int. Ed. 2005, 44, 1130. 
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3.19, -3.38, -3.44, -3.58, -3.60, -3.65, -3.66, -3.73, -3.76, -3.85, -3.87, -4.27, -4.32, -4.4, -4.5, -4.6, 
4.94, -5.0, -5.07, -5.14, -5.2 ppm. IR (film): ?̃? = 2929, 2856, 1704, 1643, 1557, 1472, 1410, 1360, 
1249, 1097 cm-1. HRMS (ESI): m/z calcd. for C46H89O9Si5BrNa
+: 1027.44287; found: 1027.44276.  
6-((1E,3E,5E)-6-Bromohexa-1,3,5-trien-1-yl)-4-(2-(trimethylsilyl)ethoxy)-3-((2S,3S,4R,5S,6R)-3,4,5-
tris((tert-butyldimethylsilyl)oxy)-6-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-yl)-
2H-pyran-2-one (46). Ac2O (92 µL, 0.97 mmol) was added to a solution of S11 (195 mg, 0.19 mmol), 
NEt3 (0.16 mL, 1.16 mmol) and DMAP (2.4 mg, 0.02 mmol) in 
CH2Cl2 (2 mL) and the resulting mixture was stirred for 16 h at 
room temperature. The reaction was quenched with sat. aq. 
NH4Cl and the aqueous layer was extracted with tBuOMe. The 
combined extracts were washed with brine and dried over MgSO4. The drying agent was filtered off 
and the solvent was evaporated (bath temperature 25 °C). The residue was dried in vacuo and used 
without further purification. 
The crude product was dissolved in CH2Cl2 (2 mL), the solution was cooled to 0 °C and DBU (0.22 mL, 
1.45 mmol) was added dropwise. The mixture was stirred for 3 h at 0 °C before the reaction was 
quenched with sat. aq. NH4Cl and the aqueous layer was extracted with tBuOMe. The combined 
organic phases were washed with brine and dried over MgSO4. The drying agent was filtered off and 
the solvent was evaporated (bath temperature 25 °C). Purification of the crude product by flash 
chromatography (SiO2, hexanes:EtOAc, 20:1) afforded the title compound as a yellow oil (168 mg, 
88%). [𝑎]D
20: ‒67.7 (c = 1.05, CHCl3); 
1H NMR (400 MHz, CDCl3, mixture of rotamers): δ = 7.23 – 7.09 
(m, 1H), 6.85 – 6.75 (m, 1H), 6.56 – 6.48 (m, 1H), 6.44 – 6.24 (m, 2H), 6.14 – 6.04 (m, 1H), 5.97 – 5.89 
(m, 1H), 4.78 – 4.40 (m, 2H), 4.20 – 4.02 (m, 3H), 3.77 – 3.52 (m, 3H), 3.47 – 3.30 (m, 1H), 1.76 – 1.09 
(m, 2H), 1.03 – 0.93 (m, 18H), 0.88 – 0.84 (m, 9H), 0.75 – 0.71 (m, 9H), 0.21 – 0.18 (m, 3H), 0.16 – 
0.13 (m, 6H), 0.12 – 0.10 (m, 9H), 0.09 – 0.07 (m, 3H), 0.06 – 0.04 (m, 3H), 0.03 – 0.00 (m, 3H), -0.17 ‒ 
-0.24 (m, 3H) ppm; 13C NMR (100 MHz, CDCl3, mixture of rotamers, some signals are overlapping): δ = 
167.9, 167.5, 164.6, 160.9, 159.4, 158.6, 137.24, 137.21, 135.69, 135.65, 135.3, 135.1, 131.7, 131.6, 
123.7, 123.5, 112.7, 112.5, 104.5, 104.1, 97.4, 96.3, 79.6, 79.5, 79.4, 79.3, 77.4, 74.5, 72.7, 71.8, 69.9, 
68.6, 67.4, 60.9, 27.31, 27.26, 26.6, 26.4, 26.3, 26.2, 26.0, 19.6, 19.4, 19.0, 18.8, 18.7, 18.23, 18.16, 
18.09, 18.05, 17.8, -1.1, -1.4, -1.9, -2.3, -3.2, -3.4, -3.5, -3.6, -3.7, -3.8, -3.9, -4.3, -4.5, -4.6, -5.0, -5.1, -
5.19, -5.20 ppm; IR (film): ?̃? = 2929, 2886, 2856, 1719, 1630, 1598, 1537, 1472, 1249, 1098 cm-1; 
HRMS (ESI): m/z calcd. for C46H87O8Si5BrNa




Compound (R,S)-48. This reaction was performed in the dark. Pd(CH3CN)2Cl2 (1.7 mg, 0.0059 mmol) 
was added to a degassed (pump and freeze, 
3 cycles) solution of Ph3As (3.6 mg, 
0.0118 mmol) and flame dried 
[Ph2O2P][NBu4]
[11] (163.2 mg, 0.3551 mmol) 
in DMF (0.5 mL). The resulting mixture was 
stirred for 5 min before it was transferred to a Schlenk tube containing alkenyl iodide (R,S)-29 
(50 mg, 0.1184 mmol) and diene 47 (56 mg, 0.1194 mmol). The resulting mixture was stirred for 20 h 
at room temperature. Aq. K3PO4 (3 M, 44 µL, 0.1326 mmol) was added in one portion followed after 
5 min by a degassed (pump and freeze, 3 cycles) solution of bromide 46 (105 mg, 0.1062 mmol) in 
THF (0.42 mL) and Pd(dppf)Cl2 (8.7 mg, 0.0119 mmol). The mixture was stirred for 18 h, the reaction 
was quenched with water and the aqueous layer was extracted with Et2O. The combined organic 
phases were washed with brine and dried over MgSO4. The drying agent was filtered off and the 
solvent was evaporated (below 25 °C). Purification of the crude product by flash chromatography 
(SiO2, pentane + 2.5% NEt3) afforded the title compound (75 mg, 58%) as a red oil. [𝑎]D
20: ‒74 (c = 0.1, 
CHCl3); 
1H NMR (400 MHz, CDCl3, mixture of rotamers): δ = 7.32 – 7.18 (m, 1H), 6.62 – 6.24 (m, 8H), 
6.17 – 6.10 (m, 1H), 6.05 – 5.96 (m, 1H), 5.93 – 5.85 (m, 1H), 5.72 – 5.58 (m, 1H), 4.82 – 4.39 (m, 2H), 
4.32 – 4.30 (m, 2H), 4.20 – 4.00 (m, 3H), 3.80 – 3.52 (m, 3H), 3.49 – 3.28 (m, 1H), 3.09 – 2.96 (m, 1H), 
1.83 (s, 3H), 1.23 – 1.05 (m, 7H), 1.03 – 1.00 (m, 9H), 0.98 – 0.92 (m, 12H), 0.88 – 0.82 (m, 15H), 0.76 
– 0.70 (m, 9H), 0.22 – -0.02 (m, 39H), -0.16 – -0.25 (m, 3H) ppm; 13C NMR (100 MHz, CDCl3, mixture of 
rotamers, some signals are overlapping): δ = 168.4, 168.0, 167.6, 164.8, 163.4, 161.0, 159.9, 159.2, 
149.8, 149.7, 139.6, 138.4, 139.2, 137.0, 136.8, 136.7, 136.0, 135.8, 135.5, 132.7, 132.6, 132.3, 132.2, 
131.0, 130.9, 130.63, 130.56, 129.6, 128.71, 128.68, 121.8, 121.6, 103.9, 103.5, 96.7, 95.6, 79.52, 
79.48, 79.4, 79.3, 77.40, 77.35, 74.5, 72.7, 71.8, 69.9, 68.6, 67.3, 63.0, 60.9, 45.2, 44.5, 32.2, 31.8, 
29.8, 29.3, 27.30, 27.25, 26.6, 26.4, 26.3, 26.2, 25.9, 20.7, 19.6, 19.4, 19.0, 18.8, 18.7, 18.2, 18.14, 
18.08, 18.0, 17.8, 17.6, 14.3, 13.7, 11.3, 9.1, -1.1, -1.4, -1.9, -2.3, -3.2, -3.4, -3.5, -3.6, -3.7, -3.8, -3.9, -
4.3, -4.5, -4.6, -5.0, -5.16, -5.22 ppm; IR (film): ?̃? = 2956, 2928, 2855, 1721, 1628, 1528, 1471, 1407, 
1251, 1101, 1005 cm-1; HRMS (ESI): m/z calcd. for C68H124O10Si6Na
+: 1291.77024; found: 1291.76933.  
Compound (S,R)-48. Prepared analogously as a red oil (46.3 mg, 57%). [𝑎]D
20: ‒81.0 (c = 0.1, CHCl3); 
1H NMR (400 MHz, CDCl3, mixture of 
rotamers): δ = 7.29 -7.17 (m, 1H), 6.60 – 6.25 
(m, 8H), 6.16 – 6.10 (m, 1H), 6.06 – 5.96 (m, 
1H), 5.94 – 5.87 (m, 1H), 5.73 – 5.61 (m, 1H), 
4.79 – 4.40 (m, 2H), 4.31 – 4.21 (m, 2H), 4.19 
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– 4.03 (m, 3H), 3.77 – 3.53 (m, 3H), 3.47 – 3.31 (m, 1H), 3.08 – 2.93 (m, 1H), 1.91 – 1.77 (m, 3H), 1.23 
– 1.07 (m, 7H), 1.04 – 1.00 (m, 9H), 0.98 – 0.94 (m, 12 H), 0.88 – 0.84 (m, 15H), 0.75 – 0.71 (m, 9H), 
0.21 – 0.00 (m, 39H), -0.16 - -0.24 (m, 3H) ppm; 13C NMR (100 MHz, CDCl3, mixture of rotamers, some 
signals are overlapping): δ = 168.39, 168.01, 167.62, 161.03, 159.92, 159.16, 149.75, 139.56, 139.46, 
139.22, 136.98, 136.81, 136.74, 135.97, 135.83, 135.47, 132.66, 132.26, 131.02, 130.88, 130.64, 
130.57, 129.61, 128.72, 121.81, 121.59, 103.52, 96.67, 95.58, 79.54, 79.48, 79.40, 79.36, 77.40, 
77.35, 74.51, 72.69, 71.82, 69.90, 68.63 67.31, 63.03, 60.93, 46.09, 44.52, 32.22, 31.81, 29.84, 29.31, 
27.31, 27.26, 26.57, 26.40, 26.30, 26.22, 25.95, 20.70, 19.56, 19.42, 18.96, 18.84, 18.69, 18.22, 18.15, 
18.09, 18.06, 17.82, 17.57, 13.70, 11.31, 1.15, -1.06, -1.39, -1.93, -2.29, -3.18, -3.40, -3.46, -3.60, 
3.69, -3.76, -3.87, -4.30, -4.44, -4.60, -5.01, -5.15, -5.21 ppm; IR (film): ?̃? = 2955, 2929, 2856, 1722, 
1628, 1528, 1462, 1408, 1251, 1100, 1006 cm-1 ; HRMS (ESI): m/z calcd. for 
C68H124O10Si6Na
+: 1291.77024; found: 1291.76961. 
Compound (R,R)-48. Prepared analogously as a red oil (32.7 mg, 49%). [𝑎]D
20: ‒62.0 (c = 0.1, CHCl3);
 
1H NMR (400 MHz, CDCl3, mixture of 
rotamers): δ = 7.29 – 7.18 (m, 1H), 6.61 – 
6.25 (m, 8H), 6.17 – 6.12 (m, 1H), 6.05 – 
5.97 (m, 1H), 5.91 – 5.88 (m, 1H), 5.68 – 
5.59 (m, 1H), 4.79 – 4.40 (m, 2H), 4.30 – 
4.21 (m, 1H), 4.18 – 4.04 (m, 3H), 3.77 – 3.53 (m, 3H), 3.46 – 3.32 (m, 1H), 3.13 – 2.97 (m, 1H), 1.94 – 
1.78 (m, 3H), 1.26 – 1.06 (m, 7H), 1.04 – 0.99 (m, 12H), 0.98 – 0.94 (m, 12H), 0.88 – 0.82 (m, 15H), 
0.75 – 0.71 (m, 9H), 0.20 – 0.01 (m, 39H), -0.17 - -0.23 (m, 3H) ppm; 13C NMR (100 MHz, CDCl3, 
mixture of rotamers, some signals are overlapping): δ = 168.4, 168.0, 167.3, 164.8, 161.0, 159.9, 
159.2, 149.5, 139.6, 139.5, 139.2, 137.0, 136.8, 136.8, 136.0, 135.8, 135.5, 132.7, 132.6, 132.3, 132.2, 
131.0, 130.9, 130.6, 130.6, 130.1, 128.8, 125.7, 121.8, 121.6, 103.9, 103.5, 96.7, 95.6, 79.6, 79.5, 
79.41, 79.4, 77.4, 77.3, 74.5, 72.7, 71.8, 69.9, 68.6, 67.3, 63.1, 60.9, 44.8, 32.7, 31.9, 30.5, 30.2, 27.3, 
27.27, 26.6, 26.4, 26.3, 26.2, 25.9, 21.5, 19.6, 19.4, 19.2, 19.0, 18.8, 18.7, 18.2, 18.16, 18.1, 18.06, 
17.8, 17.6, 13.7, 11.5, -1.1, -1.4, -1.9, -2.3, -3.2, -3.4, -3.44, -3.6, -3.7, -3.8, -3.9, -4.3, -4.4, -4.6, -5.0, 
5.1, -5.2 ppm; IR (film): ?̃? = 2955, 2929, 2857, 1722, 1629, 1529, 1471, 1407, 1251, 1167, 1101, 1006 
cm-1; HRMS (ESI): m/z calcd. for C68H124O10Si6Na
+: 1291.77024; found: 1291.76927. 
Compound (S,S)-48. Prepared analogously as a red oil (28.8 mg, 57%). [𝑎]D
20: ‒33.0 (c = 0.1, CHCl3); 
1H NMR (400 MHz, CDCl3, mixture of 
rotamers): δ = 7.24 – 7.17 (m, 1H), 6.61 – 
6.27 (m, 8H), 6.16 – 6.11 (m, 1H), 6.06 – 
5.97 (m, 1H), 5.92 – 5.86 (m, 1H), 5.66 – 
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5.59 (m, 1H), 4.78 – 4.41 (m, 2H), 4.32 – 4.21 (m, 2H), 4.17 – 4.04 (m, 4H), 3.75 – 3.54 (m, 4H), 3.49 – 
3.30 (m, 1H), 3.11 – 2.88 (m, 1H), 1.89 – 1.79 (m, 3H), 1.23 – 1.09 (m, 7H), 1.07 – 1.03 (m, 9H), 1.03 – 
0.99 (m, 12 H), 0.98 – 0.94 (m, 15H), 0.88 – 0.84 (m, 15H), 0.75 – 0.71 (m, 9H), 0.21 – 0.02 (m, 39H), -
0.16 - -0 24 (m, 3H) ppm; 13C NMR (100 MHz, CDCl3, mixture of rotamers, some signals are 
overlapping): δ = 168.42, 167.61, 161.01, 159.92, 159.16, 149.51, 139.55, 139.45, 139.21, 136.81, 
136.74, 135.83, 135.46, 132.67, 132.27, 132.21, 131.03, 130.58, 130.10, 128.74, 121.82, 103.92, 
103.53, 96.67, 95.58, 79.54, 79.49, 79.38, 79.34, 77.36, 74.51, 72.69, 71.82, 69.90, 68.63, 67.31, 
63.05, 60.93, 46.34, 44.78, 32.67, 31.89, 30.22, 29.84, 27.31, 27.26, 26.57, 26.40, 26.30, 26.22, 25.94, 
21.53, 19.55, 19.42, 19.20, 18.96, 18.84, 18.70, 18.22, 18.16, 18.09, 18.06, 17.82, 17.64, 17.56, 13.72, 
11.65, 11.45, 1.15, -1.07, -1.39, -1.93, -2.29, -3.18, -3.40, -3.45, -3.59, -3.69, -3.76, -3.87, -4.29, -4.44, 
-4.59, -5.01, -5.15, -5.21 ppm; IR (film): ?̃? = 2955, 2928, 2856, 1720, 1628, 1529, 1462, 1361, 1251, 
1099, 1048, 1007 cm-1; HRMS (ESI): m/z calcd. for C68H124O10Si6Na
+: 1291.77024; found: 1291.76960. 
Compound (R,S)-2. This reaction was performed in the dark. TASF (65 mg, 0.236 mmol) was added to 
a solution of product (R,S)-48 (25 mg, 
0.0197 mmol) in DMF (0.5 mL) and the mixture 
was stirred for 16 h at room temperature. Another 
portion of TASF (65 mg, 0.236 mmol) was added 
and stirring continued for additional 16 h. This procedure was repeated two more times. For work 
up, aq. HCl was added, the aqueous layer (pH = 3) was extracted with EtOAc (5 x 5 mL) and the 
combined organic extracts were dried over Na2SO4. The drying agent was filtered off, the solvent was 
evaporated and the residue was purified by HPLC (Column: 150 mm YMC, Ø = 10 mm; stationary 
phase: YMC Triart C18 5 μm, 10150 00550; mobile phase: MeOH: 0.1% TFA in water, 85:15) to give 
the title compound as an orange-red solid (2.4 mg, 19%). [𝑎]D
20: 147.1 (c = 0.05, MeOH). 1H NMR 
(600 MHz, [D4]-MeOH): δ = 7.14 (dd, J = 15.3, 11.3 Hz, 1H), 6.64 (dd, J = 14.7, 11.2 Hz, 1H), 6.50 (dd, J 
= 14.6, 10.3 Hz, 1H), 6.47 – 6.33 (m, 6H), 6.20 (d, J =15.0 Hz, 1H), 6.13 – 6.11 (m, 1H), 6.08 (s, 1H), 
5.64 (dd, J = 10.4, 1.2 Hz, 1H), 4.53 (d, J = 9.7 Hz, 1H), 4.19 (t, J =9.5 Hz, 1H), 3.91 (d, J = 3.1 Hz, 1H), 
3.73 (dd, J = 11.4, 6.9 Hz, 1H), 3.69 (dd, J =11.6, 5.1 Hz, 1H), 3.62 – 3.59 (m, 1H), 3.51 (dd, J = 9.4, 3.2 
Hz, 1H), 3.06 – 2.95 (m, 1H), 1.87 (d, J = 1.2 Hz, 3H), 1.45 – 1.32 (m, 2H), 1.33 – 1.25 (m, 2H), 1.21 – 
1.13 (m, 1H), 1.09 (dt, J = 12.8, 7.4 Hz, 1H), 1.00 (d, J = 6.6 Hz, 3H), 0.86 (d, J = 6.5 Hz, 3H), 0.86 (t, J = 
7.4 Hz, 3H) ppm; 13C NMR (151 MHz, [D4]-MeOH): see Table S-1;  
1H NMR (600 MHz, [D6]-DMSO): δ = 12.71 (brs, 1H), 7.00 (dd, J = 15.1, 11.4 Hz, 1H), 6.72 (dd, J = 14.6, 
11.2 Hz, 1H), 6.51 (dd, 14.4, 10.6 Hz, 1H), 6.48 – 6.39 (m, 6H), 6.32 (d, J = 15.2 Hz, 1H), 6.12 (s, 2H), 
5.62 (d, J = 10.1 Hz, 1H), 4.66 (d, J = 5.6 Hz, 1H), 4.57 (t, J = 9.3 Hz, 1H), 4.25 (d, J = 9.5 Hz, 1H), 4.08 (t, 
J = 9.3 Hz, 1H), 3.70 – 3.68 (m, 1H), 3.48 – 3.39 (m, 2H), 2.91 – 2.83 (m, 1H), 1.80 (d, J =1.2 Hz, 3H), 
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1.36 – 1.28 (m, 2H), 1.28 – 1.21 (m, 1H), 1.12 (ddd, J = 13.6, 7.9, 6.3 Hz, 1H), 1.08 – 1.01 (m, 1H), 0.94 
(d, J = 6.6 Hz, 3H),0.80 (d, J = 6.8 Hz, 3H), 0.80 (t, J = 7.0, 3H) ppm; 13C NMR (151 MHz, [D6]-DMSO): 
see Tabel S-2;  
IR (film): ṽ = 3410, 2924, 2169, 2149, 2039, 2003, 1958, 1637, 1543, 1454, 1003 cm-1; HRMS (ESI): 
m/z calcd. for C34H43O10: 611.28618; found: 611.28667. 
Compound (S,R)-2. Prepared analogously as an orange-red oil (3.6 mg, 16% after HPLC) (column: 150 
mm YMC, Ø = 10 mm; stationary phase: YMC 
Triart C18 5 μm, 10150 00550; mobile phase: 
MeOH: 0.1% TFA in water, 85:15). [𝑎]D
20: 
118.4 (c = 0.05, MeOH). 1H NMR (600 MHz, 
[D4]-MeOH): δ = 7.14 (dd, J = 15.2, 11.2 Hz, 1H), 6.64 (dd, J = 14.5, 11.1 Hz, 1H), 6.51 (dd, J = 14.7, 
10.3 Hz, 1H), 6.51 – 6.35 (m, 6H), 6.20 (d, J = 15.1 Hz, 1H), 6.14 – 6.10 (m, 1H), 6.08 (s, 1H), 5.65 (dd, J 
= 10.3, 1.2 Hz, 1H), 4.53 (d, J = 9.7 Hz, 1H), 4.19 (t, J = 9.5 Hz, 1H), 3.91 (dd, J = 3.3, 0.9 Hz, 1H), 3.74 
(dd, J = 11.5, 6.8 Hz, 1H), 3.69 (dd, J = 11.5, 5.2, 1H), 3.62 – 3.59 (m, 1H), 3.51 (dd, J = 9.4, 3.2 Hz, 1H), 
3.05 – 2.95 (m, 1H), 1.87 (d, J = 1.2 Hz, 3H), 1.45 – 1.33 (m, 2H), 1.29 (dt, J = 13.4, 6.6 Hz, 1H), 1.17 
(tdd, J = 13.2, 6.6, 5.6 Hz, 1H), 1.14 – 1.04 (m, 1H), 1.00 (d, J = 6.6 Hz, 3H), 0.86 (d, J = 6.6 Hz, 3H), 0.86 
(t, J = 7.4 Hz, 3H) ppm; 13C NMR (151 MHz, [D4]-MeOH): see Table S-1;  
1H NMR (600 MHz, [D6]-DMSO): δ = 12.75 (brs, 1H), 7.01 (dd, J =15.1, 11.3 Hz, 1H), 6.72 (dd, J = 14.7, 
11.3 Hz, 1H), 6.55 – 6.40 (m, 7H), 6.33 (d, J = 15.1 Hz, 1H), 6.15 – 6.07 (m, 2H), 5.63 (d, J = 10.2 Hz, 
1H), 4.66 (d, J = 5.6 Hz, 1H), 4.57 (t, J = 5.7 Hz, 1H), 4.25 (d, J = 9.5 Hz, 1H), 4.08 (t, J = 9.3 Hz, 1H), 3.69 
(d, J = 3.0 Hz, 1H), 3.49 – 3.38 (m, 2H), 2.93 – 2.82 (m, 1H), 1.79 (d, J = 1.2 Hz, 3H), 1.36 – 1.28 (m, 
2H), 1.24 (dt, J = 13.0, 6.4 Hz, 1H), 1.12 (tq, J = 14.5, 13.8, 8.0, 6.7, 6.4 Hz, 1H), 1.08 – 1.00 (m, 1H), 
0.94 (d, J = 6.6 Hz, 3H), 0.80 (d, J = 6.7 Hz, 3H), 0.80 (t, J = 7.0 Hz, 3H) ppm; 13C NMR (151 MHz, [D6]-
DMSO): see Table S-2;  
IR (film): ṽ = 3296, 3018, 2959, 2923, 1637, 1550, 1493, 1211, 1139, 1003 cm-1; HRMS (ESI): m/z 
calcd. for C34H43O10: 611.28618; found: 611.28681. 
Compound (R,R)-2. Prepared analogously as an orange-red oil (3.5 mg, 22% after HPLC) (column: 150 
mm YMC, Ø = 10 mm; stationary phase: YMC 
Triart C18 5 μm, 10150 00550; mobile phase: 
MeOH: 0.1% TFA in water, 85:15). [𝑎]D
20: 
44.0 (c = 0.05, MeOH). 1H NMR (600 MHz, 
[D4]-MeOH): δ = 7.14 (dd, J = 15.3, 11.5 Hz, 1H), 6.64 (dd, J = 14.4, 11.1 Hz, 1H), 6.50 (dd, J = 14.8, 
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10.1 Hz, 1H), 6.46 – 6.35 (m, 6H), 6.19 (d, J = 15.1 Hz, 1H), 6.12 (s, 1H), 6.08 (s, 1H), 5.60 (d, J = 10.3 
Hz, 1H), 4.53 (d, J = 9.7 Hz, 1H), 4.19 (t, J = 9.7 Hz, 1H), 3.94 – 3.89 (m, 1H), 3.77 – 3.67 (m, 2H), 3.63 – 
3.59 (m, 1H), 3.56 – 3.47 (m, 1H), 3.06 – 2.97 (m, 1H), 1.87 (s, 3H), 1.38 – 1.25 (m, 3H), 1.19 – 1.07 
(m, 2H), 1.01 (d, J = 6.5 Hz, 3H), 0.87 – 0.83 (m, 6H) ppm; 13C NMR (151 MHz, [D4]-MeOH): see Table 
S-1; 
1H NMR (600 MHz, [D6]-DMSO): δ = 12.75 (brs, 1H), 7.01 (dd, J = 15.1, 11.3 Hz, 1H), 6.72 (dd, J = 14.7, 
11.2 Hz, 1H), 6.56 – 6.39 (m, 7H), 6.33 (d, J =15.1 Hz, 1H), 6.13 (s, 1H), 6.12 (s, 1H), 5.58 (d, J = 10.3 
Hz, 1H), 4.66 (d, J = 5.6 Hz, 1H), 4.57 (t, J = 4.9 Hz, 1H), 4.25 (d, J = 9.5 Hz, 1H), 4.08 (t, J = 9.3 Hz, 1H), 
3.69 (d, J = 3.0 Hz, 1H), 3.49 – 3.38 (m, 2H), 2.95 – 2.86 (m, 2H), 1.80 (s, 3H), 1.30 (ddd, J = 13.3, 9.5, 
3.9 Hz, 1H), 1.27 – 1.19 (m, 2H), 1.14 – 1.06 (m, 2H), 0.96 (d, J = 6.6 Hz, 3H), 0.81 (t, J = 7.3 Hz, 3H), 
0.79 (d, J = 6.3 Hz, 3H) ppm; 13C NMR (151 MHz, [D6]-DMSO): see Table S-2;  
IR (film): ṽ = 3338, 3018, 2958, 2923, 1676, 1638, 1540, 1497, 1439, 1317,1207, 1139, 1003 cm-1; 
HRMS (ESI): m/z calcd. for C34H43O10: 611.28618; found: 611.28648. 
Compound (S,S)-2. Prepared analogously as an orange-red oil (2.2 mg, 17% after HPLC) (column: 150 
mm YMC, Ø = 10 mm; stationary phase: YMC 
Triart C18 5 μm, 10150 00550; mobile phase: 
MeOH: 0.1% TFA in water 85:15). [𝑎]D
20: 14.2 
(c = 0.05, MeOH). 1H NMR (600 MHz, [D4]-
MeOH): δ = 7.18 – 7.10 (m, 1H), 6.64 (dd, J = 14.7, 11.2 Hz, 1H), 6.51 (dd, J = 14.7, 10.3 Hz, 1H), 6.50 – 
6.35 (m, 6H), 6.19 (d, J = 15.1 Hz, 1H), 6.13 (s, 1H), 6.06 – 6.09 (m, 1H), 5.60 (d, J = 10.4, 1.2 Hz, 1H), 
4.54 (d, J = 9.7 Hz, 1H), 4.19 (t, J = 9.5 Hz, 1H), 3.92 (d, J = 3.1 Hz, 1H), 3.77 – 3.65 (m, 2H), 3.64 – 3.56 
(m, 1H), 3.52 (dd, J = 9.4, 3.2 Hz, 1H), 3.06 – 2.97 (m, 1H), 1.87 (d, J = 1.2 Hz, 3H), 1.39 – 1.25 (m, 3H), 
1.20 – 1.07 (m, 2H), 1.02 (d, J = 6.6 Hz, 3H), 0.87 (t, J = 7.3 Hz, 3H), 0.85 (d, J = 6.3 Hz, 3H) ppm; 
13C NMR (151 MHz, [D4]-MeOH): see Table S-1; 
1H NMR (600 MHz, [D6]-DMSO): δ = 12.76 (brs, 1H), 10.80 (brs, 1H), 7.01 (dd, J = 15.2, 11.4 Hz, 1H), 
6.73 (dd, J = 14.5, 11.3 Hz, 1H), 6.55 – 6.39 (m, 7H), 6.33 (d, J = 15.2 Hz, 1H), 6.13 (s, 1H), 6.12 (s, 1H), 
5.58 (d, J = 10.3 Hz, 1H), 4.66 (d, J = 4.2 Hz, 1H), 4.61 (d, J = 5.4 Hz, 1H), 4.57 (t, J = 5.6 Hz, 1H), 4.25 
(d, J = 9.5 Hz, 1H), 4.22 (s, 1H), 4.08 (t, J = 9.7 Hz, 1H), 3.69 (s, 1H), 3.47 – 3.39 (m, 2H), 3.35 (t, J = 6.2 
Hz, 1H), 2.94 – 2.87 (m, 1H), 1.80 (s, 3H), 1.36 – 1.96 (m, 2H), 1.14 – 1.05 (m, 3H), 0.96 (d, J = 6.6 Hz, 
3H), 0.81 (t, J = 7.2 Hz, 3H), 0.79 (d, J = 6.2 Hz, 3H) ppm; 13C NMR (151 MHz, [D6]-DMSO): see Table S-
2;  
IR (film): ṽ = 3370, 2963, 2919, 1675, 1567, 1540, 1423, 1379, 1251, 1208, 1139, 1093, 1054, 1003 
cm-1; HRMS (ESI): m/z calcd. for C34H43O10: 611.28618; found: 611.28684. 
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MODEL COMPOUNDS FOR COMPARISON (see Figure 1) 
(2R,3S,4R)-3,4-Bis(benzyloxy)-2-((benzyloxy)methyl)-3,4-dihydro-2H-pyran-5-carbaldehyde (S12).[14] 
POCl3 (2.45 mL, 26.16 mmol) was added dropwise over 1 h to a solution of tri-O-
benzyl-D-glucal (1.00 g, 2.4 mmol) in DMF (4 mL) at 0 °C. The mixture was stirred 
for 24 h while warming to room temperature before the reaction was quenched 
with sat. aq. NaHCO3. The aqueous phase was extracted with tBuOMe, and the combined extracts 
were washed with brine and dried over MgSO4. The drying agent was filtered off and the solvent was 
evaporated. Purification of the crude product by flash chromatography (SiO2, hexanes:EtOAc, 5:1) 
afforded the title compound as a colorless oil (807 mg, 76%). [α]D
20: +2.1 (c = 1, CHCl3), Lit.:
[14] [α]D
25: 
+6.8, c = 0.34, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 9.41 (s, 1H), 7.42 – 7.20 (m, 15H), 4.77 – 4.71 (m, 
1H), 4.71 – 4.44 (m, 7H), 4.42 (t, J = 2.3 Hz, 1H), 3.84 (t, J = 2.3 Hz, 1H), 3.80 (dd, J = 10.9, 7.8 Hz, 1H), 
3.63 (dd, 10.7, 4.7 Hz, 1H) ppm; 13C NMR (101 MHz, CDCl3): δ = 190.5, 164.4, 138.3, 137.8, 137.3, 
128.7, 128.6, 128.5, 128.2, 128.0, 127.93, 127.87, 127.8, 117.9, 79.5, 73.5, 72.6, 71.8, 71.5, 68.5, 65.4 
ppm; IR (film): ?̃? = 3064, 3031, 2866, 1673, 1626, 1454, 1294, 1199, 1089, 1072 cm-1; HRMS (ESI): m/z 
calcd. for C28H28O5Na
+: 467.18289; found: 467.18306. 
(2R,3R,4R)-3,4-Bis(benzyloxy)-2-((benzyloxy)methyl)-3,4-dihydro-2H-pyran-5-carbaldehyde (S13). 
Prepared analogously from tri-O-benzyl-D-galactal as a colorless oil (5.12 g, 65%). 
[α]D
20: 6.1 (c = 1, CHCl3); 
1H NMR (300 MHz, CDCl3): δ = 9.37 (s, 1H), 7.42 – 7.28 
(m, 15H), 7.27 (s, 1H), 4.79 – 4.77 (m, 2H), 4.75 – 4.69 (m, 2H), 4.64 (dd, J = 3.5, 1.3 
Hz, 1H), 4.60 (d, J = 12.0 Hz, 1H), 4.56 (d, J = 13.1 Hz, 1H), 4.52 (d, J = 11.9 Hz, 1H), 4.02 (d, J = 5.3 Hz, 
2H), 3.85 (dd, J = 5.3, 3.6 Hz, 1H) ppm; 13C NMR (75 MHz, CDCl3): δ = 189.5, 164.5, 138.8, 137.9, 
137.4, 128.6, 128.5, 128.3, 128.1, 128.0, 127.8, 127.7, 127.7, 127.5, 119.2, 78.8, 73.7, 73.5, 73.1, 
71.5, 68.5, 64.7 ppm; IR (film): ?̃? = 3030, 2866, 1672, 1618, 1496, 1454, 1269, 1198, 1091, 1060, 1027 
cm-1; HRMS (ESI): m/z calcd. for C28H28O5Na
+: 467.18289; found: 467.18351. 
(2R,3S,4R)-3,4-Bis(benzyloxy)-2-((benzyloxy)methyl)-3,4-dihydro-2H-pyran-5-carboxylic acid (S14). 
NaH2PO4 (5.60 g, 46.68 mmol) and H2O2 (35% in H2O, 7.5 mL, 77.17 mmol) were 
added to a solution of S12 (6.45 g, 15.49 mmol) in CH3CN/tBuOH/H2O (2:2:1, 
70 mL) at 0 °C. The mixture was stirred for 5 min before NaClO2 (8.4 g, 
92.88 mmol) was added and stirring was continued for 16 h at room temperature. The mixture was 
diluted with water and the aqueous phase was extracted with tBuOMe. The combined extracts were 
washed with brine and dried over MgSO4. The drying agent was filtered off and the solvent was 
evaporated. Purification of the crude product by flash chromatography (SiO2, hexanes:EtOAc, 5:1) 
                                                          
[14] N. G. Ramesh, K. K. Balasubramanian, Tetrahedron Lett. 1991, 32, 3875-3878. 
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afforded the title compound (5.60 g, 79%). [α]D
20: ‒4.2 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 
7.79 (s, 1H), 7.39 – 7.21 (m, 15H), 4.72 – 4.63 (m, 2H), 4.59 – 4.49 (m, 4H), 4.44 (d, J = 12.1 Hz, 1H), 
4.34 (t, J = 2.3 Hz, 1H), 3.82 (t, J = 2.2 Hz, 1H), 3.78 (dd, J = 10.7, 7.7 Hz, 1H), 3.62 (dd, J = 10.7, 4.9 Hz, 
1H) ppm; 13C NMR (101 MHz, CDCl3): δ = 172.9, 157.6, 138.3, 137.8, 137.5, 128.7, 128.6, 128.5, 
128.15, 128.11 127.91, 127.88, 127.85, 127.1, 104.7, 77.5, 73.5, 72.4, 71.6, 71.4, 68.4, 67.8 ppm; IR 
(film): ?̃? = 3063, 3030, 2863, 1647, 1453, 1362, 1238, 1097, 1069, 1047, 1027 cm-1; HRMS (ESI): m/z 
calcd. for C28H28O6Na
+: 483.17781; found: 483.17805.  
(2R,3R,4R)-3,4-Bis(benzyloxy)-2-((benzyloxy)methyl)-3,4-dihydro-2H-pyran-5-carboxylic acid (S15). 
Prepared analogously (4.22 g, 80%). [α]D
20: 27.7 (c = 1, CHCl3); 
1H NMR (300 MHz, 
CDCl3): δ = 7.66 (s, 1H), 7.40 – 7.27 (m, 15H), 4.83 (d, J = 11.1 Hz, 1H), 4.76 (d, J = 
11.1 Hz, 1H), 4.72 (d, J = 12.1 Hz, 1H), 4.69 – 4.63 (m, 1H), 4.61 (d, J = 11.9 Hz, 1H), 
4.60 (d, J = 11.9 Hz, 1H), 4.56 (dd, J = 3.5, 1.3 Hz, 1H), 4.49 (d, J = 11.9 Hz, 1H), 4.02 (d, J = 2.6 Hz, 1H), 
4.00 – 3.98 (m, 1H), 3.91 (dd, J = 5.4, 3.6 Hz, 1H) ppm; 13C NMR (76 MHz, CDCl3): δ = 172.5, 157.6, 
138.9, 138.1, 137.6, 128.7, 128.5, 128.3, 128.1, 128.0, 127.8, 127.8, 127.7, 127.5, 106.2, 77.3, 74.2, 
73.9, 73.6, 71.8, 68.4, 67.4 ppm; IR (film): ?̃? = 3030, 2866, 1674, 1619, 1496, 1453, 1433, 1369, 1305, 
1190, 1075, 1027 cm-1; HRMS (ESI): m/z calcd. for C28H28O6Na
+: 483.17781; found: 483.17772. 
2-(Trimethylsilyl)ethyl (2R,3S,4R)-3,4-bis(benzyloxy)-2-((benzyloxy)methyl)-3,4-dihydro-2H-pyran-
5-carboxylate (S16). DEAD (6.70 mL, 36.77 mmol) was added dropwise over 60 min to a solution of 
S14 (5.60 g, 12.15 mmol), 2-(TMS)-ethanol (4.5 mL, 31.39 mmol) and PPh3 (11.50 g, 
43.84 mmol) in THF (60 mL) at 0 °C. The resulting mixture was stirred for 16 h while 
warming to room temperature. The reaction was quenched with sat. aq. NH4Cl and 
the aqueous phase was extracted with tBuOMe. The combined extracts were 
washed with brine and dried over MgSO4. The drying agent was filtered off and the solvent was 
evaporated. Purification of the crude product by flash chromatography (SiO2, hexanes:EtOAc, 10:1) 
afforded the title compound (5.25 g, 77%). [α]D
20: ‒15.8 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 
7.65 (s, 1H), 7.39 – 7.20 (m, 15H), 4.65 (d, J = 11.4 Hz, 1H), 4.64 – 4.59 (m, 1H), 4.58 – 4.47 (m, 4H), 
4.43 (d, J = 11.9 Hz, 1H), 4.35 (t, J = 2.1 Hz, 1H), 4.29 – 4.21 (m, 2H), 3.80 (t, J = 2.3 Hz, 1H), 3.76 (dd, J 
= 10.6, 7.6 Hz, 1H), 3.61 (dd, J = 10.7, 4.9 Hz, 1H), 1.06 – 0.98 (m, 2H), 0.06 (s, 9H) ppm; 13C NMR 
(101 MHz, CDCl3): δ = 167.5, 155.3, 138.4, 137.9, 137.6, 128.7, 128.6, 128.5, 128.12, 128.10, 127.92, 
127.86, 127.8, 105.7, 77.1, 73.5, 72.5, 71.61, 71.56, 68.4, 68.1, 62.5, 17.6, -1.3 ppm; IR (film): ?̃? 3031, 
2952, 2897, 1701, 1633, 1454, 1293, 1275, 1250, 1195, 1071, 1028 cm-1; HRMS (ESI): m/z calcd. for 
C33H40O6SiNa




5-carboxylate (S17). Prepared analogously (4.00 g, 78%). [α]D
20: 39.3 (c = 1, CHCl3); 
1H NMR 
(300 MHz, CDCl3): δ = 7.52 (s, 1H), 7.42 – 7.27 (m, 15H), 4.83 (d, J = 11.1 Hz, 1H), 
4.76 (d, J = 11.2 Hz, 1H), 4.71 (d, J = 11.8 Hz, 1H), 4.67 – 4.55 (m, 4H), 4.48 (d, J = 
11.9 Hz, 1H), 4.30 – 4.20 (m, 2H), 4.01 (d, J = 3.1 Hz, 1H), 4.00 – 3.97 (m, 1H), 3.89 
(dd, J = 5.5, 3.5 Hz, 1H), 1.09 – 0.96 (m, 2H), 0.07 (s, 9H) ppm; 13C NMR (76 MHz, CDCl3): δ = 167.0, 
155.2, 139.2, 138.3, 137.7, 128.6, 128.5, 128.3, 128.1, 128.0, 127.7, 127.7, 127.4, 107.3, 76.9, 74.2, 
74.2, 73.5, 71.7, 68.4, 67.7, 62.6, 17.6, -1.4 ppm; IR (film): ?̃? = 3030, 2952, 1699, 1626, 1496, 1454, 




oxy)methyl)-3,4-dihydro-2H-pyran-5-carboxylate (S18). Pd(OH)2/C (375 mg, 10%w/w) was added to 
a solution of S16 (3.75 g, 6.69 mmol) in CH3OH (66 mL). The solution was purged 
with H2 and stirred for 15 h at room temperature under H2 atmosphere (1 atm). 
For work up, the suspension was filtered through a plug of Celite® and the filtrate 
was concentrated. 
TBSOTf (6.20 mL, 26.99 mmol) was added to a solution of the crude triol and pyridine (6.50 mL, 
80.36 mmol) in CH2Cl2 (16.5 mL) at 0 °C. The mixture was stirred for 16 h while warming to room 
temperature before the reaction was quenched with sat. aq. NH4Cl and the aqueous phase was 
extracted with tBuOMe. The combined extracts were washed with brine and dried over MgSO4. The 
drying agent was filtered off and the solvent was evaporated. Purification of the crude product by 
flash chromatography (SiO2, hexanes:EtOAc, 60:1) afforded the title compound (3.72 g, 88%). [α]D
20: 
+4.3 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 7.55 (s, 1H), 4.36 – 4.20 (m, 3H), 4.20 – 4.08 (m, 
1H), 3.93 (dd, J = 11.6, 8.1 Hz, 1H), 3.90 – 3.85 (m, 1H), 3.73 (dd, J = 11.7, 3.9 Hz, 1H), 1.07 – 0.97 (m, 
2H), 0.89 (s, 9H), 0.84 (s, 18H), 0.15 (s, 3H), 0.09 (s, 3H), 0.08 (s, 3H), 0.07 (s, 3H), 0.05 (s, 3H), 0.04 (s, 
12H) ppm; 13C NMR (101 MHz, CDCl3): δ = 167.7, 154.4, 106.7, 82.3, 68.3, 63.8, 62.3, 62.1, 26.1, 
25.84, 25.78, 18.5, 18.13, 18.10, 17.5, -1.3, -4.6, -4.67 (2 C), -4.71, -5.05, -5.14 ppm; IR (film): ?̃? = 
2954, 2930, 2896, 2858, 1706, 1635, 1472, 1252, 1197, 1076 cm-1; HRMS (ESI): m/z calcd. for 
C30H64O6Si4Na
+: 655.36722; found: 655.36777. 
2-(Trimethylsilyl)ethyl (2R,3S,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)-
oxy)methyl)-3,4-dihydro-2H-pyran-5-carboxylate (S19). Prepared analogously 
(1.15 g, 33%). [α]D
20: +35.2 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 7.44 (s, 
1H), 4.49 (dd, J = 3.3, 1.5 Hz, 1H), 4.33 – 4.20 (m, 2H), 4.18 – 4.05 (m, 2H), 4.00 – 
S-43 
 
3.91 (m, 2H), 1.04 – 0.97 (m, 2H), 0.92 (s, 9H), 0.89 (s, 9H), 0.85 (s, 9H), 0.17 – 0.12 (m, 6H), 0.11 (s, 
3H), 0.08 (s, 3H), 0.05 – 0.03 (m, 15H) ppm; 13C NMR (101 MHz, CDCl3): δ = 167.0, 154.5, 109.0, 81.5, 
69.4, 63.8, 62.4, 61.9, 26.2, 26.14, 26.07, 18.6, 18.5 (2C), 17.5, -1.3, -4.3, 4.7, -4.8, -4.94, -4.96, -5.1 
ppm; IR (film): ?̃? = 2953, 2929, 2857, 1703, 1628, 1472, 1389, 1361, 1307, 1274, 1064 cm-1; HRMS 
(ESI): m/z calcd. for C30H64O6Si4Na
+: 655.36722; found: 655.36741. 
2-(Trimethylsilyl)ethyl (2R,3R,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)-
oxy)methyl)-6-iodo-3,4-dihydro-2H-pyran-5-carboxylate (S20). nBuLi (1.6 M in hexanes, 1.60 mL, 
2.56 mmol) was added dropwise to a solution of iPr2NH (0.50 mL, 3.57 mmol) in 
THF (5.70 mL) at 0 °C and the resulting mixture was stirred for 15 min before it 
was cooled to ‒78 °C. A solution of S18 (540 mg, 0.85 mmol) in THF (5.70 mL) was 
added dropwise and stirring was continued for 1.5 h. A solution of iodine (1.08 g, 
4.26 mmol) in THF (5.70 mL) was then added dropwise and stirring was continued for 30 min before 
the reaction was quenched with sat. aq. Na2S2O3 and the aqueous phase was extracted with tBuOMe. 
The combined extracts were washed with brine and dried over MgSO4. The drying agent was filtered 
off and the solvent was evaporated. Purification of the crude product by flash chromatography (SiO2, 
hexanes:EtOAc, 20:1) afforded the title compound (598 mg, 92%). [α]D
20: +4.2 (c = 1, CHCl3); 
1H NMR 
(400 MHz, CDCl3): δ = 4.45 (t, J = 2.4 Hz, 1H), 4.41 – 4.32 (m, 1H), 4.32 – 4.26 (m, 1H), 4.15 – 4.06 (m, 
1H), 4.02 – 3.94 (m, 2H), 3.79 (dd, J = 11.5, 4.9 Hz, 1H), 1.06 (dd, J = 9.6, 8.1 Hz, 2H), 0.89 (s, 9H), 0.85 
(s, 9H), 0.83 (s, 9H), 0.11 (s, 3H), 0.08 (s, 9H), 0.06 – 0.02 (m, 15H) ppm; 13C NMR (101 MHz, CDCl3): δ 
= 166.7, 119.6, 112.7, 87.1, 67.9, 66.5, 63.0, 61.7, 26.1, 25.78, 25.76, 18.5, 18.10, 18.07, 17.6, -1.4, -
4.4, -4.5, -4.6, -4.8, -5.0, -5.2 ppm; IR (film): ?̃? = 2953, 2929, 2894, 2857, 1698, 1584, 1471, 1521, 
1113, 1064 cm-1; HRMS (ESI): m/z calcd. for C30H63O6Si4INa
+: 781.26387; found: 781.26417. 
2-(trimethylsilyl)ethyl (2R,3S,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)-
oxy)methyl)-6-iodo-3,4-dihydro-2H-pyran-5-carboxylate (S21). Prepared analogously (791 mg, 88%). 
[α]D
20: +19.2 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 4.59 (dd, J = 3.4, 1.7 Hz, 
1H), 4.38 – 4.28 (m, 2H), 4.20 – 4.10 (m, 2H), 4.04 (dd, J = 5.7, 3.4 Hz, 1H), 3.91 
(dd, J = 12.6, 1.1 Hz, 1H), 1.13 – 1.02 (m, 2H), 0.92 (s, 9H), 0.90 (s, 9H), 0.83 (s, 
9H), 0.18 – 0.12 (m, 6H), 0.10 (s, 3H), 0.08 (s, 3H), 0.07 – 0.03 (m, 15H) ppm; 13C NMR (101 MHz, 
CDCl3): δ = 166.0, 115.0, 114.8, 85.9, 68.8, 66.2, 63.4, 61.4, 26.2, 26.1, 25.9, 18.6 , 18.5, 18.4, 17.4, -
1.4, -4.2, -4.4, -4.8, -4.9, -5.2, -5.3 ppm; IR (film): ?̃? = 2953, 2929, 2887, 2857, 1699, 1575, 1472, 1309, 
1251, 1061 cm-1; HRMS (ESI): m/z calcd. for C30H63O6Si4INa





oxy)methyl)-6-(3-hydroxyprop-1-yn-1-yl)-3,4-dihydro-2H-pyran-5-carboxylate (S22). Pd(PPh3)2Cl2 
(13 mg, 0.02 mmol) and CuI (7 mg, 0.04 mmol) were added to a 
degassed (pump and freeze, 3 cycles) solution of S20 (147 mg, 0.19 mmol) in 
NEt3 (1.3 mL). The mixture was stirred for 5 min before propargyl alcohol 
(36 µL, 0.62 mmol) was added. After stirring for 16 h, the reaction was 
quenched with sat. aq. NH4Cl and the aqueous phase was extracted with tBuOMe. The combined 
extracts were washed with brine and dried over MgSO4. The drying agent was filtered off and the 
solvent was evaporated. Purification of the crude product by flash chromatography (SiO2, 
hexanes:EtOAc, 10:1) afforded the title compound (116 mg, 87%). [α]D
20: +6.9 (c = 1, CHCl3). 
1H NMR 
(400 MHz, CDCl3): δ = 4.50 – 4.45 (m, 2H), 4.45 (t, J = 2.4 Hz, 1H), 4.40 – 4.31 (m, 1H), 4.29 – 4.22 (m, 
1H), 4.16 – 4.07 (m, 1H), 3.95 (dd, J = 2.6, 1.4 Hz, 1H), 3.88 (dd, J = 11.2, 7.4 Hz, 1H), 3.80 (dd, J = 11.4, 
5.5 Hz, 1H), 2.26 (bs, 1H), 1.04 (dd, J = 9.5, 7.9 Hz, 1H), 0.88 (s, 9H), 0.85 (s, 9H), 0.83 (s, 9H), 0.13 (s, 
3H), 0.08 (s, 6H), 0.06 (s, 6H), 0.04 (s, 12H), ppm; 13C NMR (101 MHz, CDCl3): δ = 166.9, 143.6, 111.1, 
93.1, 82.6, 80.6, 67.5, 65.3, 62.8, 61.8, 51.6, 26.1, 25.81, 25.75, 18.5, 18.1, 17.5, 
1.2, -1.4, -4.4, -4.58, -4.63, -4.8, -5.1, -5.2 ppm; IR (film): ?̃? = 3429, 2953, 2930, 2896, 2857, 1692, 




oxy)methyl)-6-(3-hydroxyprop-1-yn-1-yl)-3,4-dihydro-2H-pyran-5-carboxylate (S23). Prepared 
analogously (530 mg, 75%). [α]D
20: +19.4 (c = 0.53, CHCl3). 
1H NMR (400 MHz, 
CDCl3): δ = 4.62 (dd, J =3.3, 1.5 Hz, 1H), 4.46 (d, J = 6.3 Hz, 2H), 4.36 – 4.24 
(m, 2H), 4.13 (dt, J = 6.3, 10.9 Hz, 1H), 4.08 (dd, J = 12.4, 8.7 Hz, 1H), 3.99 
(dd, J = 5.8, 3.4 Hz, 1H), 3.92 (dd, J = 12.4, 0.8 Hz, 1H), 1.83 (t, J = 6.3 Hz, 1H), 
1.11 – 0.99 (m, 2H), 0.92 (s, 9H), 0.89 (s, 9H), 0.83 (s, 9H), 0.13 (s, 3H), 0.12 (s, 3H), 0.11 (s, 3H), 0.063 
(s, 3H), 0.055 (s, 3H), 0.05 (s, 9H), 0.04 (s, 3H), ppm; 13C NMR (101 MHz, CDCl3): δ = 166.2, 143.4, 
113.0, 93.6, 82.0, 80.3, 68.9, 65.0, 63.1, 61.7, 51.6, 26.2 (6 CH3), 26.0, 18.6, 18.53, 18.47, 17.4, -1.4, -
4.3, -4.4, 4.8, -4.9, -5.17, -5.21 ppm; IR (film): ?̃? = 3465, 2953, 2929, 2895, 2857, 1677, 1597, 1472, 
1388, 1344, 1285, 1250, 1218, 1177, 1077, 1043 cm-1; HRMS (ESI): m/z calcd. for 
C33H66O7Si4Na
+: 709.37779; found: 709.37757. 
(2R,3R,4R)-3,4-Bis((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)oxy)methyl)-7-
(hydroxymethyl)-3,4-dihydro-2H,5H-pyrano[4,3-b]pyran-5-one (S24). 
SPhosAuNTf2 (2 mg, 0.002 mmol, 1 mol%) was added to a solution of S22 
(131 mg, 0.19 mmol) in CH3NO2 (1.3 mL) and the resulting mixture was stirred for 16 h. The reaction 
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was quenched with sat. aq. NH4Cl and the aqueous phase was extracted with tBuOMe. The combined 
extracts were washed with brine and dried over MgSO4. The drying agent was filtered off and the 
solvent was evaporated. Purification of the crude product by flash chromatography (SiO2, 
hexanes:EtOAc, 2:1) afforded the title compound (100 mg, 89%). [α]D
20: +41.1 (c = 1, CHCl3). 
1H NMR 
(400 MHz, CDCl3): δ = 6.11 (s, 1H), 4.44 – 4.32 (m, 4H), 4.00 – 3.97 (m, 1H), 3.95 (dd, J = 10.7, 7.2 Hz, 
1H), 3.81 (dd, J = 11.6, 4.3 Hz, 1H), 3.13 (bs, 1H), 0.88 (s, 9H), 0.85 (s, 9H), 0.81 (s, 9H), 0.19 (s, 3H), 
0.14 (s, 3H), 0.08 (s, 3H), 0.06 (s, 3H), 0.04 (s, 3H), 0.02 (s, 3H), ppm; 13C NMR (101 MHz, CDCl3): δ = 
164.3, 163.5, 163.2, 99.5, 99.2, 83.5, 68.1, 63.4, 62.4, 61.1, 26.0, 25.8, 25.7, 18.4, 18.2, 18.0, -4.6, 
4.7, -4.8, -5.0, -5.1, -5.2 ppm; IR (film): ?̃? = 3413, 2953, 2926, 2857, 1724, 1697, 1587, 1472, 1432, 
1254, 1077 cm-1; HRMS (ESI): m/z calcd. for C28H54O7Si3Na
+: 609.30704; found: 609.30696. 
(2R,3S,4R)-3,4-Bis((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)oxy)methyl)-7-
(hydroxymethyl)-3,4-dihydro-2H,5H-pyrano[4,3-b]pyran-5-one (S25). Prepared analogously 
(198 mg, 89%). [α]D
20: +77.1 (c = 0.78, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 
6.09 (s, 1H), 4.60 (dd, J = 3.2, 1.3 Hz, 1H), 4.41 (dd, J = 6.7, 0.7 Hz, 2H), 4.41 – 
4.35 (m, 1H), 4.14 – 4.05 (m, 2H), 4.03 (dd, J = 5.8, 3.2 Hz, 1H), 2.06 (t, J = 6.7 Hz, 1H), 0.93 (s, 9H), 
0.89 (s, 9H), 0.87 (s, 9H), 0.18 (s, 3H), 0.144 (s, 3H), 0.136 (s, 3H), 0.13 (s, 3H), 0.04 (s, 3H), 0.03 (s, 3H) 
ppm; 13C NMR (101 MHz, CDCl3): δ = 163.6, 163.4, 101.3, 99.1, 82.4, 69.1, 63.3, 62.2, 61.3, 26.1 (9 
CH3), 18.54, 18.52, 18.48, -4.3, -4.8 (4 CH3), -4.9, -5.0, -5.1 ppm; IR (film): ?̃? = 3413, 2929, 2857, 1719, 
1654, 1580, 1471, 1423, 1361, 1286, 1252, 1178, 109, 1048, 1022, 1005 cm-1; HRMS (ESI): m/z calcd. 
for C28H54O7Si3Na
+: 609.30696; found: 609.30658. 
(2R,3R,4R)-3,4-Bis((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)oxy)methyl)-5-oxo-3,4-
dihydro-2H,5H-pyrano[4,3-b]pyran-7-carbaldehyde (S26). Dess-Martin periodinane (564 mg, 
1.33 mmol) was added in one portion to a solution of S24 (600 mg, 
1.02 mmol) in CH2Cl2 (5.1 mL) and the resulting mixture was stirred for 1.5 h. 
The reaction was quenched with sat aq. Na2S2O3 and the aqueous phase was 
extracted with tBuOMe. The combined extracts were washed with brine and dried over MgSO4. The 
drying agent was filtered off and the solvent was evaporated. Purification of the crude product by 
flash chromatography (SiO2, hexanes:EtOAc, 10:1) afforded the title compound (507 mg, 87%). [α]D
20: 
+68.5 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 9.52 (s, 1H), 6.71 (s, 1H), 4.47 – 4.41 (m, 1H), 4.40 
(t, J = 2.5 Hz, 1H), 4.02 (dd, J = 2.8, 1.5 Hz, 1H), 3.96 (dd, J = 11.8, 8.2 Hz, 1H), 3.82 (dd, J = 11.9, 4.3 
Hz, 1H), 0.89 (s, 9H), 0.86 (s, 9H), 0.82 (s, 9H), 0.22 (s, 3H), 0.17 (s, 3H), 0.10 (s, 3H), 0.08 (s, 3H), 0.04 
(s, 3H), 0.02 (s, 3H) ppm; 13C NMR (101 MHz, CDCl3): δ = 183.5, 161.8, 161.3, 153.4, 108.7, 106.6, 
84.0, 67.9 63.5, 62.2, 26.0, 25.8, 25.7, 18.5, 18.2, 18.0, -4.6, -4.7, -4.8, -4.9, -5.09, -5.12 ppm; IR (film): 
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?̃? = 2953, 2929, 2857, 1734, 1714, 1642, 1584, 1432, 1254, 1081 cm-1; HRMS (ESI): m/z calcd. for 
C28H53O7Si3Na
+: 607.29131; found: 607.29207. 
(2R,3S,4R)-3,4-Bis((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)oxy)methyl)-5-oxo-3,4-
dihydro-2H,5H-pyrano[4,3-b]pyran-7-carbaldehyde (S27). Prepared analogously (156 mg, 99%). 
[α]D
20: +171.2 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): 9.50 (s, 1H), 6.69 (s, 
1H), 4.62 (dd, J = 3.0, 1.3 Hz, 1H), 4.48 – 4.40 (m, 1H), 4.12 – 4.01 (m, 3H), 
0.92 (s, 9H), 0.87 (s, 9H), 0.84 (s, 9H), 0.17 (s, 3H), 0.13 (m, 6H), 0.12 (s, 3H), 0.02 (s, 3H), 0.01 (s, 3H) 
ppm; 13C NMR (101 MHz, CDCl3): δ = 183.1, 161.6, 161.0, 153.7, 108.6, 107.8, 82.8, 68.8, 63.3, 61.9, 
26.04 (6 CH3), 26.03, 18.48, 18.47, 18.43, -4.3, -4.8, -4.89, -4.93, -5.0, -5.2 ppm; IR (film): ?̃? = 2954, 
2930, 2886, 2857, 1731, 1641, 1578, 1425, 1254, 1095 cm-1; HRMS (ESI): m/z calcd. for 
C28H53O7Si3Na
+: 607.30937; found: 607.30917. 
(2R,3R,4R)-3,4-Bis((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)oxy)methyl)-7-((E)-2-
iodovinyl)-3,4-dihydro-2H,5H-pyrano[4,3-b]pyran-5-on (S28) and (2R,3R,4R)-3,4-Bis((tert-
butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)oxy)methyl)-7-vinyl-3,4-dihydro-2H,5H-pyrano-
[4,3-b]pyran-5-on (S29). A solution of S26 (540 mg, 0.92 mmol) and CHI3 (727 mg, 1.85 mmol) in 1,4-
dioxane (8.7 mL) was added dropwise to a suspension of CrCl2·1.7 THF 
(1.36 g, 5.54 mmol) in THF (8.7 mL) at 0 °C. The mixture was stirred for 2 h 
before the reaction was quenched with sat. aq. NH4Cl. The aqueous phase 
was extracted with tBuOMe, the combined organic extracts were washed 
with brine and dried over MgSO4. The drying agent was filtered off and the solution was 
concentrated. The residue was purified by flash chromatography (SiO2, hexane:EtOAc, 100:1) 
affording S28 (365 mg, 56%) and S29 (58 mg, 11%) as a yellow solid each. 
Analytical and spectral data of S28: [α]D
20: +53.1 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 7.46 (d, 
J = 14.4 Hz, 1H), 6.95 (d, J = 14.7 Hz, 1H), 5.82 (s, 1H), 4.41 – 4.31 (m, 2H), 4.00 – 3.91 (m, 2H), 3.79 
(dd, J = 11.9, 4.0 Hz, 1H), 0.88 (s, 9H), 0.85 (s, 9H), 0.81 (s, 9H), 0.20 (s, 3H), 0.15 (s, 3H), 0.08 (s, 3H), 
0.06 (s, 3H), 0.04 (s, 3H), 0.02 (s, 3H) ppm; 13C NMR (101 MHz, CDCl3): δ = 163.1, 162.7, 136.0, 101.3, 
101.1, 87.2, 83.6, 68.2, 63.5, 62.4, 26.0, 25.9, 25.7, 18.5, 18.2, 18.1, -4.6, -4.7, -4.8, -4.9, -5.08, -5.13 
ppm; IR (film): ?̃? = 2953, 2929, 2857, 1726, 1642, 1579, 1471, 1422, 1255, 1077 cm-1; HRMS (ESI): m/z 
calcd. for C29H53O6Si3INa
+: 731.20869; found: 731.20902. 
Analytical and spectral data of S29:[α]D
20: +32.2 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 7.26 (s, 
1H), 7.01 (s, 2H), 6.57 (s, 1H), 4.44 – 4.38 (m, 1H), 4.37 (t, J = 2.3 Hz, 1H), 4.03 – 3.95 (m, 2H), 3.81 
(dd, J = 11.9, 4.0 Hz, 1H), 0.89 (s, 9H), 0.86 (s, 9H), 0.83 (s, 9H), 0.22 (s, 3H), 0.18 (s, 3H), 0.10 (s, 3H), 
0.08 (s, 3H), 0.06 (s, 3H), 0.03 (s, 3H) ppm, 13C NMR (101 MHz, CDCl3): δ = 163.1, 162.4, 130.6, 103.3, 
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101.5, 84.9, 83.5, 68.2, 63.5, 62.4, 26.0, 25.9, 25.8, 18.5, 18.2, 18.1, -4.5, -4.6, -4.8, -4.96, -5.02, -5.1 
ppm, IR (film): ?̃? = 2954, 2929, 2857, 1722, 1639, 1579, 1423, 1255, 1076 cm-1, HRMS (ESI): m/z calcd. 
for C29H54O6Si3Na
+: 582.32282, found: 582.32315. 
(2R,3S,4R)-3,4-Bis((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)oxy)methyl)-7-((E)-2-
iodovinyl)-3,4-dihydro-2H,5H-pyrano[4,3-b]pyran-5-on (S30) Prepared analogously (105 mg, 55%). 
[α]D
20: +41.6 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 7.49 (d, J = 14.6 Hz, 
1H), 6.94 (d, J = 14.7 Hz, 1H), 5.82 (s, 1H), 4.59 (dd, J = 3.1, 1.1 Hz, 1H), 4.42 
– 4.34 (m, 1H), 4.11 – 3.99 (m, 3H), 0.93 (s, 9H), 0.89 (s, 9H), 0.86 (s, 9H), 
0.18 (s, 3H), 0.14 (s, 3H), 0.13 (s, 3H), 0.12 (s, 3H), 0.031 (s, 3H), 0.025 (s, 3H) ppm; 13C NMR 
(101 MHz, CDCl3): δ = 163.0, 162.4, 157.3, 135.8, 102.6, 101.2, 87.9, 82.4, 69.0, 63.3, 62.1, 26.11 (6 
CH3), 26.10, 18.6, 18.52, 18.48, -4.3, -4.8 (2 CH3), -4.9, -5.0, -5.1 ppm; IR (film): ?̃? = 2954, 2929, 2857, 
1723, 1639, 1573, 1471, 1412, 1361, 1285, 1254, 1094, 1050 cm-1; HRMS (ESI): m/z calcd. for 
C29H53O6Si3INa
+: 731.20869; found: 731.20915. 
(Z)-2-(Prop-1-yn-1-yl)hex-2-en-1-ol (S31). Ethyl-3,3,3-trifluoropyruvate (0.70 mL, 5.28 mmol) was 
added dropwise to a solution of 2-hexyn-1-ol (0.50 mL, 4.55 mmol) at room 
temperature and the resulting mixture was stirred for 30 min before it was cooled 
to ‒78 °C. Thexylborane (0.9 M in THF, 5.80 mL, 5.22 mmol)[8] was added dropwise, 
the mixture was stirred for 5 min at ‒78 °C before it was warmed to room temperature and stirred 
for 10 min. TMAO (531 mg, 4.78 mmol) was added in one portion and stirring was continued for 15 
min at room temperature before a degassed solution of KOH (11.40 mL, 34.20 mmol, 3 M in H2O) was 
introduced. After stirring for an additional 10 min, 1-iodo-1-propyne (3.78 g, 22.75 mmol)7 and 
Pd(dppf)Cl2 (371 mg, 0.46 mmol) were added and the mixture was stirred at 70 °C (bath 
temperature) for 1.5 h. The reaction was quenched with sat. aq. NH4Cl and the aqueous phase was 
extracted with tBuOMe. The combined extracts were washed with brine and dried over MgSO4. The 
drying agent was filtered off and the solvent was evaporated. Purification of the crude product by 
flash chromatography (SiO2, hexanes:EtOAc, 10:1) afforded the title compound (420 mg, 67%). 
1H 
NMR (400 MHz, CDCl3): δ = 5.88 (t, J = 7.7 Hz, 1H), 4.15 (d, J = 6.0 Hz, 1H), 2.09 (q, J = 7.5 Hz, 2H), 1.97 
(s, 3H), 1.71 (t, J = 6.2 Hz, 1H), 1.40 (hex, J = 7.4 Hz, 2H), 0.91 (t, J = 7.3 Hz, 3H) ppm; 13C NMR (101 
MHz, CDCl3): δ = 138.5, 123.2, 85.3, 79.2, 60.3, 30.2, 22.6, 13.9, 4.4 ppm; IR (film): ?̃? = 3380, 2959, 
2931, 2918, 2872, 1461, 1378, 1336, 1033, 998 cm-1; HRMS (ESI): m/z calcd. for C9H14ONa
+: 
161.09376, found: 161.09368. 
(Z)-2-((E)-2-(Dimethyl(phenyl)silyl)prop-1-en-1-yl)hex-2-en-1-ol (S32). 
PhMe2SiLi (1 M in THF, 45 mL, 45 mmol) was added dropwise to a suspension 
of CuCN (1.65 g, 18.42 mmol) in THF (15 mL) at ‒50 °C. The mixture was warmed to ‒10 °C and 
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stirred for 45 min. After cooling to ‒50 °C, water (0.95 mL, 52.73 mmol) was added, the mixture was 
warmed to ‒10 °C and stirring was continued for 45 min. After cooling to 50 °C, a solution of S31 
(1.07 g, 7.74 mmol) in THF (15 mL) was added dropwise, the mixture was warmed to 10 °C and 
stirred at this temperature for 2 h. The reaction was quenched with sat. aq. NH4Cl and the aqueous 
phase was extracted with tBuOMe. The combined extracts were washed with brine and dried over 
MgSO4. The drying agent was filtered off and the solvent was evaporated. Purification of the crude 
product by flash chromatography (SiO2, hexanes:EtOAc, 20:1 to 10:1) afforded the title compound 
(1.76 g, 83%). 1H NMR (400 MHz, CDCl3): δ = 7.54 – 7.49 (m, 2H), 7.37 – 7.33 (m, 3H), 6.27 (s, 1H), 
5.53 (t, J = 7.6 Hz, 1H), 4.23 (s, 2H), 2.18 (q, J = 7.4 Hz, 2H), 1.86 (d, J = 1.8 Hz, 3H), 1.44 (hex, J = 7.3 
Hz, 2H), 0.94 (t, J = 7.3 Hz, 3H), 0.38 (s, 6H) ppm; 13C NMR (101 MHz, CDCl3): δ = 139.4, 138.4, 137.9, 
136.4, 134.2, 134.1, 129.0, 127.9, 60.7, 30.1, 23.1, 16.8, 14.0, -3.3 ppm. IR (film): ?̃? = 3355, 2957, 
2872, 1591, 1427, 1377, 1247, 1110, 998, 949 cm-1; HRMS (ESI): m/z calcd. for C17H26OSiNa
+: 
297.16429, found: 297.16451. 
(Z)-2-((E)-2-(Dimethyl(phenyl)silyl)prop-1-en-1-yl)hex-2-enal (S33). Dess-Martin-periodinane 
(636 mg, 1.5 mmol) was added in one portion to a solution of S32 (275 mg, 
1.00 mmol) in CH2Cl2 (10 mL) at room temperature. The resulting mixture was 
stirred for 1.5 h before the reaction was quenched with sat. aq. Na2S2O3 and 
the aqueous phase was extracted with tBuOMe. The combined extracts were washed with brine and 
dried over MgSO4. The drying agent was filtered off and the solvent was evaporated. Purification of 
the crude product by flash chromatography (SiO2, hexanes:EtOAc, 20:1) afforded the title compound 
(226 mg, 83%). 1H NMR (400 MHz, CDCl3): δ = 10.13 (s, 1H), 7.55 – 7.51 (m, 2H), 7.37 – 7.33 (m, 3H), 
6.54 (dt, J = 4.2, 1.0 Hz, 1H), 6.48 – 6.44 (m, 1H), 2.69 – 2.60 (m, 2H), 1.75 (d, J = 1.8 Hz, 3H), 1.62 – 
1.52 (m, 2H), 1.00 (t, J = 7.3 Hz, 3H), 0.40 (s, 6H) ppm; 13C NMR (101 MHz, CDCl3): δ = 191.0, 151.7, 
140.4, 138.0, 137.1, 134.2, 133.6, 129.1, 127.9, 29.2, 23.0, 17.1, 13.9, -3.4 ppm; IR (film): ?̃? = 2959, 
2872, 1744, 1678, 1603, 1427, 1373, 1248, 1192, 1111 cm-1; HRMS (ESI): m/z calcd. for C17H24OSiNa
+: 
272.15937, found: 272.15964. 
2-(Trimethylsilyl)ethyl (Z)-2-((E)-2-(dimethyl(phenyl)silyl)prop-1-en-1-yl)hex-2-enoate (S34). 
NaH2PO4 (745 mg, 6.21 mmol) and H2O2 (35% in water, 1.10 mL, 11.32 mmol) 
were added to a solution of S33 (561 mg, 2.06 mmol) in tBuOH/water (1:1) 
(6.50 mL) at 0 °C. The mixture was stirred for 10 min, NaClO2 (895 mg, 
9.90 mmol) was added, and stirring was continued for 18 h at room temperature. The reaction was 
quenched with sat. aq. NH4Cl and the aqueous phase was extracted with hexane. The combined 
extracts were washed with brine and dried over MgSO4. The drying agent was filtered off and the 
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solvent was evaporated. The crude acid was dried in vacuum and used in the next step without 
further purification.  
DEAD (1.14 mL, 6.26 mmol) was added over 30 min to a solution of the crude acid, PPh3 (1.95 g, 
7.43 mmol) and 2-TMS-ethanol (0.81 mL, 5.65 mmol) in THF (10.30 mL) at 0 °C. After stirring for 2 h, 
the reaction was quenched with sat. aq. NH4Cl and the aqueous phase was extracted with tBuOMe. 
The combined extracts were washed with brine and dried over MgSO4. The drying agent was filtered 
off and the solvent was evaporated. Purification of the crude product by flash chromatography (SiO2, 
hexanes:EtOAc, 100:1) afforded the title compound (514 mg, 64%). 1H NMR (400 MHz, CDCl3): δ = 
7.57 – 7.47 (m, 2H), 7.39 – 7.30 (m, 3H), 6.35 (dd, J = 1.5, 1.0 Hz, 1H), 5.88 (td, J = 3.8, 0.8 Hz, 1H), 
4.30 – 4.19 (m, 2H), 2.38 (q, J = 7.4 Hz, 2H), 1.73 (d, J = 1.8 Hz, 3H), 1.53 – 1.41 (m, 2H), 1.07 – 1.00 
(m, 2H), 0.94 (t, J = 7.3 Hz, 3H), 0.37 (s, 6H), 0.05 (s, 9H) ppm; 13C NMR (101 MHz, CDCl3): δ = 168.7, 
143.2, 138.2, 137.6, 136.3, 134.2, 131.3, 129.1, 127.9, 62.9, 31.6, 22.7, 17.4, 16.4, 14.1, -1.4, -3.4 
ppm; IR (film): ?̃? = 2956, 2899, 1456, 1428, 1380, 1328, 1249, 1211, 1157, 1111 cm-1; HRMS (ESI): m/z 
calcd. for C22H36O2Si2Na
+: 411.21468, found: 411.21461. 
2-(Trimethylsilyl)ethyl (Z)-2-((E)-2-iodoprop-1-en-1-yl)hex-2-enoate (S35). NIS (165 mg, 0.73 mmol) 
was added in one portion to a solution of S34 (190 mg, 0.49 mmol) and 2,6-lutidine 
(86 µL, 0.74 mmol) in hexafluoroisopropanol (1.50 mL) at 0 °C. The mixture was 
stirred for 2 min before the reaction was quenched with sat. aq. Na2S2O3 and the 
aqueous phase was extracted with tBuOMe. The combined extracts were washed with brine and 
dried over MgSO4. The drying agent was filtered off and the solvent was evaporated. Purification of 
the crude product by flash chromatography (SiO2, hexanes:EtOAc, 100:1) afforded the title 
compound (156 mg, 84%). 1H NMR (400 MHz, CDCl3): δ = 6.85 – 6.78 (m, 1H), 5.94 (td, J = 3.8, 1.3 Hz, 
1H), 4.28 – 4.20 (m, 2H), 2.49 – 2.40 (m, 2H), 2.46 (d, J = 1.5 Hz, 3H), 1.53 – 1.41 (m, 2H), 1.07 – 1.00 
(m, 2H), 0.93 (t, J = 7.6 Hz, 3H), 0.05 (s, 9H) ppm. 13C NMR (101 MHz, CDCl3): δ = 166.6, 146.1, 138.4, 
130.0, 89.3, 63.1, 31.6, 29.1, 22.5, 17.4, 14.0, -1.3 ppm; IR (film): ?̃? = 2956, 1714, 1631, 1456, 1428, 
1379, 1248, 1218, 1157, 1069 cm-1; HRMS (ESI): m/z calcd. for C14H25O2SiINa
+: 403.05626, found: 
403.05608. 
Compound S36. This reaction was performed in the dark. Pd(CH3CN)2Cl2 (1.5 mg, 0.005 mmol) was 
added to a degassed (pump and freeze, 3 
cycles) solution of Ph3As (3.2 mg, 0.01 mmol) in 
DMF (0.05 mL) and the mixture was stirred for 5 
min. The resulting mixture was transferred to a degassed (pump and freeze, 3 cycles) solution of S34 
(40 mg, 0.105 mmol), tetraene 35 (55 mg, 0.105 mmol) and [Ph2PO2][NBu4] (146 mg, 0.32 mmol)
[11] in 
DMF (0.5 mL) and stirring was continued for 20 h at room temperature. Degassed K3PO4 (3 M in 
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water, 0.05 mL, 0.15 mmol) was then added, followed by a solution of pyrone S28 (68 mg, 
0.095 mmol) in THF (0.5 mL) and Pd(dppf)Cl2 (7.7 mg, 0.01 mmol). The resulting mixture was stirred 
for 16 h, the reaction was quenched with water and the aqueous phase was extracted with Et2O. The 
combined extracts were washed with brine and dried over MgSO4. The drying agent was filtered off 
and the solvent was evaporated (below 20°C). Purification of the crude product by flash 
chromatography (SiO2, hexanes + 2.5% NEt3) afforded the title compound (48 mg, 54%). [α]D
20: +47.0 
(c = 0.1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 7.17 (dd, J = 15.0, 11.5 Hz, 1H), 6.52 (dd, J = 14.9, 10.6 
Hz, 1H), 6.47 – 6.27 (m, 7H), 6.15 (s, 1H), 6.03 (d, J = 15.9 Hz, 1H), 5.92 (t, J = 7.6 Hz, 1H), 5.82 s, 1H), 
4.42 – 4.33 (m, 2H), 4.29 – 4.22 (m, 2H), 4.01 – 3.92 (m, 2H), 3.81 (dd, J = 11.7, 4.2 Hz, 1H), 2.41 (q, J = 
7.5 Hz, 2H), 1.83 (s, 3H), 1.48 (q, J = 7.4 Hz, 2H), 1.09 – 1.00 (m, 2H), 0.94 (t, J = 7.3 Hz, 3H), 0.89 (s, 
9H), 0.86 (s, 9H), 0.82 (s, 9H), 0.22 (s, 3H), 0.17 (s, 3H), 0.09 (s, 3H), 0.07 (s, 3H), 0.06 – 0.03 (m, 12H), 
0.02 (s, 3H) ppm; 13C NMR (101 MHz, CDCl3): δ = 168.3, 163.7, 163.2, 158.4, 143.8, 139.3, 138.7, 
136.5, 135.9, 135.64, 135.55, 132.7, 132.3, 131.3, 131.2, 130.4, 128.8, 121.8, 101.0, 100.0, 83.4, 68.4, 
63.6, 63.0, 62.5, 31.9, 26.0, 25.9, 25.8, 22.7, 18.5, 18.2, 18.1, 17.5, 14.0, 13.8, -1.4, -4.55, -4.63, -4.8, -
4.9, -5.07, -5.14 ppm; IR (film): ?̃? = 2954, 2929, 2857, 1715, 1635, 1568, 1543, 1426, 1252, 1217, 
1075, 1005 cm-1; HRMS (ESI): m/z calcd. for C51H86O8Si4Na
+: 731.20869, found: 731.20902. 
Compound S37. Prepared analogously as a red oil (18 mg, 56%). [α]D
20: +88 (c = 0.1, CHCl3); 
1H NMR 
(400 MHz, CDCl3): δ = 7.18 (dd, J = 15.0, 11.4 
Hz, 1H), 6.54 (dd, J = 14.5, 10.7 Hz, 1H), 6.50 
– 6.27 (m, 7H); 6.13 (s, 1H), 6.02 (d, J = 15.1 
Hz, 1H), 5.83 (s, 1H), 5.66 (dd, J = 10.3, 0.8 
Hz, 1H); 4.62 (dd, J = 3.1, 1.2 Hz, 1H), 4.39 – 4.33 (m, 1H), 4.29 – 4.22 (m, 2H), 4.14 – 4.05 (m, 2H), 
4.03 (dd, J = 5.6, 3.2 Hz, 1H), 3.08 – 2.95 (m, 1H), 1.83 (d, J = 0.9 Hz, 3H), 1.39 – 1.25 (m, 3H), 1.13 – 
1.03 (m, 4H), 1.01 (d, J = 6.6 Hz, 3H), 0.93 (s, 9H), 0.89 (s, 9H), 0.88 (s, 9H), 0.85 (d, J = 6.2 Hz, 3H), 
0.84 (t, J = 6.6 Hz, 3H), 0.19 (s, 3H), 0.16 (s, 3H), 0.13 (s, 3H), 0.12 (s, 3H), 0.05 (s, 9H), 0.04 (s, 3H), 
0.03 (s, 3H) ppm; 13C NMR (101 MHz, CDCl3): δ = 168.4, 163.5, 163.1, 158.9, 149.8, 139.5, 139.1, 
136.8, 136.3, 135.9, 135.5, 132.7, 132.3, 131.0 ,130.6, 129.6, 128.7, 121.5, 101.5, 100.8, 82.2, 69.1, 
63.4, 63.1, 62.3, 44.5, 32.2, 31.8, 29.3, 26.2, 26.1 (6 CH3), 20.7, 19.6, 18.57, 18.55, 18.5, 17.6, 13.7, 
11.3, -1.4, -4.2, -4.7, -4.8, -4.9, -5.0, -5.1 ppm; IR (film): ?̃? = 2956, 2928, 2857, 1721, 1633, 1543, 1462, 
1416, 1379, 1361, 1251, 1205, 1166, 1123, 1070, 1050, 1005 cm-1; HRMS (ESI): m/z calcd. for 
C55H94O8Si4Na




Compound 39. This reaction was performed in the dark. A solution of TASF (62 mg, 0.225 mmol) in 
DMF (0.3 mL) was added to a solution of S37 (30 mg, 
0.031 mmol) in DMF (0.3 mL) at 0 °C. The resulting 
mixture was stirred for 30 min at 0 °C and for 18 h at 
room temperature before the reaction was quenched with aq. HCl. The aqueous phase (pH = 3) was 
extracted with EtOAc, the combined extracts were dried over MgSO4, the drying agent was filtered 
off and the solvent was evaporated (below 20 °C). Purification of the crude product by HPLC (column: 
150 mm YMC Actus, Ø = 20 mm; stationary phase: YMC ODS-A, 5 μm, 20150 00456; eluent: methanol 
/ TFA in water pH 3.5 = 75:25) afforded the title compound (8.6 mg, 54%). [α]D
20: +10.2 (c = 0.5, 
DMSO); 1H NMR (600 MHz, [D6]-DMSO): δ = 12.72 (bs, 1H), 7.04 (dd, J = 15.2, 11.4 Hz, 1H), 6.72 (dd, J 
= 14.6, 11.2 Hz, 1H), 6.57 – 6.38 (m, 7H), 6.33 (d, J = 15.2 Hz, 1H), 6.21 (s, 1H), 6.15 (s, 1H), 5.88 (t, J = 
7.8 Hz, 1H), 5.41 (d, J = 4.8 Hz, 1H), 5.32 (d, J = 3.8 Hz, 1H), 4.95 (t, J = 5.5 Hz, 1H), 4.29 (m, 1H), 4.23 
(m, 1H), 3.88 – 3.80 (m, 1H), 3.75 – 3.68 (m, 1H), 3.66 – 3.58 (m, 1H), 2.30 (dt, J = 7.8, 7.3 Hz, 2H), 
1.81 (s, 3H), 1.42 (h, J = 7.3 Hz, 2H), 0.89 (t, J = 7.3 Hz, 3H) ppm; 13C NMR (151 MHz, [D6]-DMSO): δ = 
169.3, 163.2, 162.5, 157.6, 140.7, 138.9, 138.6, 136.3, 135.4, 134.62, 134.56, 132.9, 132.6, 132.5, 
131.4, 130.4, 128.8, 122.1, 101.0, 100.2, 82.4, 67.0, 61.9, 60.2, 31.2, 22.1, 13.7, 13.2 ppm; IR (film): 
?̃? = 3450, 2995, 2912, 1662, 1436, 1407, 1310, 1042, 1026, 952 cm-1; HRMS (EI): m/z calcd. for 
C28H31O8
-: 495.20245, found: 495.20314. 
Compound 40. Prepared analogously from (R,S)-29 and S30 as a red solid (5 mg, 50%). [α]D
20: ‒32 (c = 
0.05, DMSO); 1H NMR (600 MHz, [D6]-DMSO): δ 
= 12.76 (bs, 1H), 7.04 (dd, J = 15.2, 11.4 Hz, 1H), 
6.73 (dd, J = 14.5, 11.4 Hz, 1H), 6.53 (dd, J = 
14.3, 10.5 Hz, 1H), 6.50 – 6.40 (m, 6H), 6.32 (d, J 
= 15.2 Hz, 1H), 6.20 (s, 1H), 6.13 (s, 1H), 5.64 (d, J = 10.3 Hz, 1H), 5.20 (bs, 1H), 5.10 (bd, J = 4.7 Hz, 
1H), 4.96 (m, 1H), 4.50 (m, 1H), 4.22 (dt, J = 6.4, 3.8 Hz, 1H), 3.93 (dd, J = 5.8, 3.0 Hz, 1H), 3.78 – 3.67 
(m, 2H), 2.88 (ddqd, J = 10.3, 7.7, 6.6, 6.4 Hz1H), 1.81 (s, 1H), 1.36 – 1.28 (m, 2H), 1.25 (dt, J = 13.3, 
6.4 Hz, 1H), 1.13 (ddd, J = 13.3, 7.7, 6.1 Hz, 1H), 1.09 – 1.02 (m, 1H), 0.95 (d, J = 6.6 Hz, 3H), 0.811 (d, J 
= 6.7 Hz, 3H), 0.806 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (151 MHz, [D6]-DMSO): δ = 169.4, 164.2, 162.1, 
157.7, 146.7, 139.0, 138.7, 136.4, 135.5, 134.8, 134.6, 132.9, 132.6, 131.3, 130.8, 130.4, 128.8, 122.0, 
101.0, 100.7, 80.1, 64.7, 61.6, 59.3, 43.8, 31.6, 31.3, 28.5, 20.6, 19.4, 13.2, 11.0 ppm; IR (film): ?̃? = 
3396, 2940, 2913, 2822, 2253, 2126, 1662, 1446, 1411, 1050, 1023, 1003 cm-1; HRMS (ESI): m/z calcd. 
for C32H39O8











































































































































































































































Spectra comparison of isolated and synthetic compounds 
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